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Abstract 
This thesis is composed of two parts: Part I is focused on studying how 
quantum dot (QD) surface small-molecule capping ligands affect its Förster 
resonance energy transfer (FRET) with a fluorescent protein (FP); Part II is 
focused on developing an ultrasensitve DNA sensing technology by 
combining magnetic nanoparticle (MNP) and enzymatic signal amplification. 
 
Part I 
The FRET between a CdSe/ZnS core/shell QD capped with three different 
small-molecule ligands and a hexa-histidine (His6)-tagged FP (mCherry) has 
been studied. Results show that small-molecule ligands strongly affect the 
FRET behaviours between QD and FP. The QD-FP self-assembly process is 
fast (complete in minutes at low nM concentration), strong (with Kd ~ 1 nM), 
suggesting that the QD-His6-tagged biomolecule self-assembly is an 
effective approach for making compact QD-bioconjugates which may have a 
wide range of sensing and biomedical applications. 
 
PART II 
I have developed a facile, rapid, and sensitive DNA sensor by combining the 
efficient MNP-based target capture with the highly efficient signal 
amplification power of enzymes to achieve ultra-sensitivity. This sensor 
works efficiently in both pure buffer and complex media (such as 10% 
human serum in buffer). Moreover, this developed approach is able to 
quantitate two distinct DNA strands in a homogenous phase at the same 
time with a detection limit of ~5 pM.  
 
Second, I have developed a novel, highly sensitive and selective approach 
for label-free DNA detection and single-nucleotide polymorphism (SNP) 
discrimination by combining target-recycled ligation (TRL), MNP assisted 
target capture/ separation, and efficient enzymatic amplification. This 
- vii - 
approach possesses a detection limit of 600 fM unlabelled DNA targets and 
offers exquisitely high discrimination ratio (up to > 380 fold) between a 
perfect-match mutant and its single-base mismatch DNA target. Furthermore, 
it can quantitate the rare cancer mutant in large excesses of coexisting wild-
type DNA down to 0.75%.  
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Chapter 1 
Quantum dot (QD) based fluorescent techniques for biological 
applications 
 
The investigation of many fundamental biological processes and disease 
diagnostics largely relies on the ability to detect biomolecule interactions and 
quantify small amount of disease biomarkers by some ultra-fast, sensitive, 
reliable and reproducible techniques. In this regard, fluorescence based 
techniques are well-suited to meet such requirements and challenges. 
Fluorescence analysis techniques encompass several unique experimental 
parameters such as excitation/emission wavelength, intensity, fluorescence 
lifetime and anisotropy).1 Among which, Förster resonance energy transfer 
(FRET) is one of the most powerful techniques for biomolecule structure 
analysis2, enzymatic activity assays3-4, and biosensors5-6. 
 
Particularly, FRET analysis at single molecule (SM) level is leading a revolution 
in the real-time visualization and ultra-sensitive detection of biomarkers by 
providing previously unobtainable information on fundamental molecular 
processes. 2, 7-8 A unique advantage for SM fluorescence analysis is that it has 
the capabilities of detecting static conformational heterogeneity and dynamic 
conformational changes of single biological molecules that are not detectable at 
the bulk level both in solution and immobilized to surfaces.9-11 In addition, SM 
fluorescence analysis also offers the possibility for ultrasensitive detection of 
low abundant species because it can probe single-fluorophore-labelled 
biomolecules in solution under biological conditions. In addition to FRET, two-
colour coincidence detection (TCCD) is another favourite SM fluorescent 
approach which relies on coincidence event counting.12-13 
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In this chapter, the intrinsic properties of QD in comparison with organic dyes 
and/or fluorescent proteins (FPs) will be discussed first. Then several 
representative strategies for the preparation, modification and bioconjugation of 
QD will be introduced. Following on that, the principle and applications of FRET 
based on QDs will be illustrated. Then after discussion of the TCCD approach, 
an overview of the first part of my project will be discussed. 
 
1.1 Distinct properties of QDs as fluorophores 
 
In fluorescence spectroscopy, a fluorescent label, i.e. fluorophore, is of critical 
importance for fluorescence imaging or sensing applications. Fluorophore 
properties (such as size, stability, chemical and optical nature, and 
biocompatibility) could affect their detection limit and dynamic range, the 
reliability of the result for a particular target or event, and the suitability for 
parallel detection of different targets.1 
 
When a fluorophore is attached to a biological molecule, it can send back a 
report about its host molecule in a stream of photons when excited. An ideal 
fluorophore should: (a) be easy to excite and detect with conventional 
instrumentation; (b) soluble in relevant buffers; (c) posses high fluorescence 
quantum yield (QY); (d) show steady emission and be reproducible; (e) be 
stable and not perturb the properties and conformation of the host molecule; (f) 
and maintain photo-activity over a sufficiently long time under relevant 
conditions.1, 14  
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The optical properties of organic dyes/ FP (Figure 1.1A) are determined by the 
inherent electronic transition(s) involved. Thus their optical properties are 
tunable via careful structural design, which can be done, but in practice this is 
often limited by synthetic capabilities and therefore difficult to achieve.15 
Generally speaking, conventional fluorophores (for instance, organic dyes, FPs, 
and fluorescent polymers) tend to have narrow excitation bands and broad 
emission spectra. Moreover, many conventional fluorophores have relatively 
low QYs. In addition, they can be sensitive to environmental changes, such as 
pH, temperature and local environmental hydrophobicity, and often liable to 
chemical and photo-degradations. 16 
 
QDs are fluorescent semiconductor nanocrystals with a size of ~ 1-10 nm. QDs 
have a number of unique attractive electronic and optical properties which 
deviate substantially and cannot be extrapolated from those of the bulk 
materials. These unique electronic and optical properties are determined not 
only by the constituent materials, but also particle size, and size distribution 
(dispersity), and surface chemistry and coating.17  
 
Compared to organic dyes or FPs, QDs have several unique advantageous 
properties which make them well-suited for analytical and imaging 
applications.18 By varying the nanocrystal size and composition, QDs’ emission 
can cover a wide range of wavelengths, from the near UV to the near IR regions 
of the optical spectrum.18-20 Besides, the emission spectrum of QDs is typically 
narrow and symmetric (see Figure 1.1B). Furthermore, QDs possess a broad 
absorption (excitation) which allows the simultaneous and efficient excitation of 
different coloured QDs with a single wavelength light source far from their 
respective emissions; this makes QDs excellently suited for multiplexing 
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applications. QDs are also extremely photostable and are hundreds of times 
more resistant to photobleaching than conventional organic fluorophores, 
making them extremely useful in long term bio-imaging, cell-tracking and 
trafficking applications. Additionally, QDs have a comparatively long 
fluorescence lifetime (typically 5 to 100 nanoseconds) which enables significant 
and selective reduction of the fluorescence background from cellular auto-
fluorescence by using time-gated excitation measurement, thereby enhancing 
the sensitivity.21 
 
QDs are considerably larger than organic dye molecules which can make them 
inefficient for FRET based applications (to be discussed in the section 1.3), 
especially at low target: QD copy number situations, because of the resulting 
large donor-acceptor distance. Their hydrodynamic radius (5 - 50 nm) could be 
affected by surface ligands which is dependent on a combination of factors, 
such as the inorganic core (or core-shell) dimension, shape, and the type of 
hydrophilic surface capping.24 In comparison to organic dyes, the large surface 
area of QD can offer multiple binding sites so that several biomolecules could 
be simultaneously immobilized onto a single QD to increase the target: QD copy 
numbers (n) and improve the FRET efficiency for a single-donor-multiple 
acceptor FRET system. This offers significant advantages for applications 
where high FRET efficiency is required.23  
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Figure 1.1 Comparison of absorption and emission spectra for different 
fluorophores and photo for different sized QDs.  
Absorption (ABS) and Emission (EM) spectra for organic dyes (A, 
rhodamine red), genetically encoded FP (A, DsRed2)22 and QDs (B, six 
different QD dispersions). C, Photo demonstrating the size-tunable 
fluorescence properties and emission spectral peak of the six QD 
dispersions plotted in B versus CdSe core size. All samples were excited 
at 365 nm with a UV source. (Reprinted by permission of the Nature 
Publishing Group)23 
 
- 7 - 
 
1.2 Preparation, modification and bioconjugation of QD 
 
The synthesis of monodisperse QDs, such as CdSe, CdS, or CdTe, can be 
achieved by high-temperature (~300 °C) thermal decomposition means.25 
Generally, uniform nanocrystals are obtained by rapidly injecting organometallic 
reagents into a hot coordinating solvent to generate homogeneous nucleation 
followed by the slow growth and annealing.25 This approach requires inert 
atmosphere and appropriate organic solvents. By adjusting the concentration of 
precursors and reaction time, different sized nanocrystals could be obtained.25-
26 Furthermore, in order to achieve higher QY and improve resistance against 
chemical-/ photo- oxidation, the synthesized core-only QDs are usually coated 
with an inorganic shell surrounding it.27 For instance, ZnS, a high band-gap 
semiconductor material, was used to coat a CdSe QD core and the QY 
increased up to 80%.28-29 The high temperature synthetic route is capable of 
producing highly crystalline and uniformly sized QD with narrow size distribution. 
And this approach allows the facile core/shell growth control, which is 
significantly important for improvement of QY.  
 
Nevertheless, the semiconductor nanocrystals synthesized as above are coated 
with hydrophobic surface layer and only soluble in non-polar solvents, which 
severely hamper their biorelated applications which require working in aqueous 
media. In this regard, the aqueous synthetic approaches have attracted 
researchers’ attentions widely. The aqueous synthetic method not only uses the 
biocompatible solvent (water), but also offers versatile functionalization 
possibilities during the synthetic process. Usually in the aqueous strategy, metal 
ions or their complexes react with chalcogen containing precursors forming 
nuclei, which then grow to nanocrystals in the presence of appropriate capping 
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ligands. This method has been employed to yield stable nanocrystals such as 
CdS30, CdTe31, CdSe32, ZnSe33, ZnCdSe33, etc.34 Moreover, although a little bit 
difficult, core/shell QDs could also be yielded by this means.35-36 The QDs 
prepared by this low temperature aqueous route are readily water soluble and 
so no post synthesis modifications are needed. However, the quality of the QDs 
is poorer than those prepared by the high temperature method.27, 34 Thus in 
order to obtain mono-disperse QDs with improved stability and higher QY, the 
most often used synthetic method is the high temperature approach. 
 
Consequently, to facilitate the bio-applications of hydrophobic QDs, post 
synthesis modifications are critical to render them water-soluble and 
biocompatible. The hydrophobic ligands of QDs could be exchanged by excess 
bifunctional molecules such as mercaptocarbonic acid37 and bidentate 
dihydrolipoic acid derivatives38. These ligand exchange methods are easy to 
conduct and the yielded QDs are small-sized, which is important for efficient 
FRET. Nevertheless, the QDs subjected to ligand exchange procedures suffer a 
decreased fluorescent QY and lack long term stability. Silane shells39-40 and box 
dendrimers41 around QDs can also be achieved through metal-thiol bonds. In 
addition, the hydrophobic QDs can be coated with amphiphilic polymers such as 
poly(acrylic acid)-octadecyl- amine polymers42-43 or amphiphilic saccharides44, 
or can be encapsulated within PEGylated lipid micelles42. These coating 
methods make highly stable and biocompatible QDs while maintaining their high 
QY. Unfortunately, the QDs modified by these macromolecules are not 
preferred for bioapplications because of their big hydrodynamic sizes, which 
lead to poor FRET efficiency and low permeability into cells. Several 
representative surface capping approaches to make hydrophobic QDs 
hydrophilic are listed in Table 1.1. 
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Monothiolated caps Dative thiol bond 
Mercaptocarbonic acids37 
Alkylthiol terminated DNA48 
Thioalkylated oligo-
ethyleneglycols56 
Bidentate thiols Two interactions/ligand 
Dihydrolipoic acid 
derivatives38, 57 
Silane shell or Box 
dendrimer Cross-linked shell 
Mercaptopropyl silanols39-40 
Amine box dendrimers41 
Amphiphilic polymer Hydrophobic interactions 
Phospholipid micelles42 







To explore the bio-applications of QDs in live cells or tissue imaging, drug 
delivery, and biosensing and so on, QDs need to be conjugated to bioactive 
molecules (such as oligonucleotides, peptides, proteins or drugs) without 
hampering the biological functions of these molecules. Several strategies have 
been employed to conjugate biological molecules to QDs, including adsorption, 
electrostatic interaction, mercapto (-SH) exchange, metal affinity, and covalent 
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linkage.45 The adsorption method is simple but nonspecific.46-47 The 
electrostatic interactions are usually used to conjugate positively charged 
proteins to negatively charged surfaces of QDs. The QD-protein conjugates 
obtained by this method are stable and maintain high fluorescence yield.38 
Mercapto exchange can conjugate thiol group containing biomolecules directly 
to the QD surface. Nevertheless, the yielded conjugates are not quite stable 
due to the weak bond between Zn2+ ion and thiol group resulting in the easy 
detachment of the biomolecules.48-49  
 
Metal affinity coordination enables direct attachment of the peptides and 
proteins with polyhistidine groups onto QDs.50-53 This self-assembly interaction 
is very strong with a dissociation constant (Kd) of nanomolar level.52-53 Thus this 
metal affinity induced self-assembly strategy can be utilized as an effective way 
for preparing functional QD-bioconjugates. Nevertheless, the tricky issue of this 
approach is that polyhistidine group needs to be introduced to the biomolecules 
first prior to their conjugation with QDs. 
 
In addition, the covalent linkage method is a more reliable way to make stable 
QD-biomolecule complexes. QDs subjected to versatile surface chemistries 
(see Table 1.1) can bear various functional groups such as –OH, -COOH, -SH, 
or -NH2. If the biomolecules to be conjugated with QDs also possess these 
functional groups, it is easy to covalently link QDs and biomolecules through 
chemical reactions.6, 39-41, 54-55 
 
1.3 Förster resonance energy transfer (FRET) 
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1.3.1 FRET principle 
 
FRET is a process that involves non-radiative energy transfer from a photo-
excited donor to an acceptor in close proximity (i.e. typically < 10 nm). 
Absorbing a photon excites the donor, which can then transfer the excitation 
energy to the acceptor, and the acceptor subsequently relaxes to its ground 
state by emitting a lower energy photon (Figure 1.2).  
 
 
Figure 1.2 Schematic diagram of the FRET interaction between a donor 
fluorophore and an acceptor fluorophore.  
The donor and acceptor are brought into close proximity by a linker (black 
line). Upon photo-excitation of the donor, energy is transferred to the 
acceptor non-radiatively, leading to donor sensitized acceptor emission. 
 
This process is strongly dependent on the separation distance between donor 
and acceptor. It also requires finite spectral overlap between donor emission 
and acceptor absorption profiles.59 Elaborate selection of an appropriate donor-
acceptor pair could lead to improved FRET efficiency.  
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The FRET efficiency, E, represents the fraction of photon energy that is 
transferred from the donor to the acceptor non-radiatively. In a typical single-
donor-single-acceptor FRET system, E is defined as:  
E=R0
6/(R0
6 + r6)     (1.1)  
Where r is the donor-acceptor distance and R0 is the Förster radius of the FRET 
pair under which E = 50% FRET. 
 
If enhancement of the energy transfer is required, multiple acceptors may be 
brought close to the same donor so that one donor can transfer energy to 
several acceptors. In this regard, the above analysis can be modified to account 
for these complicated energy transfers, and the increased efficiency can be 
expressed as:  
E = n×R0
6/(n×R0
6 + r6)    (1.2)  
In this expression, n is the average number of acceptor molecules interacting 
with one donor. From the equation, it is easy to figure out that the presence of 
several acceptor fluorophores should increase the FRET efficiency. Such 
efficiency enhancement may be attributed to an effective proportional 
enhancement of the energy transfer cross section (the overlap integral) 
between a donor and several acceptors around its centre. 
 
The FRET between two different coloured QDs,60 QD and dye-labelled 
biomolecule,61-62 QD and gold nanoparticle,63 and QD and dye-labelled 
polymers64 have been reported. Figure 1.3 depicts the spectral overlap profiles 
for some QD→organic dye, organic dye→QD, and QD→QD photo energy 
transfer pairs.65 
  
Figure 1.3 Spectral overlap profiles for three possible FRET scenarios with QD
a) a QD donor and an organic fluorophore acceptor; 
fluorophore as donor and a QD as acceptor; 
and the other coloured QD as acceptor. In 
are shown as potential donors. Absorption spectra are shown as solid lines; 
luminescence spectra are shown as broken lines. Thick lines represent the 
donor and thin lines represent the acceptor. 
the Springer)65
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c) one coloured QD as donor 
b), two fluorophores, (I and ii), 




b) an organic 
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As shown in Figure 1.3, it is possible to excite the QD donor without directly 
exciting the acceptor dye fluorophore (a). However, in both b) and c), it is 
impossible to only excite the donor without directly exciting the acceptor QD, 
and hence there will always be strong background emission. Therefore, 
although all three combinations shown above can produce efficient FRET, only 
the FRET between a QD donor and organic dye acceptor is most suitable for 
ultra-sensitive detection. In other words, a QD is naturally not a good acceptor 
because of its broad absorption spectral profile which will always lead to direct 
acceptor excitation even in the absence of FRET. 
 
1.3.2 Nucleic acid sensing  
 
FRET in SM level has been applied to detect DNA targets by the Wang group. 
Sandwiched hybrids labelled with organic dyes are conjugated onto the QD 
surface via streptavidin-biotin interaction (Figure 1.4).7 
 
This DNA nanosensor consists of two target-specific oligonucleotide probes, 
which are designed to possess complementary sequences to two different 
segments of a target DNA. These two probes are a ‘reporter probe’ labelled with 
an organic dye acceptor and a ‘capture probe’ labelled with biotin respectively. 
In addition, a QD conjugated with several streptavidins is the central part of the 
nanosensor (Figure 1.4a). Target DNA strands present in the solution could be 
sandwiched by a pair of reporter-capture probes and several sandwich 
structures could then be captured by a single QD through the biotin–streptavidin 
interaction. Thus, multiple acceptor dyes are brought into close proximity to the 
QD donor and the FRET efficiency is enhanced. In this design, the QD functions 
as both a FRET energy donor and a target concentrator (Figure 1.4b). The 
 solution was then injected into a glass microcapillary and flowed through a small 
excitation spot. The fluorescence signals from individual bioconjugates could be 
monitored as they traverse the laser confocal volume (Figure 1.4c). 
 
Figure 1.4 Schematic of single
a, Conceptual scheme showing the formation of a nanosensor assembly in 
the presence of targets. 
illumination on QD caused by FRET between Cy5 acceptors and a QD 
donor in a nanosensor assembly. 
permission of the Nature Publishing Group)
 
This assay format requires no separation of the sample, as the unhybridized 
probes do not participate in FRET and are non
provides much higher sensitivity 
dual roles of the central QDs. It should be noted however, this design only 
works well in situations of multiple target:QD copy number (
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-QD-based DNA nanosensors. 
b, Fluorescence emission from Cy5 on 
c, Experimental setup.
7 
-fluorescent. This system 




 (Reprinted by 
e.g. n > 20), it is 
 inefficient at the low target:QD ratios (
efficiency obtainable due to the large donor
 
Figure 1.5 Schematic 




Besides biotin-streptavidin interactions, functional thiols have also been 
demonstrated to be a very useful QD coating and/or linkers between the QD 
donors and dye acceptors, 
ligands. In this regard, a thiolate linker has been used to directly couple a dye
labelled double-stranded DNA (ds
(MPA) capped QD donor.
producing high FRET, however the strong nonspecific adsorption of the DNA on 
the MPA-capped QD has prevented it from being useful for specific DNA 
sensing application. To overcome the problem of nonspecific adsorption, our 
group has developed another compact, functional QD
Figure 1.5) where a tri(ethylene glycol) linker, EG
- 16 - 
e.g. 1:1) because of the small FRET 
-acceptor distance.
principle of the approach for label-free DNA 
a covalently coupled QD
d FRET signal. (Reprinted by permission of the American 
6 
because QDs have a high affinity for thiolated 
DNA) acceptor to a 3-mercaptopropionic acid 
66 Although the above design was very efficient in 
-DNA conjugate (see 
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ability to resist non-specific adsorption, has been introduced in between the QD 
and the functional DNA in this configuration.6  
 
The advantages of introducing the EG3 linker are: (1) it can eliminate the strong, 
nonspecific adsorption of DNA onto the QD surface, and (2) it allows control of 
the separation distance between the QD donor and dye acceptor within the 
range of the Förster radius by tuning the number of the repeat units. Moreover, 
this study provides a model system for both label and label-free detection of 
nanomolar complimentary DNA at low DNA probe/QD copy numbers. 
 
 
Figure 1.6 Schematic illustration of multiplexed DNA detection.  
DNA hybridization brought the FRET donor-acceptor pairs (QD donors and 
dye accepters) together. Thus by examining the FRET behaviors of the 
donor-accepter pairs, quantifications of DNA were realized 
correspondingly. (Reprinted by permission of the American Chemical 
Society)5 
 
- 18 - 
 
More recently, multiplex DNA detection has been performed by employing 
different coloured QDs donors based FRET.5 In this developed system, two 
different coloured QDs (green- and red- emitting) were capped with thioalkyl 
acid ligands and immobilized on the polystyrene microwells using multidentate 
imidazole linkers. As presented in Figure 1.6, QDs are modified with two 
different capture-DNA strands (c1 and c2) which are complementary with two 
different DNA targets (T1 and T2), respectively. In the presence of Cy3-labelled 
T1, FRET between green-emitting QD and Cy3 accepter happens upon DNA 
hybridization. Likewise, hybridization of Alexa Fluor 647-labelled T2 and C2 
would induce FRET process between Alexa Fluor 647 and the red- emitting 
QDs. Consequently, DNA quantifications have been effectively achieved via the 
FRET efficiency analysis. This assay demonstrates excellent resistance to the 
nonspecific adsorption of DNA, associated with the detection limit of 4 nM. 
Furthermore, this strategy is able to discriminate the single base-pair 
mismatched sequences with a discrimination ratio >2.  
 
1.3.3 FRET between QD and dye-labelled protein or FP  
 
The Mattoussi group has investigated the FRET between fluorescent QD donor 
and dye-labelled protein (see Figure 1.7).50 In this research, the maltose binding 
protein (MBP) is engineered appended with a polyhistidine tag and labelled with 
a dye (Cy3). The dye-labelled MBP self assembled on to the QD via metal 
affinity interaction between Zn2+ ions and the polyhistidine tag. Thus the QD 
donor and dye acceptor are in close proximity providing a good model system to 
explore FRET phenomena. By carefully choosing donor-acceptor pairs (different 
QD donors with the same Cy3 acceptor), this designed QD-MBP configuration 
offers the possibility for adjustment of the degree of spectral overlap between 
- 19 - 
 
donor and acceptor. Moreover, more than one acceptor could be 
accommodated around one single QD donor via self-assembly. In other words, 
FRET efficiency can be delicately controlled either by tuning the emission peak 
of QDs or by adjusting the copy number of dye-labelled proteins around the QD 
donor. 
 
Figure 1.7 Schematic representation of the QD-MBP-dye nanoassembly (not 
drawn to scale).  
The total number of proteins immobilized on each QD surface is ~15. The 
distance r represents the radius or average distance between the QD 
centre and location of the Cy3-labeled residue on MBP. (Reprinted by 
permission of the American Chemical Society)50 
 
On the basis of the above designed QD–protein assemblies, a competitive 
sensing format has been developed by the same group.67 As demonstrated in 
Figure 1.8A, MBP self assembles onto QD and functions as a sugar receptor 
and each QD-MBPs conjugate is bound with a β-cyclodextrin-QSY9 dark 
quencher in the MBP saccharide binding site to quench QD photo- 
luminescence via FRET. Upon addition of maltose, which can effectively 
substitute the β-cyclodextrin-QSY9 dark quencher, the QD photoluminescence 
recovers gradually. Thus the quantification of maltose is realized by monitoring 
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the QD emission increase. Another maltose sensor developed in this research 
consists of self assembled QD, Cy3-modified MBP and Cy3.5-labelled β-
cyclodextrin (Figure 1.8B).  
 
 
Figure 1.8 Schematic illustration of the QD-MBP nanosensor for maltose 
detection.  
Each QD is surrounded by multiple copies of MBP (~10) but only a single 
MBP is shown for clarity. (A) QD emission at 560 nm is quenched by 
QSY9 (maximum absorption ~565 nm) labelled β- cyclodextrin in the 
absence of maltose. As the maltose is added, and displaces the β- 
cyclodextrin-QSY9, the QD emission increases schematically. (B) 530 nm- 
emitting QD is self assembled with Cy3-labelled MBP and Cy3.5-labelled 
β- cyclodextrin. Upon excitation, two step FRET happens from QD to Cy3 
and from Cy3 to Cy3.5. Added maltose substitutes β- cyclodextrin-Cy3.5 
hampering the second FRET process. Thus by carefully examine the 
fluorescent signal change, the detection of maltose is realized. (Reprinted 
by permission of the Nature Publishing Group)67 
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In the absence of maltose, the complex undergoes two-step FRET 
(QD→Cy3→Cy3.5). Added maltose displaces the β-cyclodextrin-Cy3.5, 
resulting in the suspension of the second-step FRET in a systematic manner. 
This sensing protocol by employing two-step FRET overcomes the distance 
limitations between donor and acceptor and thus leads to enhanced sensitivity. 
 
 
Figure 1.9 Principle of QDs conjugated to dye-labelled MBP acceptors for 
FRET in a multiplexed format.  
(A) a single colour QD interacts with multiple distinct acceptors (Cy3 and 
QSY7) (B) three different coloured (blue, green and yellow emitting) QD 
donors interact with one type of acceptor (QSY7). (Reprinted by 
permission of the American Chemical Society)68  
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Subsequently, QD-based multiplexed FRET to dye-labelled MBP has been 
demonstrated.68 Figure 1.9A shows that two distinct dyes labelled MBP interact 
with a single QD donor leading to two simultaneous FRET processes between 
the two donor-acceptor pairs (QD-Cy3 and QD-QSY7). Furthermore, FRET 
assay between various QD donors and one type of acceptor has been 
investigated. Due to different degrees of spectral overlap and various donor-to-
acceptor ratios, FRET behaviours of the assemblies are versatile. This provides 
guidance in designing QD-based sensors especially for multiplexing detection. 5   
 
Later on, FRET between QD and Cy3-labelled MBP at the SM level has been 
also demonstrated by the same group.69 The same QD-MBP-dye configuration 
is achieved by employing the same polyhistidine mediated self-assembly 
interaction. Direct correlation between single-particle and ensemble FRET has 
been obtained in terms of donor-acceptor separation distances and FRET 
efficiencies. Compared with ensemble FRET measurement, the single-particle 
FRET not only offers higher FRET efficiency because a threshold is applied, 
which only counts brighter particle and disregards the dim ones, but also 
reveals distribution information about FRET efficiency. 
 
Encouraged by the success in FRET studies on QD and organic dye labelled 
protein, there has been a growing interest in evaluating FRET between QD and 
FPs. Since these studies use FP as the acceptor, replacing organic dyes, post-
synthesis dye-labelling of protein is not necessary.  
 
FRET characteristics based on QD-FP pairs (Figure 1.10) including the 
efficiency, donor-acceptor distance and the self-assembly binding strength have 
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been studied by the Bao group.52 In this research, polyhistidine- appended FPs 
self assemble onto PEGylated lipid encapsulated QDs. Different QD donors 
(520, 540, 560 nm-emitting) and different FP acceptors (mOrange, tdTomato 
and mCherry) are paired to tune the degree of spectral overlap, and thus to 
control FRET behaviours. By using the Forster dipole-dipole interactions 
formalism, the FRET results are analyzed and discussed. These results 
demonstrate that FPs are efficient acceptors for QD donors with up to 90% 
FRET efficiency obtained.  
 
 
Figure 1.10 Schematic diagram of the FRET interaction between a QD and a 
FP.  
FP is self assembled onto the QD via the poly-histidine tail, bringing the 
donor and acceptor together, and allowing the FRET to happens upon 
excitation. (Reprinted by permission of the American Chemical Society)52 
 
Further development of this configuration has been conducted by the Niemeyer 
group where the FP was used as a relay in between the QD-dye FRET.70 As 
demonstrated in Figure 1.11A, single stranded DNA (ssDNA) -FP conjugate 
(termed as 1) is attached onto QD via a polyhistidine tag to form a QD-FP-
ssDNA conjugate (2). Then organic dye (Atto647)- labelled complementary 
ssDNA (3) hybridizes with the DNA strand on 2 forming QD-FP- dsDNA-Atto 
 647 complex (4), which enables two
sites on the DNA2 sequence, the separation distance between FP donor and 
Atto 647 acceptor of the second FRET interaction could be tuned delicately 
allowing the FRET to 
 
Figure 1.11 Schematic illustration of the two
Atto647 configurations. 
(A) Initially, ss
forming QD-FP conjugate (2). Atto647
through DNA hybridization forming the final two
(B) four different dye
dye-labelling 
behaviours. (Reprinted by permission of the American Chemical Society)
 
Based on the above QD
been developed by using peptide substrates.
this sensing system utilizes specific cleavable peptide substrate
between QD donor and FP (mCherry)
protease (Caspase 3), the peptide substrate is cleaved resulting in the 
detachment of FP from 
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-step FRET. By varying the dye
happen in a controllable manner (Figure 1.1
-step FRET system based QD
 
DNA1-FP conjugate (termed as 1) is assembled onto QDs 
- labelled DNA(3) is attached with (2) 
-step FRET conjugate (4); 
-labelled DNA conjugates (3a-d), 
sites are attached onto 2 to generate versatile FRET 
-FP system, a proteolytic activity sensing platform has 
3 As demonstrated in Figure 1.1
 acceptor. In the pres





which have different 
70 
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ence of the target 
 activity (peptide 
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cleavage) is a kinetic process, it will rely on the caspase 3 concentration and 
this can be tracked by monitoring the QD emission recovery following substrate 
cleavage. Several inherent advantages of this sensing strategy include bacterial 
expression of the protease substrate with FP as FRET acceptor and 
polyhistidine tail for facile self-assembly to QDs, and the potential to target other 
proteases of interest by delicate modification of the substrate. 
 
 
Figure 1.12 Peptide substrate-mCherry conjugate is assembled via metal 
affinity interaction between polyhistidine (His6) and Zn2+ on QD surface.  
This configuration allows FRET to happen from QD donor to mCherry. 
Addition of Caspase 3 leads to the cleavage of peptide linker resulting in 
the release of mCherry from QD. Thus the detection of the Caspase 3 
could be represented by QD emission changes in a systematic manner. 
(Reprinted by permission of the American Chemical Society)3 
 
Inspired by this sensing format for an enzymatic activity assay, other FRET- 
based strategies have also been reported using QD-dye-labelled peptides/ 
oligonucleotides as substrates.4, 71 In addition, multiplexed protease activity 
sensing is also possible by adapting multiple distinct dye-labelled peptides as 
FRET acceptors and substrates.72-73 
 
1.4 Two-colour coincidence detection (TCCD) 
 
 Although FRET can provide accurate donor
has been demonstrated 
conformation of complex biomacromolecules, as well as for sensing 
applications, an essential requirement for
acceptor pair should be brought into close proximity, 
impossible for large molecular complexes, limiting its areas of application. This 
limitation can be overcome by TCCD, another SM fluorescen
relies on coincidence event counting. In this regard, the sample is 
simultaneously excited by two focused, overlapped laser beams 
is depicted by Figure 1.1
the fraction of coincident fluorescent bursts from the overall fluorescent 
signals.12 It is worth to mention that if both of the two fluorophore
QDs, only one laser is
 
Figure 1.13 Schematic representation of the apparatus setup used for 
colour excitation and two
permission of the American Chemical Society)
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TCCD has been shown to be less sensitive to background fluorescence than 
single-colour excitation and capable of detecting femtomolar levels of individual 
DNA molecules labelled with two different fluorophores.74 In order to achieve 
high sensitivity, selection of a proper fluorescence counting threshold is very 
important: on one hand, it should be high enough to exceed the background 
fluorescence; on the other hand, it should also ensure a low rate of chance 
coincident events to achieve high reliability. More recently, automatic 
determination of optimized thresholds for SM analysis in TCCD has been 
reported.75 This new development has enabled the detection of a small fraction 
(<1%) of dual-labelled duplex DNA molecules within a large excess of single-
labelled single- stranded DNAs. 
 
TCCD has also been used to direct counting of individual protein G-antibody 
complexes with red- and blue-excited fluorophore labelled antibodies (Figure 
1.14).76 The advantages for this method include, being sensitive (femtomolar 
sensitivity), being label-free (no target labelling required), requiring simple 
sample preparation (no separation); and being able to make measurements in 
complex media such as diluted serum. This method offers an opportunity for 
ultra sensitive detection and quantitation of proteins of interest. Besides, it is 
also possible to measure the stoichiometry, equilibrium constant, and 
dissociation rate of protein- protein complexes by TCCD. However, it should be 
noticed that despite its general applicability, TCCD can only work with target 
analytes with two or more accessible, independent binding sites because two 
different antibodies are required to form the protein complex. 
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Figure 1.14 The principle of TCCD.  
(A) Coincidence events are detected when a protein molecule labelled with 
a red-excited and a blue-excited antibody enters the probe volume. There 
are also coincident events when unbound red-excited and blue-excited 
antibodies enter the probe volume at the same time. This constitutes a 
statistical background below which it is not possible to detect dual-labelled 
proteins. (B) Fluorescence bursts on both the blue- and red-excited 
channels for protein G/IgG complexes in PBS buffer formed in solution at 
initial concentrations of 50 pM protein G, 50 pM IgG labelled with Alexa 
647 and 50 pM IgG labelled with Alexa 488. Coincident bursts on both 
channels are marked with an asterisk. (Reprinted by permission of the 
American Chemical Society)76 
 
While most TCCD approaches rely on using two overlapped excitation lasers as 
depicted in Figure 1.14, it is also possible to use only one laser to achieve 
TCCD by adapting the unique absorption and fluorescence properties of QDs. 
For instance, a new genotyping method based on TCCD has been 
demonstrated with only one laser.77 The method is based on bioconjugates of 
oligonucleotide ligation and a QD-mediated TCCD scheme (see Figure 1.15).  
 
 Figure 1.15 Schematic 
using QD-mediated TCCD analysis using a single excitation laser. 
(A) Process flow for OG
in the presence of match templates (left). No QD
are formed in the presence of the mismatch templates (right). 
Detection of ligation products is carried out using a single wavelength
excitation, dual wavelength
OBJ, objective; DM(1 and 2), dichroic mirrors; PH, pin 
filters; APD(1 and 2), avalanche photodiodes. 
nanoassembly flows through the detection volume, simultaneous burst 
signals, or coincident signals (marked by dash lines), are detected in the 
two detection channels. 
probes in the mismatch experiments so no coincident signals will be seen. 
The coincident signals 
targets. (Reprinted by permission of the 
 
The sample preparation is started from two probes, which are compl
parts for two different sections of the template target. The two probes are 
recognition probe and reporter probe conjugated with biotin and organic dye, 
respectively. Consequently, a DNA ligase is introduced to link the two probes in 
the hybrids. After denaturing the duplex by heat, the reporter probes or the 
fluorescent ligation 
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Right: QDs are bound only with nonfluorescent 
therefore serve as indicators of perfect match 
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the extremely strong streptavidin-biotin interaction. The fluorescence signals 
could be monitored as the conjugates flow through the laser confocal volume. 
When the mismatch templates were present in the solution, the two probes 
could not be covalently linked together. Thus no coincident events could be 
detected. This approach is able to detect zeptomoles of targets associated with 
an allele discrimination selectivity factor >105 offering a possibility for sensitive 
and specific detection of homogeneous point mutations in separation-free 
format. 
 
Another example is a homogenous sensitive detection of nucleic acids using 
two-colour QDs based on SM coincidence detection (Figure 1.16).78 Similarly, 
one target DNA is captured by two complementary biotinylated probes to form 
sandwiched hybrids. Then the hybrids are captured by streptavidin-coated 
606QDs and 525QDs through specific steptavidin-biotin interactions 
sequentially. Here, the QDs function as both a nano-scaffold and as a 
fluorescence pair for TCCD. Only in the presence of target DNA, the 
605QD/DNA hybrid/525QD complexes could form and the coincidence 
fluorescence events could be detected. This QD-based single-molecule 
coincidence detection offers a simple, highly efficient and ultra sensitive (with 
detection limit of 5 fM) approach for DNA analysis in a homogenous format. 
This assay offers a model system for the detection of DNA hybridization, single 
nucleotide polymorphisms, proteins and RNA.78  
 
 Figure 1.16 The principle of QD
(A) The experimental setup for QD
detection. The sample was passed through a laser
volume using the pressure
ion laser was used to excite both 525QD and 605QD.
emissions from 525QD and 605QD were separated and detected in green 
and red channels, separately. 
single-molecule coincidence detection. Two biotinylated oligonucleotide 
probes were used to recogn
DNA through 
first caught and assembled on the surface of 605QDs through specific 
streptavidin–biotin binding; then the second 525QDs were added to bind 
the other end of DNA hybrids to form the 605QD/DNA hybrid/525QD 
complex. C, The normalized emission spectra of 525QD and 605QD.
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-based single-molecule coincidence 
-driven flow of a syringe pump. A 488 nm argon 
(B) The conceptual schematic for QD
ize and detect specific complementary target 
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1.5 Overview of the project (part I) 
 
The unique optical properties (broad absorption and narrow emission, and 
excellent stability against photobleaching) of the QDs make them highly 
attractive for FRET based applications although most biolabels are still dye- or 
FP- based. Moreover, their promising applications in imaging, therapy and 
biosensing are attracting more and more researchers’ attention. One of the 
trickiest issues hindering their effective biomedical applications is their surface 
chemistry. As discussed above, amphiphilic polymers (or PEGylated lipids 
micelles) encapsulated QDs suffer from large overall sizes that are mostly 
coming from the thick surface coatings. In FRET-based biosensors, the big-
sized QD leads to large distances between the QD and dye labelled 
biomolecules, which can severely limit their sensitivity because FRET efficiency 
decreases dramatically with the increasing donor-acceptor distance. 
Furthermore, the oversized QDs might be unsuitable to target specific 
intracellular sites79 which will hamper their applications in therapy, imaging or 
sensing in cells.80 In this regard, small-molecule ligands capped QDs appear to 
be better-suited for situations requiring compact sizes. As a result, significant 
efforts have been devoted to prepare stable, compact QDs with specifically 
designed small-molecule ligands.6, 66 
 
Consequently, in the first part of my project, the optical properties of QDs 
capped by three different small-molecule ligands, 3-mercaptopropionic acid 
(MPA), glutathione (GSH), and dihydrolipoic acid (DHLA), are investigated. 
Then the metal affinity induced self-assembly interaction between the QD and 
His6-tagged FP is employed to conjugate the QD and FP. Following that, the 
FRET studies between QD and FP are carried out to elucidate how different QD 
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surface small-molecule capping affects their FRET behaviours (see Figure 1.17 
for illustration). The experimental results are carefully analyzed and possible 
QD-FP interaction models are proposed to explain the observed FRET 
differences.   
 
 
Figure 1.17 Schematic diagram of the FRET interaction between a QD donor 
and FP acceptors.  
A His6-tag at the N-terminus of the mCherry (FP) coordinates to the Zn2+ 
ions on the QD ZnS shell which brings the two into close proximity. Upon 
photo-excitation of the QD, energy is transferred to the FP non-radiatively, 
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Chapter 2 





The development of rapid, sensitive and selective detection methods for water-
soluble analytes is of critical importance in biosensing, environmental surveys 
and clinical diagnostics. Over the past decade, strongly fluorescent 
semiconductor nanocrystals (also known as QDs) that have prominent photo-
stability, wide absorption cross sections and size-tunable, narrow symmetric 
emission, have been demonstrated as promising fluorescent probes for a wide 
range of imaging, biosensing and diagnostic applications.1-7 In particular, their 
broad absorption and narrow symmetric emission make the QDs extremely 
well-suited as donors in FRET based sensors with organic fluorophores or FPs 
as acceptors.8-9 This is because this FRET design can take the full advantage of 
the broad absorption and narrow symmetry emission of the QD; such that wide 
choices of the excitation wavelengths can be selected to minimise direct 
excitation of the acceptor and narrow band-path filters used to effectively 
separate the donor-acceptor fluorescence which lead to greatly reduced 
fluorescence background and hence higher sensitivity.9-11 Over the past decade, 
QD-FRET based sensors have attracted considerable interest because of their 
important applications in biosensing, disease diagnostics, explosive detection, 
and environmental monitoring.7, 12-14 
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Since most high quality QDs (e.g. CdSe/ZnS core/shell) are synthesized by a 
high- temperature organometallic route in high-boiling point, coordinating 
organic solvents, they are naturally capped with hydrophobic ligands, such as 
trioctylphosphine oxide (TOPO), trioctylphosphine, and therefore insoluble in 
aqueous media.15-18 To facilitate their biological applications, QDs have to be 
made water-soluble; the hydrophobic TOPO ligands are either capped with 
amphiphilic polymers/PEGylated lipids via hydrophobic van der Waals 
interactions19-20 or completely substituted by hydrophilic small molecule ligands 
via ligand exchange reactions.21-25 For biosensing applications, functional 
biomolecules acting as the bio-recognition elements also need to be conjugated 
to the QD. This can be done by using covalent or non-covalent linking 
approaches. In addition, most QD sensors are FRET based, where the 
efficiency E decreases dramatically with the increasing donor-acceptor distance 
(r), E = [1 + (r/R0)6]-1 where R0 is the Förster radius of the QD-dye FRET pair at 
1:1 molar ratio. A key requirement is therefore to create a compact, stable QD-
bioconjugate to increase sensor sensitivity and robustness. Over the past few 
years, metal ion-polyhistidine coordination based self-assembly has proven to 
be an attractive way to prepare compact, functional QD-bioconjugates.13, 26-29 
This is because polyhistidine is able to chelate the metal ions on some of the 
most commonly used CdSe/ZnS or CdTe QD surfaces.26 It can produce 
functional, compact QD-FRET systems with relatively small donor- acceptor 
distances. Moreover, the number of acceptors arrayed on a single QD can also 
be controlled through modulation of the respective molar ratios in this highly 
efficient, self-assembly process.30-31  
 
More recently, FRET systems based on the self-assembly of mFruit FPs (His6-
tagged) and several commercial water-soluble CdSe/ZnS core/shell QDs have 
been reported.12-13, 32-33 Results show that different QD surface capping agents 
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have a profound impact on the FRET efficiency of the self-assembled 
systems.33 For example, at a mCherry:QD ratio of 12, an E of ~50% was 
observed for a DHLA capped QD; while the QD capped by DHLA-PEG600-OH 
exhibited an E of only ~ 20%, possibly due to the steric hindrance from the PEG 
coating that may prevent efficient FP binding.33 However, to date, FRET 
systems with CdSe/ZnS core/shell QDs capped with other commonly used short 
thiolated ligands, which may form more compact QD-FP conjugates and hence 
more efficient FRET, and how such ligands may affect their FRET behaviour 





















Figure 2.1 Chemical structures of the three ligands used in this study. 
(Reprinted by permission of the PCCP Owner Societies)34 
 
In this chapter, systematic studies on the FRET between QD donors capped 
with different small-molecule ligand coatings (MPA; DHLA; and GSH, see 
Figure 2.1) and a His6-tagged FP (mCherry) acceptor are described. The FP 
was self-assembled onto the QDs capped with three different short thiolated 
ligands to form the QD-FP FRET systems. I found that the QD-FP FRET was 
strongly dependent on the QD surface small-molecule coating in terms of both 
the resulting donor-acceptor distance and FRET efficiency. Two types of QD-FP 
interaction schemes were proposed to explain the significant difference in the 
apparent donor-acceptor distance for QDs capped with these different short 
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thiolated ligands. The dissociation constants Kd for specific QD-FP self-
assembly interactions were also measured.  
 




UV-vis absorption spectra of QDs and mCherry were recorded on Varian Cary 
50 UV-Visible Spectrophotometer (range from 300-800 nm). Fluorescence 
measurements were performed on a Spex Fluoro Max-3 Spectrofluorometer. 
Transmission electron microscopy (TEM) micrographs were taken on the Philips 
CM200 transmission electron microscope. The specimen for TEM study was 
prepared by depositing a drop of the QD solution onto a carbon-coated TEM 
grid. pH adjustments were done using a Fisher brand Hydrus 300 pH meter at 
room temperature. Millipore water (resistance >18.2 MΩ·cm), purified by ELGA 
Purelab classic UVF system, was used for all experiments and making buffers. 
All other chemicals and reagents were purchased from Fisher Scientific and 
used as received unless otherwise stated. The QYs of QDs were measured in 
water against rhodamine 6G in ethanol standard (QY = 95%) as described in a 
previous publication.35-36  
 
2.2.2 QDs and mCherry preparations 
 
Table 2.1 shows the constituents information of phosphate-buffered saline (PBS) 
solution and ten-fold concentrated PBS (10 × PBS) I used. All of the salts are 
dissolved in the deionized water, and the pH is adjusted to 7.4 with HCl or 
NaOH.  
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Table 2.1 Information of PBS constituents 
Salt PBS  Concentration (Mm) 10 × PBS Concentration (mM) 
NaCl 137 1370 
KCl 10 100 
Na2HPO4 2.7 27 
KH2PO4 1.8 18 
 
The CdSe/ZnS core/shell QDs (EM ~540) were purchased from Evident 
Technologies Inc (Troy, USA). They were supplied in toluene solutions capped 
with TOPO ligands with an average crystal core diameter of ~3.4 nm (namely 
the TOPO-QD). The water soluble QDs used in this study were prepared by 
ligand exchange5, 22-25, 37-39  by Haiyan Zhang, School of Chemistry, University of 
Leeds (See appendix for details).  
 
The FP, mCherry and its fluorophore engineered version (P, with the 
fluorophore residue sequences mutated and so no longer fluorescent), were 
engineered, expressed and purified by Dr Michael Webb and Dr Jeff Hollins at 
the School of Chemistry at Leeds. Both proteins were tagged with an N-termini 
His6-tag that can facilitate the QD-FP self-assembly via metal affinity 
coordination interactions. The detailed synthetic procedures are given in the 
Appendix.  
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2.2.3 FRET assays and data analysis 
 
The method for QY determination used here is the comparative method, which 
involves the use of a standard sample of known QY value. In this regard, 
Rhodamine 6G (in ethanol under 480 nm excitation) was used as the standard 
whose QY is 0.95. The QY of the QD were calculated by the equation5: 
 =  × /	 × 
/
	    (2.1) 
Where Yu, Fu and Au are the QY, integrated fluorescence intensity and 
absorbance at 480 nm of the QD sample, and Ys, Fs, and As are the QY, 
integrated fluorescence intensity and absorbance at 480 nm of Rhodamine 6G.  
 
For steady-state titration studies, the solutions were placed in a 10 mm optical 
path quartz fluorescence cuvette. The steady-state fluorescence spectra were 
recorded under an exciting wavelength of 425 nm, corresponding to the 
minimum absorption of mCherry to minimise the direct excitation of the FP. Both 
the excitation and emission band-pass were 5 nm and scan rate was 10 nm/s.  
 
The FRET efficiency, E, represents the fraction of photon energy that is 
transferred from the donor to the acceptor non-radiatively. Here, FRET 
efficiency is presented by donor quenching efficieny which is defined as,40 
  = 1 −      (2.2) 
Where IDA is the fluorescence intensity of the donor in the presence of the 
acceptors and ID is the fluorescence intensity of the donor in the absence of 
acceptors. 
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Using the Förster dipole-dipole interaction formulism, the energy transfer 
efficiency E for a single donor FRET with multiple identical acceptors can be 
expressed as28  
   =         (2.3) 
Where n is the average number of acceptor molecules interacting with one 
single donor. R0 is the Förster radius of the FRET pair at single donor-single 
acceptor situation, under which E = 50% and r is the apparent donor-acceptor 
distance. The Förster radius R0 is defined as28: 
  =  × 	 !
"
#$ %& '(  )* +,
 -.
  (2.4) 
Where QY is the QY of the donor; nD is the refractive index of the medium and 
its value is estimated at 1.4 here; NA is Avogadro’s number; kp2 is the orientation 
factor and its value varies between 0 (for orthogonal alignment) and 4 (for 
parallel dipoles), and for random orientated fluorophores kp2 =2/3. The integral 
of the spectral overlap I, is defined as28 
 + =  / 01	∞ = / 23451	 671	
∞
  18 91   (2.5) 
Where I represents the integral of the donor-acceptor spectral overlap over all 
wavelengths λ; in equation (2.5), FD-corr and εA designate the normalized donor 
emission profile and the acceptor absorption spectrum, respectively. 
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For binding strength investigations of the self-assembly interaction between 
QD and FP, the chosen excitation wavelength was 425 nm and the emission 
wavelengths were 538 nm for the QD(MPA) and 546 nm for QD(GSH) which 
corresponded to their respective maximum emission wavelengths. Both the 
excitation and emission band-pass are 5 nm. The required amount of H2O, 
10 × PBS and QD solutions were first added into a cuvette, and then the 
time-based scan was started. After about 40 seconds, the required amount 
of the FP solution was added rapidly and the time-dependent QD emission 
intensity was monitored continuously.  
 
The photoluminescence (PL) intensity values at different QD concentrations 
prior to FP addition were normalized by their corresponding highest value to 
give a value of 1. After the addition of FP, FRET happened immediately. The 
decrease of QD PL intensity caused by dilution was also corrected. The 
correction was done by using a concentration dilution factor (DF). According to 
equation (2.2), the formula used to calculate QD quenching efficiency is 
modified to be 
 E = 1 − I DF⁄    (2.6) 
Where I represents the final normalized QD PL intensities at different 
concentrations; DF represents the dilution factor. 
 





   (2.7) 
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And the condition under which [B]free ~ [B]total is [B]free>>[AB], which usually 
requires [B]total >> [A]total. And the hill equation utilized here to fit the 
fluorescence data is defined as13, 41 
  = JKL  M   HI 4⁄ 	GN =
OPBQ×4G
4GHIG       (2.8) 
Where Emax is the maximum FRET efficiency, c is the concentration of the 
acceptor, Kd is the dissociation constant defined as the acceptor concentration 
at which the quenching efficiency of the QDs is 50%.13 Comparison of equations 
2.7 and 2.8 shows that it is assumed c = [B]free and E / Emax = [AB] / [A]total. The 
hill coefficient, h, in this equation could provide specific information about the 
cooperativity of the self-assembly interaction. 
 
For the investigation of the relationship between concentration and acceptor 
emission intensity in QD-FP systems, the required amounts of H2O, PBS and 
FP were first mixed in the cuvette with the scan started. Then after about 40 
seconds of base line scan, the required amount of the QD solution was 
added rapidly and the FP fluorescence was monitored continuously. The 
corresponding QD solutions without FP were used for background control 
here. Sensitized FP emission intensity was obtained by deducting the QD 
contribution from the total emission intensity at 605 nm, the maximum FP 
emission wavelength. 
 
2.3 FRET studies between QD and FP 
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2.3.1 Determination of the Förster radius for QD-FP pairs  
 
According to the obtained fluorescence intensity of QD and Rhodmine 6G (see 
Figure 2.2), the QYs of the three QDs were calculated following the equation 
(2.1). Compared to the parent TOPO-QD, the QYs of QD(MPA) and QD(DHLA) 
decreased by around 60% (from 71% to ~30%), in good agreement with earlier 
reports.22, 38 However, the QD(GSH) showed a much smaller QY decrease of 
only 8% (from 71% to 65%), suggesting that GSH is better at preserving the QY 
of QD than MPA or DHLA.  
 

























Figure 2.2 The relative fluorescence spectra of the QDs (all of the same 
concentration). (Reproduced by permission of the PCCP Owner Societies) 
34 
 
The much smaller decrease of QY for QD(GSH) compared to the MPA- or 
DHLA- capped QD after the ligand exchange may reflect the mild reaction 
conditions (simply stirring at room-temperature) used to make QD(GSH), which 
lead to smaller levels of damage to the ZnS shell quality (e.g. etching away 
some surface Zn2+ ions to create surface defects) as compared to the harsher 
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conditions used to prepare the QD(DHLA) (heating under reflux), enabling the 
QD to maintain a higher QY.42  
 
The normalized fluorescence spectra of the three prepared QDs are shown in 
Figure 2.3. They all show the characteristic narrow (with a full-width at half-
maximum of ca 30 nm) and symmetric fluorescence emission of the parent QD 
(TOPO capped), where the emission peaks remain virtually unchanged for the 
MPA and DHLA capped QDs, which remained at ~538 nm, while that for the 
GSH capped QDs appeared to have red-shifted by 7 nm to 545 nm. This 
suggests that all the QD emissions are from exiton recombinations. 
 




























































Figure 2.3 Photophysical characteristics of the QD donors and FP acceptor.  
(A) Normalized emission spectra of the three QDs (QD(MPA), QD(GSH) 
and QD(DHLA) are shown in blue, red and green lines, respectively) and 
the absorption spectrum of FP (purple square). (B) Spectral overlap 
functions for each of the three QD -FP pairs. (Reproduced by permission 
of the PCCP Owner Societies) 34 
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The Förster radius of the donor-acceptor pair (R0) is the distance at which the 
energy transfer efficiency is 50% for a single-donor-single-acceptor FRET 
system. R0 value depends on several parameters, especially the overlap 
integral of the donor emission spectrum with that of the acceptor absorption 
spectrum (See Figure 2.3). The corresponding R0 values for these QD-FP 
FRET pairs were determined using equation (2.4): the results are summarized 
in Table 2.2. The values of the overlap integral (I) for each of the systems were 
also calculated. The R0 value varies from one pair to another, with the QD(GSH) 
being the largest while the QD(MPA) being the smallest, which is largely 
determined by the magnitudes of the spectral overlap and the QY of the QDs. 
 
Table 2.2 Calculated Förster radiuses (R0) for the three QD -FP pairs. 







QD(MPA)-FP 9.27 × 10-14 0.27 39.5 
QD(GSH)-FP 1.10 × 10-13 0.65 47.1 
QD(DHLA)-FP 8.97 × 10-14 0.31 40.2 
 
2.3.2 QD-FP FRET study by static fluorescence scan 
 
2.3.2.1 QD-FP FRET titrations 
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B Ratio of FP/QD(GSH)
























































C Ratio of FP/QD(DHLA)


































Figure 2.4 Fluorescent emission spectra and the corresponding QD quenching 
efficiencies for different ligand capped QD-FP FRET systems at different 
QD:FP ratios. 
The excitation wavelength is 425 nm. (A-C) correspond to the 
fluorescence spectra of QD(MPA)-FP, QD(GSH)-FP, and QD(DHLA) -FP 
pairs, respectively, and (D-F) give the plots of the corresponding FRET 
efficiencies as a function of the FP-to-QD ratio with fits for the three QD-FP 
pairs. (Reproduced by permission of the PCCP Owner Societies)34 
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QD-FP bioconjugate complexes were prepared by adding appropriate amounts 
of the FP and QDs capped with different small molecule coatings into PBS. The 
final concentration for the QDs in the conjugates was 40 nM and the FP/QDs 
molar ratios were ranged from 0 to 8.  
 
The fluorescent emission spectra after excitation at 425 nm for three QD-FP 
FRET systems at increasing ratio of FP to QD are shown in Figure 2.4A-C. The 
fluorescence backgrounds from FP direct excitation (determined from FP-only 
samples excited at 425 nm, the λmin of the FP), although small, were also 
carefully subtracted from these spectra. The corresponding donor quenching 
(FRET) efficiency as a function of the FP:QD ratio are shown in Figure 2.4D-F, 
respectively. The fluorescence quenching data were fitted accordingly to the 
single QD donor-multiple identical acceptor FRET model,32 and the apparent 
separation distances between the donor and acceptor in each of the FRET pairs 
were calculated from these steady-state fluorescence data using equations (2.2) 
and (2.3) and the results are summarized in Table 2.3. The measured donor-
acceptor FRET distance (r) for the QD(DHLA)-FP complex is ca 58 Å, which is 
consistent with the literature.13 
 
Figure 2.4A-C show that the QD fluorescence (~540 nm) is quenched 
significantly while the FP fluorescence (~605 nm) is simultaneously enhanced 
with the increasing FP:QD ratio, suggesting QD-sensitized FRET. Comparing 
the donor quenching efficiencies and the apparent donor-acceptor distances 
obtained for the three FRET systems, it is clear that different small-molecule 
ligand capping on the QD appears to have a significant impact on the QD-FP 
FRET behaviours. The FRET interactions could be roughly categorized into two 
groups. For Group I, (QD(MPA), the QD fluorescence quenching efficiency as 
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well as the FP FRET signal) increased very rapidly with the increasing FP:QD 
ratio, reaching a saturated value of ~85% at a low FP:QD ratio of only 2:1. As 
the accepter-to-donor ratio further increases to above 2, the donor quenching 
efficiency (as well as the FP FRET signal) did not show any apparent change. 
While for the GSH- and DHLA- capped QDs (Group II), there was a progressive 
decrease in the QD fluorescence accompanied with a simultaneous gradual 
increase in the FP emission as the FP:QD ratio is systematically increased from 
0 to 8, similar to the observations for the DHLA-QD system reported by Bao et 
al.33 There was no sudden change of the quenching behaviour as a function of 
the increasing FP:QD ratio. Furthermore, the apparent FRET distance (r ~60 Ǻ) 
between the QD and FP calculated using the single-donor-multiple-acceptor 
FRET model (fitted based on equation 2.3 using Origin software) for the Group 
II is significantly greater than that for the Group I (ca. ~35 Ǻ).  
 
2.3.2.2 QD-FP (P) FRET titrations 
 
To eliminate the possible variation of QD fluorescence QY at different QD:FP 
ratios (which has been reported previously), a corresponding set of samples 
with the mutated non-fluorescent mCherry (P, essentially the same protein but 
with the fluorophore core being mutated so that it became non-fluorescent) 
were also tested. In this system, the final QD concentrations of the conjugates 
were also 40 nM, while the molar ratios of FP to the QDs were systematically 
varied but the overall ratio of the protein (FP + P) to the QD was always 
maintained at 8. This configuration allowed us to maintain a fixed number of 
proteins per QD, removing issues associated with the possible QD QY change 
which would further affect the R0 of the resulting QD-FP FRET pair and hence 
interfere with the QD-FP FRET study. 
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Figure 2.5 Fluorescent emission spectra and the resulting QD quenching 
efficiencies for the QD-FP-P systems. 
The excitation wavelength is 425 nm. The ratios of (FP+P):QD were fixed 
at 8:1 in these systems. Fluorescent emission spectra (A-C) correspond to 
the QD(MPA)-FP-P, QD(GSH)-FP-P, and QD(DHLA)-FP-P respectively. 
(D-F) show the plots of the corresponding FRET efficiencies as a function 
of the FP-to-QD ratio for QD(MPA)-FP-P, QD(GSH)-FP-P and QD(DHLA)-
FP-P conjugates. (Reproduced by permission of the PCCP Owner 
Societies)34 
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Table 2.3 The calculated Förster radius (R0) and measured donor-acceptor 
FRET distances (r) for the three QD-FP pairs.  
FP and (FP + P = 8) show the FRET studies done in the absence and presence 
of the engineered non-fluorescent mCherry (P) respectively. (Reproduced by 








QD(MPA)-FP 39.5 36.0 ± 0.7 46.3 ± 1.0 
QD(GSH)-FP 47.1 61.0 ± 0.7 62.4 ± 0.8 
QD(DHLA)-FP 40.2 57.5 ± 0.7 61.9 ± 0.9 
 
The fluorescent spectra of the QD-FP-P systems were shown in Figure 2.5A-C. 
The corresponding FRET (donor quenching) efficiencies as a function of FP to 
QD ratio were shown in Figure 2.5D-F respectively. Similarly, according to the 
equation (2.2) and (2.3), the apparent separation distances between donor and 
acceptor pairs were calculated from these steady-state fluorescence data and 
the results were shown in Table 2.3. The fluorescent spectra clearly showed 
that for all the MPA-, GSH-, and DHLA- QD-FP (P) FRET systems, there was a 
progressive decrease of the QD PL intensity with a simultaneous increase of 
the FP FRET signal as the number of FPs per QD was increased from 0 to 8, 
suggesting that all of the FPs were able to bound to the QD and produce FRET.  
 
This conclusion was further supported by a gel-filtration experiment where 
almost all of the FPs were found to be bound to the QD and co-migrated 
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together on the gel-filtration column with little free FPs as monitored at 580 nm, 
the λmax for the FP (the QD does not absorb at this wavelength, see Figure 2.6 
for details).  
 














 mCherry 580 nm /20
 QD(GSH)+mCherry 400 nm
 QD(GSH)+mCherry 580 nm
 QD(MPA)+mCherry 400 nm
 QD(MPA)+mCherry 580 nm
 
Figure 2.6 Gel-filtration chromatography for QD(MPA), QD(GSH) and FP.  
Absorption at 580 nm comes from the FP only (corresponding to its 
maximum absorption, λmax), while that at 400 nm mainly comes from the 
QD. (Reproduced by permission of the PCCP Owner Societies)34 
 
 
Interestingly, the two QD-FP FRET groups also showed different behaviours in 
the apparent donor-acceptor distance (r) in the presence of the non-fluorescent 
protein (P), for group I, there was a considerable increase of r by about 10 Ǻ 
(from ~35 to ~46 Ǻ), while for Group II, the r values appeared to be effectively 
unchanged, suggesting that there were some degrees of FP re-arrangement in 
the self-assembled Group I system but not the group II system. 
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2.3.3 QD-FP FRET Interaction by time-based scan 
 
2.3.3.1 QD-FP FRET titrations 
 
As representatives of the two groups, titrations of the two QD-FP systems 
(QD(MPA)-FP and QD(GSH)-FP) were investigated here using the time based 
scan program (Figure 2.7). The concentration of the QDs was maintained at 40 
nM while the ratio of FP/P to QD was changed. The required amount of H2O, 10 
× PBS and FP were first added into a cuvette placed in the fluorimeter, and then 
the time based scan program was triggered immediately once the required 
amount of QD solution was added in.  
 
The excitation wavelength (425 nm) was the same as that used in the emission 
scan method, while the emission wavelengths, where the data were collected, 
were carefully selected to be 538 nm for QD(MPA) and 545 nm for QD(GSH) 
which correspond to the maximum emission peaks of the two QDs. Both the 
excitation and emission band-pass are 5 nm.  
 
The studies on QD-FP titrations using the time based scan method show that 
the calculated distances between QD and FP are 34.7 ± 0.7 Ǻ for QD(MPA)-FP 
and 56.8 ± 0.7 Ǻ for QD(GSH)-FP, which are consistent with the QD-FP 
titrations results (36.0 ± 0.7 Ǻ for QD(MPA)-FP and 61.0 ± 0.7 Ǻ for QD(GSH)-
FP) obtained by the static emission scan method. For the QD-P (1:1) system, 
the engineered non-fluorescent protein P with His6-tag could also quench the 
QD PL intensity. The quenching effect is stronger for the QD(MPA)-P compared 
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to the QD(GSH)-P system with quenching efficiencies of 0.30 and 0.14 
respectively.  
 
















































































































Figure 2.7 Time based fluorescent intensity scans and the corresponding QD 
quenching efficiencies.  
Time based QD PL intensity of QD(MPA)-FP (A) and QD(GSH)-FP (B) 
conjugates. Plots of the QD quenching as a function of the FP-to-QD ratio 
for QD(MPA)-FP (C) and QD(GSH)-FP conjugates (D). (Reproduced by 
permission of the PCCP Owner Societies)34 
 
2.3.3.2 Equilibrium dissociation constant for QD-FP FRET interaction 
 
Two representative QD-FP systems (using QD(MPA) and QD(GSH)) were used 
to estimate the strength of binding between the QD and His6-tagged proteins by 
- 59 - 
 
using the time-based scan method. In this case, the ratio of FP to QD was 
maintained at 1:1 following the literature26 while the concentration of QD (FP) 
was systematically changed from 1 to 16 nM.  
 
To derive the equilibrium dissociation constant Kd of the QD-FP self-assembly, 
the time based scan method was implemented by following the fluorescence 
intensity of the QD and the resulting plots of corrected QD intensity as a 
function of time are shown in Figure 2.8A and 2.8B, respectively. The data were 
corrected by the sample dilution factor. The corresponding donor quenching 
efficiencies were fitted by the Hill function in Equation (2.8). Because the basic 
assumption of Hill equation is [B]total >> [A]total (see equation 2.7), the use of Hill 
equation for this system  may be inappropriate. Hence the Kd and h values are 
unreliable. Nevertheless, the data do suggest that the binding between QD and 
FP is srong, and stronger for QD(GSH)-FP than for QD(MPA)-FP. 
 
The time-dependent QD fluorescence traces show a rapid decrease of the QD 
fluorescence upon the FP addition, and quickly reaching completion in minutes, 
suggesting the QD-FP self-assembly happens very rapidly and reaches 
equilibrium in minutes even at low nM concentrations. Fitting of the binding 
curves using the Hill equation yields apparent Kd values of 1.4 nM for 
QD(MPA)-FP and 0.63 nM for QD(GSH)-FP systems, respectively (see Table 
2.4).  
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Figure 2.8 Kd measurement for the QD-FP self-assembly interaction using time 
based scan.  
Normalized and corrected time-based QD fluorescence intensity scans (at 
540 nm) of the QD(MPA)-FP (A) and QD(GSH)-FP (D) systems upon the 
addition of FP at different concentrations. Plots of PL intensity (absolute 
value of initial QD emission before addition of FP and without 
normalization) as a function of concentration for QD(MPA) (B) and 
QD(GSH) (E). The QD quenching efficiency (the differences of the PL 
intensities at 40 s and 300 s) as a function of concentration for the 
QD(MPA)-FP (C) and QD(GSH)-FP (F) systems. (Reproduced by 
permission of the PCCP Owner Societies)34 
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Table 2.4 The calculated FRET and thermodynamic parameters for the QD-FP 
self-assembly interactions by time-based scan method. (Reproduced by 
permission of the PCCP Owner Societies)34 
D-A pair Emax Kd /nM h 
QD(MPA)-FP 0.87±0.01 1.39±0.04 3. 1±0.3 
QD(GSH)-FP 0.90±0.02 0.63±0.10 2.2±0.7 
 
These Kd values are at least an order of magnitude lower than those reported 
for the T2 EviTag-QD-FP systems (~40-90 nM),13 but are consistent with those 
of DHLA-QD-Histag-peptide systems (e.g. 1.7 nM for His6-peptide).26 This 
observation suggests that QD-Histag based self-assembly is stronger for QD 
capped by small-molecule ligands than by the T2-Evitag, possibly due to the 
fact that the Histag has to overcome steric hindrance of the hydrophobic inner-
ligands of the T2-Evitag to reach the QD core for binding (the T2-Evitag QD is 
based on the TOPO-QD capped with PEGylated phospholipids), but this is not 
required for small-molecule capped QDs. 
 
The Hill coefficients h were found to be 3.1 for the QD(MPA)- FP and 2.2 for 
QD(GSH)-FP interactions, which are both greater than 1, suggesting that the 
QD-FP self-assembly interaction is positively cooperative, i.e. once one FP 
molecule is bound to a QD, the affinity of the QD for a second FP molecule is 
increased.13 This is possibly due to increased tendency to form multimeric 
structures (e.g. DsRed appeared as a tetramer in its crystal structure) of the 
modified red-fluorescent proteins.43 
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2.3.3.3 Relationship between concentration and acceptor emission 
intensity 
 
As a representative, the QD(GSH)-FP system was used to study the 
relationship between concentration and acceptor emission intensity. The QD 
sensitized FP FRET emission intensity traces (at 605 nm) as a function of time 
at different concentrations (FP:QD ratio was fixed at 1:1) were studied and the 
results were shown in Figure 2.9 (all traces were corrected for the residue QD 
fluorescence and direct excitation of the FP at this wavelength). Following the 
addition of the QDs at 50 s, a rapid increase of the FP FRET signal was 
observed (Figure 2.9A).  
 
A good positive linear relationship between the saturated FP FRET signal and 
FP concentration was found (Figure 2.9B), confirming that the QD-FP self-
assembly is very efficient even at low nM concentrations. This is because FRET 
only happens over short distances (< 10 nm), any free FPs not attached to the 
QD do not produce any FRET signal. The FP FRET signal enhancement also 
happened very rapidly, and reached saturation within 100 s of QD addition even 
at low nanomolar (e.g. 4 nM) concentrations.  
 
This behaviour is very similar to that observed in the QD fluorescence 
quenching shown in Figure 2.8. The fact that the quenching of the QD 
fluorescence and the enhancement of FP FRET signal happened 
simultaneously, strongly suggests the observed fluorescence changes are 
indeed due to QD-FP FRET interactions. 
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Figure 2.9 Study on relationship between QD(FP) concentration and FP 
emission intensity using time based scan.  
(A) Time based PL intensity scan at 605 nm for QD(GSH) only samples. 
(B) Time based total emission intensity scan at 605 nm (QD + FP) 
samples. (C) QD sensitized FP FRET emission (at 605 nm) intensity 
traces at different concentrations using time-based scan method. All traces 
were corrected for the residue QD fluorescence background at this 
wavelength and FP direct excitation. The required amounts of QDs were 
added to the FPs at the time point of 50 s to reach a fixed FP:QD ratio of 
1:1. (D) The corresponding plot of the FP FRET emission intensity as a 
function of concentration. (Reproduced by permission of the PCCP Owner 
Societies)34 
 
2.3.4 Proposed interaction models for the QD-FP assemblies 
 
 To examine whether the size of the core/shell QDs has changed after the ligand 
exchange, i.e. the original TOPO ligands were substituted by water
ligands, TEM images have been taken (see Figure
capped core/shell QDs. It is poss
suggesting these QDs are highly crystalline, but the particle borders could not 
be identified clearly. A few white circles drawn on each QD crystals were used 
to indicate the rough diameters of the QD particles, and
diameter of about 3.4 nm, consistent with the product description from the 
manufacture (e.g. crystal diameter ~ 3.4 nm).
 
Figure 2.10 Representative TEM images for QD(MPA) and QD(GSH).
(Reproduced by 
 
In thisHis6-tagged FP design, there is a linker of 4 amino acid residues before 
the His6-Tag and the linker between the His
is 21 residues long.
50 Ǻ × 25 Ǻ (length × barrel diameter), obtained from the crystal structure of 
mCherry from the Swiss PDB Viewer.
assumed to be in the middle of the protein barrel.
QD(MPA) 
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ible to see QD particle crystal lattice, 
 these gave a rough QD 
 
permission of the PCCP Owner Societies
6-tag and the N-
 The FP β-barrel structure has dimensions of approximately  







terminal of mCherry 
mcherry was 
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From the experimental data, the small molecule ligands capping the QD have a 
significant impact on the FRET between the QD and FP. It is widely accepted 
that the QD-FP self-assembly interaction is mainly through coordination of the 
His6-tag inserted at the N-terminus of the mCherry to the Zn2+ ions on the QD 
ZnS shell surface, which brings the two into close proximity for FRET 
interaction.26, 33, 44-45 The small-molecule capping ligands also bind to the QD 
surface primarily through coordination of their thiolate (with minor contribution 
from the amine and carboxylic acid) groups to the QD surface Zn2+. Therefore 
the introduced FPs will compete with the small molecule capping ligands for the 
QD surface Zn2+ ion binding and effectively displace some of the small-
molecule ligands. The multi-dentate nature of the QD-DHLA (or GSH) 
interaction, means the  binding strength should be significantly stronger than 
that for the QD-MPA interaction, which is effectively mono-dentate. As a result, 
few GSH or DHLA ligands may be displaced by the incoming His6-tag (FP), 
leading to high surface ligand densities that repel the FP from QD surface to 
greater distances, and hence a relatively long QD-FP (donor-acceptor) distance 
for the GSH or DHLA coated QDs. 
 
Similarly, the weak binding between the MPA and QD means that not only could 
the His6-tag substitute more MPA ligands and bind  more strongly to the QD but 
also the FP protein could itself interact with the QD by some weak electrostatic 
and/or coordination (via surface carboxylate and amine groups) interactions that 
could also displace some coating ligands. This may lead to stronger QD-FP 
interaction and hence a much shorter apparent QD-FP separation distance. 
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Figure 2.11 Possible model structures for the QD(MPA)-FP (A) and QD(GSH)-
FP and  QD(DHLA)-FP (B) conjugates.  
The QD with a radius of ~17 Å (green) is coated by organic ligands (grey). 
The thickness of all three organic shells is assumed to be 10 Å. The FP is 
attached to QD surface via His6-tag and the fluorophore is assumed in the 
middle of the FP (magenta). The yellow line corresponds to the theoretical 
separation distance (39.5 Å for (A) and 52 Å for (B)). The separation 
(His6-tag and the 21 amino acid linker between the terminal His6-tag and 
FP) have been omitted. And only one FP per QD is shown here for 
simplification. 
 
Effects of the small molecule ligands on the QD-FP self-assembled structure 
may be qualitatively explained from a simple molecular model shown in Figure 
2.11, which illustrates two model conformations for the QD-FP assembly.  
 
According to the measured donor-acceptor distance, Group I (MPA-) QD-FP 
conjugate that has a smaller separation distance of ~37 Ǻ may correspond to 
the configuration shown in Figure 2.11A; while the Group II conjugates with 
bigger separation distances of 60 Ǻ may adapt the configuration shown in 
Figure 2.11B. Assuming that the QD core/shell crystal is perfectly spherical with 
a radius of 17 Å (green, the same as the manufacture’ product description and 
also the TEM image) and is surrounded by a uniform organic ligand coating 
shell of ~10 Å (grey), and the FP is attached to the QD via its His6 sequence, 
and the flexible 21 amino acid linker does not contribute to any donor-acceptor 
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distance, and the chromophore is located at the centre of the FP structure 
(shown in magenta), then these simplified models would yield a donor-acceptor 
distance of ~40 (17 + 10 + 12.5) and 52 (17 + 10 + 25) Å for structure models A 
and B, respectively. These values are in reasonable good agreement with the 
experimental values of ~37 Å (for Group I, i.e. model A) and ~60 Å (for Group II, 
model B). The small deviations from the predicted values may due to the fact 
that the thickness of the organic ligands in the Group I QD is shorter than 10 Å 
(the thickness is more likely to be ~ 5 rather than 10 Å), while in model B, the 
distance contribution from the 21 amino acid residue linker cannot be neglected. 
Despite small differences between the model and experimental values, these 
simple models can nevertheless provide a qualitative explanation about the 





In summary, I have shown that the FP appended with a His6-tag can rapidly and 
effectively self-assemble onto the QDs capped with different short thiolated 
ligands to form efficient FRET systems. The QD-FP interaction schemes can be 
roughly categorized into two groups from their corresponding apparent donor-
acceptor distance, r, values. Highly efficient FRET (E ~ 85%) has been 
achieved at the low FP:QD copy number of 2 for QD capped by weak mono-
thiolate ligands (MPA) which has short r values of ~35 Å. In contrast, QDs 
capped by strong chelative ligands (e.g. DHLA and GSH) have significantly 
greater r values of ~60 Å. Therefore different short thiolate ligands surrounding 
the QD can significantly affect the r value of the resulting QD-FP FRET systems 
by as much as 25 Å, despite using the same attachment chemistry (metal 
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coordination between the His6-tag and the QD surface Zn2+ ions). This implies 
that the original short thiolate ligands on the QD surface have a profound impact 
on the orientation of subsequently attached FPs. The possible different 
conformations for the QD-FP conjugates have been illustrated from two 
simplified models that can qualitatively explain the observed significant r value 
differences.  
 
The QD-FP self-assembly interactions appeared to happen very rapidly 
(complete in minutes at low nM concentration), to be very strong (with apparent 
Kd ~ 1 nM) and positively cooperative. These results suggest that the QD-His6-
tagged biomolecule self-assembly can be used as a general, efficient way for 
preparing compact, functional QD-bioconjugates. Extension of this self-
assembly strategy to other proteins and/or DNA/RNA aptamers39, 46 may lead to 
the development of a range of compact, functional QD-bioconjugates that may 
have broad ranges of sensing and biomedical applications. In general, QDs 
capped with weak ligands can offer higher FRET efficiency and hence 
sensitivity, however, they often cannot prevent non-specific adsorption and can 
compromise sensor robustness and specificity; while strong ligand capped QDs 
are generally more stable and resistant to non-specific adsorption, they are 
however generally bulkier, with lower FRET efficiency and potentially less 
sensitive. Therefore a balance between the requirements for sensitivity, stability 
and specificity should be carefully considered in designing QD-FRET based 
sensors, as these requirements are often non-compatible.  
 
2.5 Appendix (Preparations of QD and mCherry) 
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2.5.1 QD synthesis  
 
As mentioned before, the QDs used in this study are provided by Haiyan Zhang, 
School of Chemistry, and University of Leeds. The following synthetic protocol 
is provided by her. 
 
2.5.1.1 Modification of QDs with DHLA  
 
DHLA was used to replace the native TOP/TOPO ligands via ligands 
exchange.23, 47-48 QD-TOPO was repeatedly dispersed in toluene and 
precipitated by adding ethanol, followed by centrifugation and discarding clear 
supernatant. This process removes the free TOP/TOPO ligands that are not 
bound to the QDs. The precipitated QD was dissolved in chloroform and mixed 
with a large excess of DHLA (approx 1:1000 molar ratio). The mixture was 
purged N2 for 5-10 minutes, and heated to 60-80 °C for 3~4 hours. The DHLA 
capped QDs were separated from the dissociated TOP/TOPO by precipitation 
with heptane and chloroform. EtOH was used to remove the excess DHLA. The 
DHLA capped QDs (QD-DHLA) were soluble in water, but not in organic 
solvents. The transformed solubility was the most direct evidence that the ligand 
exchange had taken place. 
 
2.5.1.2 Preparation of GSH-capped QDs 
 
Glutathione is a small tri-peptide (Glu-Cys-Gly) which has a free thiol amine and 
two carboxylic acid groups. The thiol group can bind on to the QD surface, while 
the amine and carboxylic acid groups can promote water-solubility. The 
preparation of GSH capped QDs has been reported 24.  
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2.5.1.3 Preparation of MPA-capped QDs  
 
TOPO capped QDs (83.9 nmol/ml 0.25 mL) were precipitated by EtOH as 
above. The precipitate was dissolved in chloroform (1 mL) to form 20 µM QDs 
solution. 2000 mg TMAH (Tetramethyl ammonium hydroxide) was mixed with 
1000 µL MPA in 20 ml chloroform. The solution was mixed well by vigorous 
shaking and allowed to stand for 1 h to equilibrate. The bottom organic phase 
was transferred to a polypropylene tube for ligand exchange with QD. 500 µL 20 
µM QD was added to the MPA chloroform solution and mixed well. The solution 
was allowed to stand at room temperature for 40 h and then 40 h. At the 
beginning of the reaction, the TOPO-capped QDs were homogenously 
dispersed in chloroform with MPA. After standing at room temperature for 40 h, 
the QDs was separated out and gathered as a highly fluorescent droplet 
suspended on the top of the chloroform. After a further 40 h, the fluorescent 
droplet precipitated down to the bottom. The precipitate was collected and was 
washed with ethanol for three times, and then dissolved in water.  
 
2.5.2 Preparation of mCherry and mCherry mutant 
 
As mentioned before, the mCherry (FP) and mCherry mutant (non-fluorescent) 
used in this study are provided by Jeff Hollins, School of Chemistry, and 
University of Leeds. The following protocol is provided by him. 
 
Site directed mutagenesis to generate the expression construct pRSETB-
mCherryY22F was performed via the QuikChange Site-Directed Mutagenesis 
protocol (Stratagene). The sequences of the oligonucleotides were 5´-
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CCTCAGTTCATGTTCGGCTCC-3´ (forward) and 5´-
GGCCTTGGAGCCGAACATGAA-3´. Mutation was confirmed by DNA 
sequencing (GATC Biotech). mCherry and mCherry-Y22F were overexpressed 
in Escherichia coli C41 (DE3)49 by growth for 24 hours in auto-induction media 
following the protocol of Studier.50 Cells were harvested by centrifugation at 
10,000g for 15 mins at 4 °C before storage at -80 °C. The cell pellet was 
resuspended in buffer A (50 mM Potassium Phosphate pH 7.4, 100 mM NaCl) 
with 10 mM imidazole and lysed by sonication using a Bandelm Sonopuls 
HD2070 sonicator. The lysate was cleared by centrifugation (31,000g for 45 min 
at 4 °C) and the supernatant applied to a pre-equilibrated nickel-NTA agarose 
column (5ml, Qiagen), and the column washed sequentially using buffer A with 
20 mM imidazole and buffer A with 50 mM imidazole. Protein was eluted using 
buffer A with 500 mM imidazole and collected in 5 ml fractions. Fractions 
containing protein were pooled, concentrated and further purified by gel filtration 
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Chapter 3 
Magnetic particle (MP) based ultrasensitive biosensors and 
bioassays 
 
Magnetic particles (MPs) have recently received significant research interests 
due to their unique magnetic properties and low toxicity.1 They can be easily 
prepared in different sizes and functionalized with stable, nontoxic protective 
coatings with well-controlled surface functional groups for efficient 
bioconjugation.2-4 Moreover, their tiny particle sizes combined with strong 
superparamagnetic properties allow them to form stable dispersions in reaction 
media for rapid homogenous reaction in the absence of an external magnetic 
field, while they are still easily collectable upon application of an external 
magnetic field. These unique properties make them well suited for target 
capture, separation, enrichment and biosensing. Indeed, MP-bioconjugates 
have been widely used in bioimaging5, targeted delivery of therapeutic agents6, 
biosensing and diagnostics7, bio-separation3, 8, and catalysis9.  
 
3.1 MP properties 
 
The magnetic properties of MPs are dominated by two key features: (1) The 




Magnetic domains here indicate groups of molecules whose spins are all 
pointing in the same direction, i.e. all magnetic moments of the constituent 
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atoms are all parallel to each other. In conventional magnetic materials, 
domains are usually separated by domain walls and each domain possesses a 
unique size and spin direction. In ferromagnetic bulk materials, large domains 
tend to be split up into several smaller domains to decrease the magnetostatic 
energy (∆EMS) of the materials.10 Nevertheless, domain walls require some 
energy (ED) associated with their creation. Therefore, the domain size must 
have a limit, below which the energy required for the generation of one more 
domain wall exceeds the amount of reduced magnetostatic energy (∆EMS). 
Thus, when the diameter of MP decreases to a critical size, the domain wall 
formation is not favourable at all such that the MP would rather contain one 
single domain.10-11 Critical single-domain sizes for some common MPs have 
been estimated by Kittle11-12 (See Table 3.1). 
 
Table 3.1 Estimated critical single–domain sizes for spherical MPs with no 
shape anisotropy. (Reprinted by permission of the American Chemical 
Society)11 
Material Diameter (nm) Material Diameter (nm) 
Co 70 Fe3O4 128 
Fe 14 γ−Fe2O3 166 
Ni 55   
 
3.1.2. Superparamagnetic limit 
 
 
 Figure 3.1 Illustrations
In the middle is the energy diagram of MNPs. 
the magnetic anisotropy energy 
Thus the spins are not able to flip freely and the material behav
ferromagnetic; whereas for small MPs (red line), the 
energy (U2) is lower than the thermal energy. Thus the spin c
freely and the material 
permission of the American Chemical Society)
 
As illustrated in Fig
hinders the spin fluctuations in a single domain particle, is proportional to K
(Ku is the magnetic a
the magnetic anisotropic energy of MPs is higher than the thermal energy kT (k 
is the thermal constant and T represents temperature). Thus the magnetic 
moments are not allowed to flip from one d
of MNPs decreases, the magnetic anisotropic energy is also reduced 
correspondingly. If the MNPs are small enough
anisotropic energy can be lower than the thermal energy kT, the magnetic 
moments are able to overcome the energy barrier and reverse the spin direction. 
- 78 - 
 of MNPs of ferromagnetism and superparamagnetism
For large MPs (blue line), 




ure 3.1, the magnetic anisotropy energy 
nisotropic constant and V is the particle volume).






 (Reprinted by 
(U) barrier which 
uV 
13 Usually, 
 their magnetic 
 In this case, the MNP is deemed to be superparamagnetic, because it behaves 
like a paramagnet and all the individual atomic moments add up to one (super) 
moment. Sometimes, MNP
magnetisms (ferro-
energy. The transition temperature (TB) where K
temperature. 
 
Figure 3.2 (a) Relationship between coercivity and nanoparticle size. 
Magnetization curves of 
Single-domain ferromagnetic nanoparticles ex
coercivity. (Reprinted by permission of the 
 
Figure 3.2 shows three 
For the extremely small MP, the magnetization and magnetic field exhibits linear 
relationship, and the magnetization is not saturated until very high magnetic 
field is applied (Fig
domain range), it exhibits superparamagneti
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s with a certain diameter c
 or super-) according to different temperatures, 
uV= kTB, is called 
MPs.  
hibit remanence and 
Royal Society
typical hysteresis curves for MPs with different sizes. 
ure 3.2b). As the MNP size increases (still in the single 
sm, where the magnetization curve 
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shows rapid magnetic saturation with no remanence and coercivity (Figure 3.2c). 
As the particle size increases further, it exhibits ferromagnetism showing 
significant remanence and coercivity in its magnetization curve (Figure 3.2d). 
Maximum coercivity is observed at the transition from the multidomain to single 
domains. In a multidomain regime, the coercivity increases as the overall 
particle size decreases. While In a single domain regime, the coercivity 
decreases to zero as the particle size decreases (Figure 3.2a).15  
 
3.2 MP synthesis and modifications 
 
Magnetite (Fe3O4) and maghemite (γ−Fe2O3) are the main representatives of 
the MPs, which have attracted massive attention so far in the medical and 
biosensing fields, due to their good biocompatibility and non-toxicity. As 
mentioned above, MPs exhibit unique, sized-dependent magnetic properties 
that are quite different and unavailable from the bulk counterparts, and their 
magnetic properties are strongly dependent on their dimensions, size 
distribution and surface functionality. In order to obtain uniform size MPs, 
several different synthetic approaches have been reported which are critical for 
realizing their specific bio-related applications.  
 
The co-precipitation approach is one of the most often used methods to 
produce magnetite (Fe3O4) and maghemite (γ−Fe2O3) nanoparticles due to its 
facile and convenient procedure. In this approach, the synthesis of iron oxide is 
usually carried out by co-precipitation of iron (II)-, and iron (III) salts (e.g. 
chlorides, sulfates, nitrates) in aqueous solution assisted by addition of alkaline 
reagent.16-18 Besides its simplicity, this method has other advantages such as 
high product yield, low cost and good reproducibility.19 In addition, this method 
can also control the nanoparticle size effectively by adjusting the reaction pH, 
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time and temperature, etc. Nevertheless, this approach does suffer a few 
disadvantages, such as the prepared iron oxide nanoparticles can be poorly 
crystalline if carried out at or near room temperature, or easily aggregated if 
performed at higher temperature (80~100°C).20  
 
High-temperature decomposition of organometallic precursors in high-boiling 
solvents in the presence of surfactant molecules is another often used method 
for MP preparation. Inspired by the successful preparation of high quality 
semiconductor nanocrystals in organic phase,21-22 this approach has been 
developed to prepare monodisperse MPs. For example, uniform size Fe3O4 
MPs have been synthesized by thermally decomposing iron acetylacetonate 
[Fe(C2H3O2)2)] in an inert gas protected atmosphere.23 In addition, using the 
synthesized small MPs as seeds, larger MPs could be prepared by this means. 
Thus controlled synthesis of different sized MPs could be realized by carefully 
optimizing the experimental conditions.23 Compared with the co-precipitation 
method, the thermal decomposition strategy is more complicated but could 
narrow the size distribution and improve the morphology of the MPs. 
Nevertheless, MPs prepared by this method are often coated by organic ligand 
and have to be transferred to the aqueous phase for further bio-applications. 
 
Hydrothermal synthesis is another favourite approach for nanomaterial 
preparation because it is facile and convenient.24-26 This method is often carried 
out in a sealed autoclave at high pressure and temperature which is well above 
the boiling point of the solvent used. Thus the iron salts (nitrates, sulfates, 
chlorides, acetates, etc) are forced to hydrolyse and then dehydrated, resulting 
in the nucleation for nanoparticle formation. With this strategy, many 
nanomaterials could be prepared at temperatures well below those required by 
the thermal decomposition approach. Similarly to the chemical co-precipitation 
method, this approach is able to control the geometry of the resulting 
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nanomaterials by choosing suitable reactants and solvent and tuning the 
reaction time, temperature and the reactant concentrations.27 Nevertheless, 
MPs prepared by this method are usually composed of fine crystals compared 
with those prepared by the chemical co-precipitation method.25  
 
Besides these frequently used methods discussed above, there are some other 
means for MP preparations such as microemulsions28-29, gas phase 
deposition30, sol-gel method.31-32 Researchers could choose the most suitable 
strategy to synthesis MPs according to their desire and research requirements. 
 
Generally, due to their high surface/volume ratio, the prepared MPs have high 
surface energy which makes them readily aggregated or easily oxidized, which 
can significantly reduce their intrinsic magnetic properties. In this regard, the 
prepared MPs are usually modified with a protective coating to improve their 
stability. A number of different surface coating have been explored, which 
include siloxane33-35, amphiphilic micelles (such as PEG-phospholipids36, PEG-
Phosphine Oxide Polymer37), or polymeric ligands (such as polypyrrole38, 
polyaniline39, polyethyleneimine40 ).10, 32, 41 Not only can these coatings increase 
their stability, but they are also able to introduce functional groups such as 
amine or carboxyl moieties to facilitate their further conjugation with 
biomolecules. Besides, Au coating is another favourite means42-43, which not 
only enables surface plasmon resonance (SPR), but also gives the particles 
strong and specific affinity for thiolate compounds through the facile gold-thiol 
self-assembly. 
 
For any bio-related applications, the ability of controlled and efficient attachment 
of biomolecules to the outer shell of the MPs is of critical importance.44 Table 
3.2 summarises some of the main immobilization approaches that have been 
used to conjugate biomolecules with MPs. 
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Table 3.2 A list of immobilisation protocols of biomolecules used to my 













Amine glutaradehyde amine 46 
gold -- Thiol 47 
gold 2-iminothiolane amine 48-49 
carboxyl EDC, NHS amine 9 
avidin -- biotin 50 
 
These strategies listed above facilitated the applications of MPs especially in 
the bioanalytical and disease diagnostic areas. Indeed, MP-bioconjugates have 
been widely used in bioimaging 5, targeted delivery of therapeutic agents 6, 
biosensing and diagnostics 7, bio-separation 3, 8, and catalysis 9. In the following 
section, the recent developments of MP-based ultrasensitive biosensors for 
diagnostics will be discussed.  
 
3.3 Biosensors and bioassays based on MPs 
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Currently, the most often used assay in clinical disease diagnosis is enzyme 
linked immunosorbent assay (ELISA), an antibody (Ab) based technique using 
a surface immobilized Ab1 and an enzyme-linked Ab2 to sandwich the target, 
converting each target into an Ab1/target/Ab2 sandwich for sensitive enzymatic 
detection. Although widely used, its sensitivity is often limited by factors such as 
the low activity of surface- bound Abs, inefficient target capture and slow 
binding kinetics.51 As a result, ELISA often cannot provide the speed and, 
particularly sensitivity, required for early diagnosis because of the extremely low 
levels of biomarkers. Therefore there is great clinical need to develop faster, 
more sensitive assays for early diagnosis.  
 
In this regard, MPs have recently received significant research interest due to 
their unique magnetic properties and low toxicity 1. These sensors employing 
MPs include three major types, DNA-, antibody- and aptamer- based assays, 
from their target-recognition elements used. 
 
Ab is the most often used target-binding element in current clinical assays. The 
use of MP-Ab conjugates in immunoassays can offer several advantages over 
surface-immobilized Abs, 1) improve target capture efficiency via the use of 
excess MP-Ab conjugates that can push the equilibrium toward the captured 
protein state 51 as well as increased target-binding affinity from the multi-valency 
of the MP-Ab capture probes; 51-52 2) increase target binding kinetics (the 
binding interaction now takes place in homogeneous solution rather than 
solid/solution interface); 51 and 3) enable more efficient signal amplification (via 
multi-tags on each MP).53 Over the past decade, several ultrasensitive assays 
with limit of detection (LOD) down to low fM to aM level (several orders of 
magnitudes lower than ELISA) have been reported. These are mostly based on 
sandwich assays similar to ELISA. A few significant developments are 
highlighted below. 
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Aptamers are short, single-stranded DNA or RNA molecules selected from large 
random pool of sequence libraries by SELEX (systematic evolution of ligands by 
exponential enrichment) process 54-56. Compared to Abs, aptamers have 
several advantageous properties, such as broader target choice (e.g. proteins, 
small molecules, metal ions and even whole cells) with comparable affinity, 
higher thermal and long-term stability, cheaper and easier production and 
modification, and no batch-to-batch variations 57-58. Therefore it is unsurprising 
that aptamers have been widely used in MP-based biosensing and diagnostic 
applications 59. Herein the sensors are highlighted accordingly to their readout 
strategies.  
 
The unique magnetic properties of the MPs allow for efficient target capture, 
and enrichment by convenient magnetic separation and removal of unwanted 
species, making them ideally suited for developing ultrasensitive assays. 
Furthermore MPs can be combined with sensitive readout and signal 
amplification strategies to achieve femtomolar - attomolar sensitivities. Some 
typical biosensing approaches based on MPs will be highlighted in the following 
section defined by their signal-amplifying means.  
 
3.3.1 The giant magnetoresistive (GMR) sensor  
 
Instead of using MP purely for target capture and enrichment, this sensor, 
developed by the Wang group, detects the magnetic field of the MPs by the 
underlying giant magnetoresistive (GMR) sensor by applying a small external 
modulated magnetic field.60 As illustrated in Figure 3.3, capture DNAs (grey) 
immobilized on the sensor surface (a) are used to capture the biotinylated target 
DNAs via specific DNA hybridization (blue, b); (c) after washing away any free 
unbound species, streptavidin modified MPs are bound to the duplexes via 
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streptavidin-biotin interactions. The magnetic fields from the MPs are then 
detected by the underlying GMR sensor in real-time in the presence of a small 
external modulated magnetic field. Nevertheless, this sensing platform needs to 
be further improved for label-free detection, which is more valuable for real 
applications rather than biotinylated DNA strands detection. 
 
 
Figure 3.3 Schematic principle of the GMR sensor. (Reprinted by permission of 
the Elsevier)60 
 
Subsequently, this sensor has been used to detect protein targets via a 
sandwich assay format.61 Here, Capture Abs were first immobilized on the 
sensor surface to capture the target antigens. After washing away free unbound 
antigens, biotinylated probe Abs were added into the system, where only the 
Abs specific for the target antigens will bind and any unbound free Abs are 
washed away. Streptavidin-modified MPs were then added in to bind with the 
sandwiches via streptavidin–biotin interactions. Thus label-free protein target 
detection has been realized by applying the GMR sensor.  
 
Furthermore, it is claimed that the sensor can simultaneously quantitate multiple 
proteins in various clinical fluids with LODs down to approximately 50 aM, and 
can monitor multiple protein markers in real time.61 More importantly, this 
sensor is matrix-insensitive: its sensing performance is not affected by 
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environmental changes, such as pH, temperature, ionic strength, and serum 
proteins, making it a very promising ultrasensitive sensing platform for early 
clinical diagnosis. 
 
3.3.2 Magnetic relaxation switch (MRS) assay 
 
 
Figure 3.4 Schematic representation of the MRS assay principle for lysozyme 
detection.  
Self-assembled MPs aggregates (via hybridization of complementary 
DNAs tagged on two kinds of MPs) disassemble on introduction of the 
lysozyme, leading to T2 increase. (Reprinted by permission of the 
American Chemical Society)64 
 
MP based biosensors that do not use other signal transducers usually use 
magnetic relaxation switch (MRS) as the readout signal, by measuring the 
change in the spin-spin relaxation time (T2) between dispersed MPs and their 
aggregated forms. The MRS assay was first developed by the Weissleder group 
for specific DNA detection.62 Subsequently, this strategy was extended to detect 
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thrombin using corresponding aptamers by the same group.63 This assay uses 
two well-dispersed gold-coated Fe3O4 MPs, each tagged with a different 
aptamer targeting each of the two binding sites on thrombin. When thrombin is 
present, both aptamers bind to thrombin, leading to the MP aggregation and T2 
decrease. Using this approach, a detectable T2 change is observed in the 
presence of 1 nM human -thrombin. 
 
This method has recently been used for lysozyme detection using a single 
aptamer-MP conjugate (with LOD ~ 0.5 nM).64 As illustrated in Figure 3.4, two 
kinds of MPs are modified with anti-lysozyme DNA aptamer and linker DNA 
respectively. Since the lysozyme aptamer and linker DNA are complimentary, 
the MPs self-assemble into aggregates via DNA hybridization initially. After 
introduction of lysozyme, the aggregates disassemble leading to T2 increase. 
The MRS assays are simple with good selectivity, although their sensitivities 
(typically low nanomolar) have yet to match current clinical assays. 
 
3.3.3 Surface plasmon resonance (SPR)-based assay 
 
SPR is a label-free surface based bioassay widely used to detect target binding 
induced changes of reflection intensities or angles. It can follow the bindings in 
real time without target labelling.  
 
Figure 3.5 shows the principle for detection of a small-molecule target (ATP).65 
Firstly, the ssDNA which is partial complementary to the ATP aptamer was 
immobilized on an SPR gold film as a sensing surface. In the absence of ATP, 
ATP-aptamer functionalized MPs (MPs-apt) would bind to the SPR sensor by 
DNA hybridization reaction resulting in a significant change of SPR signal due 
to the huge mass of MPs. Whereas in the presence of ATP, the aptamer would 
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conjugate with ATP. Thus more ATP target existence leads to less MP-apt 
binding to the SPR surface. The concentration of ATP has a proportional 
relationship with the SPR signal decrease (with nanomolar sensitivity).  
 
 
Figure 3.5 Schematic principle of the SPR biosensor for the detection of small 
molecule (ATP). (Reprinted by permission of the American Chemical 
Society)65 
 
This developed SPR biosensor has also been used for detection of protein (e.g. 
thrombin) with picomolar sensitivity66. The MPs here are used as signal 
amplification tags for each target binding event via their significant mass. 
 
3.3.4. The bio-bar-code-based assay 
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The Bio-Bar-Code-Based assay was developed by the Mirkin group, where two 
types of probes were applied: a probe DNA1-conjugated magnetic microparticle 
(MMP; P1-MMP) and a probe DNA2-attached gold nanoparticle (GNP) each 
tagged with hundreds of barcode DNAs (P2-GNP), which were used to 
sandwich the target associated with the anthrax lethal factor (T), forming a 
MMP-P1/T/P2-GNP sandwich. It was then separated magnetically, followed by 
washing to remove any unbound species. Then the barcode DNAs were 
released from the sandwich, converting each target DNA into hundreds of 
barcode DNAs, which were detected sensitively by scanometric assay coupled 
with silver amplification. This assay combines efficient target capture, 
enrichment, target conversion and amplification (each target is amplified to 
hundreds of barcode DNAs, which greatly reduces the background). As a result, 
it can achieve label-free detection of target DNA down to 500 zeptomolar (zM = 
10-21 M) sensitivity (see Figure 3.6).67 
 
This assay has also been used to detect prostate specific antigen (PSA, a 
protein biomarker for prostate cancer) achieving a sensitivity of ~ 30 aM level, 
approximately five orders of magnitudes lower than ELISA allows.51 
Subsequently, multiplexed detection of protein cancer markers based on bio-
bar-coded nanoparticle probes has been performed using two different DNA 
barcodes for respective protein targets for signal amplifications.68 Moreover, this 
assay has been recently adapted to monitor the PSA level of patients after 
surgical treatments far below what was possible by ELISA,51, 69-70 thus 
highlighting its great potential in early clinical diagnosis. 
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Figure 3.6 The DNA detection based on bio-bar-coded assay.  
(A) Preparations of the two types of probes conjugated particle. (B) 
Illustration of the DNA amplification and analysis procedures. (Reprinted 
by permission of the American Chemical Society)67  
 
3.3.5 Enzymatic assay  
 
Enzymes are efficient biocatalysts that can offer great amplification power 
through efficient catalytic turnover of specific substrates under mild reaction 
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conditions mostly in aqueous environment, and thus are often regarded as 
“green” and environmental friendly. They are therefore often combined with the 
MPs to develop ultrasensitive sensors. Several readout strategies, such as 
electrochemical,71 colorimetric,72 fluorimetric,73 chemiluminescence,71, 74 and 
more recently via a personal glucose meter,50 have been used in these assays. 
 
3.3.5.1 Electrochemical redox detection  
 
Electrochemical redox detection is one of the most widely used readout 
strategies in MP-aptamer sensors. For example, ochratoxin A (OTA), an 
important mycotoxin contaminant in food, has been detected sensitively in an 
electrochemical competitive assay. This is based on the fact that OTA can 
effectively compete with the binding of OTA tagged HRP on anti-OTA aptamer-
MP conjugates. Therefore, when OTA is added, it reduces the amount of OTA-
HRP that can bind to the MPs, reducing the electrochemical response 
(originating from OTA-HRPs remaining attached to the MPs) for OTA readout. 
This ‘signal-off’ sensor gives a detection limit of 0.07 ng/mL OTA and works in 
food extracts 71.  
 
More recently, multi-HRP-tagged GNP has been used for greater signal 
amplification in a thrombin sensor. This assay took the unique feature of the 
thrombin target, having two independent binding sites recognized by two 
different aptamers; therefore, an aptamer-MP conjugate (MP-Apt1) and a 
second aptamer-GNP conjugate tagged with multi-HRPs (Apt2-GNP-HRPm) can 
sandwich thrombin, forming an MP-Apt1/thrombin/Apt2-GNP-HRPm sandwich, 
which was separated magnetically, and effectively converting each thrombin 
into multiple HRPs. The HRPs within the sandwich were detected 
electrochemically. This ‘signal-on’ sensor offered an impressive sensitivity for 
thrombin (LOD: ~30 fM)75. Despite displaying high sensitivity, this assay only 
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works for targets with two or more binding sites, limiting the scope of its 
application. The combined use of HRPm-GNP and MP-Apt conjugates has 
recently been extended to the detection of cocaine 76. 
 
 
Figure 3.7 Detection principles of the immunosensor based on MB-HRP 
conjugated cluster and Au NPs.  
In the left corner is the Ab2 functionalized MB-HRP conjugate (HRP is 
denoted as ●). The immunosensor immobilized with Ab1 was exposed to 
target antigen. And after protein capture, Ab2-MB-HRP conjugate clusters 
were added for specific binding to obtain amplification. (Reprinted by 
permission of the Wiley-vch Verlag GmbH)53 
 
In addition, an electrochemical-based sandwich nanostructured assay has 
recently been reported by Munge et al.53 As depicted in Figure 3.7, this 
immunosensor involved a glutathione-modified GNP surface tagged with Ab1, 
and a second Ab functionalized MMP tagged with approximately 500,000 
enzymes (HRPs), which were employed to sandwich the target cancer marker, 
Interleukin-8, for sensitive electrochemical redox detection. The massive 
number of HRP tags on the MMP greatly increased the signal amplification, 
 allowing detection of Interleukin




This simple and sensitive readout strategy is widely used in MP based 
sensors.77-79 For instance, 
quadruplex complex for catalysis of lumin
(CL), have been used for amplified DNA detection by the Zhang group.
nicking endonuclease assisted strand
developed in this study. 
 




As presented in Figure 3.8
sequence (orange) for nicking endonuclease and two domains of the DNAzyme 
sequences (blue), were immobilized
orange region of the hairpin DNA is complimentary to target DNA (
the existence of target DNA, they hybridize with target DNA forming duplex. 
Subsequently, nicking endonuclease was added, which recogni
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-8 down to 100 aM level in serum, over four 
 
 (CL) detection 
HRP mimicking DNAzymes, mostly using a hemin/G
ol-H2O2 based Chemiluminescence 
-scission cycle has been delicately 
 
cycle. (Reprinted by permission of the Royal Society 
, the thiolated hairpin DNA, which includes a specific 




red), thus in 
zes only the 
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specific sequences (orange) in dsDNA and cleaves them to generate two 
separated DNAzyme domains and release the target DNA spontaneously at an 
elevated temperature. Consequently, the target strands were recycled for 
further strand-scission cycles and the signal enhancement was realized with an 
estimated LOD down to 76 aM. More importantly, this developed sensing 
platform could be extended to analyze the concentration of cancer cells (Ramos 
cells) assisted by respective aptamers.78 
 
Similar sensitivity has also been achieved by combining the DNAzyme with 
rolling circle amplification (RCA) by the same group.79 Instead of converting 
each target into one DNAzyme as above, a novel sensing strategy combining 
DNA-ligation and efficient RCA amplification was designed, where each target 
was converted into many DNAzymes, and hence greatly improved the signal 
amplification power. Impressive sensitivities have been realized for both protein 
(thrombin, LOD: 6.6 pM) and DNA (LOD: 71 aM) targets. Moreover, this sensor 
had extremely high single-nucleotide polymorphism (SNP) discrimination 
factors > 10,000:1, and worked in human serum without polymerase chain 
reaction (PCR) pre-amplification79. Since SNP is widely associated with 
diseases, this sensor is likely to have broad applications in diagnosing many 
genetic-related diseases. 
 
Furthermore, the Lu group has used two different enzymes, alkaline 
phosphatase (ALP) and HRP, and substrate-resolved chemiluminescence (CL) 
technology to simultaneously detect adenosine and cocaine (see Figure 3.9).80 
In this system, a set of a capture DNA-MP conjugate, biotin- (or digoxigenin-) 
modified probe DNA, and a specific aptamer (the capture and probe DNAs are 
complementary to each half of the aptamer sequence) were used for each 
target. They were assembled into two individual MP-capture 
DNA/aptamer/probe DNA sandwiches. Introduction of a specific target 
 displaced its specific probe DNA from the sandwich, reducing the amount of 
streptavidin-HRP (or anti
leading to reduced CL as readout signal. This signal
simultaneously quantitate adenosine and cocaine down to an approximately 10 
nM level. 
 
Figure 3.9 Schematic illustration of the CL detection of two small molecules 
(adenosine ● and cocaine
Two aptamers for adenosine and cocaine are sandwiched by 
DNA and probe DNA
events, the probe DNA
after magnetic separation, the reduced enzymatic signals of the system 
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 ●).  
-HRP (or ALP). Upon target-aptamer recognition 
-HRP (or ALP) would detach 
(Reprinted by permission of the
)80   
 personal glucose meters 
-off sensor could 
 
MP-capture 
from the MP. Thus 
 Royal 
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Figure 3.10 Detection of small molecules using MP-aptamer and glucose meter. 
First, DNA-invertases are immobilized on the MP-aptamer conjugate 
surface through hybridization. Then target molecules are captured by the 
MP surface aptamers, releasing invertases from the MP. After magnetic 
separation, sucrose is added to initiate the invertase- catalysed glucose 
production. Target quantitation is realized by measuring the glucose 
concentration using a glucose meter. (Reprinted by permission of the 
Nature Publishing Group)50 
 
This simple, general ‘sweet-sensing’ aptasensor developed by the Lu group can 
quantitate multiple targets: cocaine, adenosine, interferon-gamma (IFN-γ) of 
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tuberculosis and uranium.50 This assay used a MP-conjugated with multiple 
different aptamers, each hybridized to a specific, short DNA-tagged invertase. 
The specific recognition of a target by its aptamer triggers the release of a DNA-
invertase from the MP surface. After magnetic separation to remove the MPs, 
sucrose was added to the supernatant, and glucose production catalyzed by the 
released invertase in the supernatant was monitored by a personal glucose 
meter for target quantitation (see Figure 3.10).  
 
This assay is general (applicable to any targets with known aptamers) and 
simple (detection via existing personal glucose sensors), so is well-suited for 
home diagnosis. However, its sensitivity (approximately micromolar for small 
molecules and nanomolar for proteins) has yet to match those of current clinical 
assays. Therefore it is most suitable for detection of relatively highly abundant 
targets only, limiting its potential for early diagnosis.  
 
Lately, this sensing platform has also been applied for DNA detection based on 
the sandwich assay format by the same research group with a detection limit of 
~40 pM with SNP discrimination ability.81 
 
3.3.6 Fluorescence detection 
 
Adenosine detection using a DNA aptamer as the recognizing element and MPs 
as carriers has also been performed using fluorescence detection.82 This 
fluorescence-based detection approach uses a fluorophore-labelled aptamer 
(F*-aptamer)-MP conjugate hybridized with a quencher-tagged anti-aptamer 
strand. Upon target binding to the aptamer, the quencher-tagged anti-aptamer 
is displaced from the MP conjugate, resulting in a significant increase of the 
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fluorescence intensity of the MP–F*-aptamer conjugate that can be used for 
target quantitation.  
 
An advantage here is that it can be combined with flow cytometry to measure 
each individual MP–F*-aptamer conjugate under a capillary flow that 
significantly reduces the background and improves assay throughput (see 
Figure 3.11). However, the sensitivity achieved here (LOD: ~170 µM) is 
considerably lower than other ultrasensitive approaches described above. 
 
 
Figure 3.11 MMP assisted fluorescent aptamer sensor for adenosine.  
In the presence of adenosine (denoted as a red star), a quencher labelled 
DNA is displaced making the fluorescence signal enhanced. F represents 
FAM fluorophore and Q represents quencher. (Reprinted by permission of 
the American Chemical Society)82 
 
In addition, two sets of F*-aptamer and MP–aptamer conjugate probes have 
been used to simultaneously detect two protein targets, thrombin and lysozyme, 
using the sandwich-binding format with LODs of 60 and 200 pM, respectively.83 
A limitation of the sandwich assay is that it only works for a target that has two 
accessible binding sites, limiting its application scope. More recently, an F*-
aptamer has been combined with molecular beacon and RCA for greater signal 
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enhancement. The resulting sensor achieved an impressive LOD of 0.48 nM for 
cocaine, a small-molecule target.84 
 
Lately, a RCA immunoassay for protein detection based on DNA enriching MPs 
and assembled fluorescent DNA nanotags has been designed.85 In this versatile 
assay illustrated in Figure 3.12, one target protein detection event was first 
converted into the detection of massive p-DNA in one binding event. Then 
through the RCA process, p-DNA probes were extended to much longer DNA 
strands with repeated units.  
 
 
Figure 3.12 Principle of the ultrasensitive MPs-RCA immunoassay facilitated by 
fluorescent DNA nanotags.  
(A) Design and preparation of dsDNA (p-DNA–c-DNA) and Anti-human 
IgG modified MPs; (B) Process of the immunoreaction for specific protein 
(Human IgG) detection followed by the release of p-DNA for further signal 
amplification; (C) Process of the RCA initiated by p-DNA probes and 
formation of the fluorescent DNA nanotags (dsDNA- SYBR Green 1). 
(Reprinted by permission of the Royal Society Chemistry)85  
 
Subsequently, probe DNA was added in to hybridize with the RCA product 
forming duplex DNA. SYBR Green 1 is an intercalating dye whose fluorescence 
will significantly increase after intercalation in dsDNA. Thus the fluorescent DNA 
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nanotags (SYBR Green 1 in dsDNA) were self-assembled. Thus the protein 
quantification could be realized by monitoring the fluorescence of the 
assembled DNA nanotags, whose fluorescence is significantly stronger than 
that of the non-intercalating SYBR Green 1 molecules. This developed sensing 
platform achieves a competitive estimated LOD of 8.3 aM. 
 
3.3.7 Electrochemiluminescence (ECL) detection  
 
Electrochemiluminescence (ECL) is another sensitive readout strategy recently 
exploited by the Zhang group in detecting whole cancer cells using structure-
switching MP-aptamer sensors 47, 74, 86. A MP-Au-CdS complex74 or a 
CuS/DNA/Au/DNA/MP nanoprobe86 was used for efficient amplification of the 
CL or ECL signal used in these sensitive MP-based sensors. These sensors 
showed impressive sensitivities for specific target DNA sequences (LOD: 6.8 
aM) and Ramos cells (LOD: 56 cells/mL)86.  
 
More recently, a multiple CdSe/ZnS QDs -modified dendrimer and a nicking 
enzyme catalyzed target cycling strategy have been combined for the sensitive 
detection of cancer cells.47 As depicted by Figure 3.13, multiple dendrimer/QDs-
DNA probes were attached to gold-coated MPs through a thiolated linker DNA 
sequence. Meanwhile, a signal anti-aptamer DNA was hybridized to an 
aptamer-MP conjugate, which upon binding to target cell, was displaced. The 
displaced anti-aptamer DNA could then hybridize to the linker DNA in-between 
the gold-coated MPs and dendrimer/QDs-DNA probe, promoting specific 
cleavage on the linker DNA by a nicking enzyme, and was subsequently 
recycled for further cleavage, releasing multiple dendrimer/ QDs-DNA probes. 
The released dendrimer/QDs-DNA probes were then hybridized to a capture 
DNAs-coated GNP surface for sensitive ECL detection. This sensors showed 
high sensitivity for cancer cells (LOD: 68 cells/mL), so may have potential in 
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Figure 3.13 Illustration of the process for cancer cell detection.  
(A) Preparation of the dendrimer /QD probes and (B) ECL assays for 
cancer cells based on dendrimer/QD Nanoclusters assisted with nicking 
cycles. (Reprinted by permission of the American Chemical Society)47 
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 3.4 Overview of the project (part ǁ) 
 
The unique magnetic properties of the MPs have been most exploited in 
ultrasensitive MP-based assays, where MPs are combined with sensitive 
readout and signal amplification strategies to achieve femtomolar - attomolar 
sensitivities, several orders of magnitudes higher than ELISA. These assays 
appear well suited for early disease diagnosis by detecting the very low levels of 
disease biomarkers that are impossible to detect with current clinical assays. A 
few significant examples here include the nanoparticle barcode assay69, the 
nanostructured immunosensor53, and enzyme based amplification coupled with 
sensitive fluorescence or CL (ECL) detections47, 86.  
 
Nevertheless, most of these sensors have demonstrated high sensitivity for just 
a single target, and biosensors based on MPs for sensitive multiplexed analysis 
of biomolecule targets (DNA87, protein61, small molecule80) have rarely been 
reported.  
 
Multiplexed DNA detections based on a MP-dye sandwich assay have been 
reported by the He group.87 In this assay, two dyes (Cy3 and Cy5) were 
employed as signal reporters for respective DNA targets. Although this strategy 
is simple and easy to handle, its sensitivity (~100 pM) has yet to be able to 
match the more established clinical assays. A “signal-off” biosensor for 
simultaneous analysis of adenosine and cocaine has been designed by 
adapting two enzymes (ALP and HRP) for signal amplification.80 Nevertheless, 
the LOD of this assay is ~10 nM, which may be further improved by switching 
the “signal-off” to the “signal-on” principle. The giant magnetoresistive sensor, 
which combines ultra-high sensitivity, multiplexed- and matrix-insensitive 
detection, appears to be extremely well-suited for early clinical diagnosis.61 
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However, this assay requires specific instrumentation and well-trained 
researchers, which limits its generalization. 
 
Consequently, the second part of my project is to develop a facile sensitive 
DNA sensor with multiplexing ability based on a MP-based enzymatic sandwich 
assay. Firstly, uniform and stable MPs are to be prepared, modified and 
functionalized with capture DNA strands. In this regards, a careful management 
of the MP surface and DNA conjugation chemistry is key to ensure a low 
background (by reducing non-specific absorption). Then efficient enzymes 
(HRP and ALP) will be used to enhance the signal significantly, which is very 
important for pushing down the detection limit. Another issue to be addressed is 
to realize ultrasensitive SNP discriminations in cancer specific genes, which is 
key to develop sensitive, reliable early clinical diagnostic assays (most protein 
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Chapter 4 
Simultaneous quantification of multiple DNA targets using 




Many important human diseases are often associated with the presence of 
specific biomarkers (e.g. DNA sequences, proteins and small molecules) in 
abnormal concentrations. Therefore massive attention is being paid towards the 
development of facile and sensitive biosensors capable of screening a wide 
variety of disease biomarkers in clinical samples, allowing for diagnosis of 
diseases, and the prediction of patients’ responses to treatment, risk of relapse 
of disease and outcomes for clinical diagnostics.1 Among which, DNA based 
diagnostics is the most important which alone has accounted for a $17.3 billion 
market in 2012. PCR is the most widely used technique currently for DNA 
detection due to its exponential amplification capability.2-3 However, as a result 
of its massive amplification power, even a tiny amount of contaminant in 
samples could produce non- negligible false positive results which can hamper 
the fidelity and accuracy of this technique. Whereas enzymes, such as HRP 
and ALP, are highly efficient biocatalysts, offering robust and large signal 
amplification power even within complex media such as whole blood. As a 
result, they are widely used in the development of sensitive biosensors using a 
wide range of different readout strategies, such as electrochemical,4 
colorimetric,5 fluorimetric,6 chemiluminescence, 4, 7-9 
 
Among these methods, electrochemical detections using enzymes as sensing 
elements have been generally reported.10-12 For example, enzyme based 
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specific DNA sensors have been demonstrated by employing a hairpin DNA 
probe as recognizing element and HRP as signal transducer.13-14 ALP has also 
been employed to amplify signals by catalyzing soluble product into insoluble 
products.15-16  
 
At present, the gold standard technique employed in clinical disease diagnosis 
of low abundant protein biomarkers is ELISA, which uses a surface immobilized 
antibody (Ab1) and an enzyme-conjugated antibody (Ab2-enzyme) to sandwich 
the target, effectively converting each captured protein target into an Ab1-
target-Ab2-enzyme sandwich for sensitive target readout. This approach 
generally possesses good sensitivity and specificity, but constraints such as 
reduced reactivity and accessibility of surface immobilized Ab1, inefficient target 
capture (limited by the fundamental target-Ab binding affinity) and slow binding 
kinetics between surface immobilized Ab1 and target in solution, often result in 
relatively long assay time, preventing it achieving ultra-high sensitivity (fM-aM) 
that is highly valuable for earlier diagnosis.17  
 
A major improvement on the sensing performance of ELISA has been the 
introduction of nanomaterials which can offer sufficient surface spaces to 
immobilize multiple capture molecules, and allow for fast and efficient target 
capture in a homogenous environment.17 Besides these advantages, dedicated 
and cost-effective synthesis and modification methods of nanomaterials have 
also promoted their general usage. Among these nanomaterials, MNPs have 
recently attracted significant attention due to their unique superparamagnetic 
properties and low toxicity, making them especially advantageous for 
biosensing.18  
 
MNPs can be synthesized by well established methods and modified with stable 
and nontoxic functional coatings 19-22 for bioconjugation. Moreover, the tiny 
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particle size coupled with superparamagnetic property allows them to form 
uniform, homogenous dispersions in solution (hence rapid, target binding) in the 
absence of an external magnetic field, yet they are readily retrieved upon 
application of an external magnetic field. These characteristics make them well-
suited for target capture, separation and enrichment from real-world samples to 
achieve sensitive biosensing.23 
 
In real-world clinical sample analysis, the detection of one single disease 
marker may not be able to provide an unambiguous diagnosis of disease (to 
date, ″no tumor marker identified to date is sufficiently sensitive or specific to be 
used on its own to screen for cancer″),24 and therefore multiple markers should 
be used to improve the diagnostic robustness and accuracy. Thus development 
of a sensitive assay that can simultaneously detect multiple cancer markers is a 
necessary and urgent need for enhancing the fidelity and accuracy of early 
clinical diagnosis. In this regard, several nanosensors capable of 
simultaneously detecting multiple different targets have been reported over the 
past few years. For example, a GMR sensor developed in the Wang group 
recently has been shown to be capable of multiplexed cancer marker monitoring 
by using the GMR property of MNPs as signal reporter. The GMR sensor is 
highly sensitive and robust, and more importantly it is effectively insensitive to 
environmental sensing conditions (pH, temperature, ionic strength), and thus 
has great potential for sensing and diagnostic techniques for real-world 
samples.25 In addition, gold nanoparticles are reported to have extraordinary 
universal quenching ability for different fluorescent dyes in close proximity.26 
Taking advantage of this, a multicolor GNP based nanobeacon has been 
designed for selective analysis of three DNA targets.1 Similarly, planar 
graphene has been employed to detect multiple DNAs by using its universal 
efficient quenching property for organic dyes.27-28 Nevertheless, the LOD of 
these approaches (~nM level) has to be improved to make them competitive 
against current clinical assays. 
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Herein, I developed a simple, rapid, sensitive and highly specific DNA sensor 
using a MNP based DNA-sandwich assay combined with efficient enzymatic 
amplification. Thiolated capture DNA (cDNA) strands are covalently immobilized 
onto the amine- functionalized MNPs using a PEGylated heterofunctional 
crosslinker (NHS-PEG12-Maleimide) to form a MNP-cDNA probe. In the 
presence of DNA target, the MNP-cDNA and an enzyme conjugated signal DNA 
(sDNA-En) could sandwich bind the target DNA, forming a MNP-dsDNA-En 
sandwich, which effectively converts each captured target DNA into an enzyme 
and is readily separated from the reaction media. Therefore, the detection and 
quantification of the DNA targets could be readily realized by simply monitoring 
the catalyzing property of the converted enzymes. 
 
4.2 Material and methods 
 
4.2.1 Materials and instruments 
 
All DNA probes and target strands were purchased commercially from IBA 
GmbH (Germany). They were all HPLC purified by the supplier and their 
sequences are summarized in Table 4.1. Both HRP-NAV and ALP-NAV were 
purchased from Thermo Fisher Scientific (UK). Amplex red and fluorescein 
diphosphate (FDP) were purchased from Invitrogen Life Technologies (UK). All 
other chemicals and reagents were purchased from Sigma-Aldrich (UK) and 
used without further purification unless otherwise stated. PBS buffer (137 mM 
NaCl, 10 mM Na2HPO4, 2.7 mM KCl and 1.8 mM KH2PO4, pH is 7.4 unless 
otherwise noted) and Tris buffer (100 mM Tris-base, 100 mM NaCl, pH 8.5) was 
made with ultra-pure MilliQ water (resistance > 18 MΩ.cm-1). The MNPs were 
synthesized and modified in house. All UV absorption spectra were recorded on 
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a Cary 50 Bio UV-Vis spectro- photometer in a quartz cuvette with an optical 
path length of 1.0 cm.  
 
Table 4.1 DNA sequences used (5’-3’) in this study. 
Name Sequence (5’-3’) 






cDNA3 TGGCGTAGGCAAGAGTTT TTT TTT TT-HS 
sDNA3 Biotin-TTT TTT-GTGGTAGTTGGAGCTGG 
DNA3 ACTCTTGCCTACGCCACCAGCTCCAACTACCAC 
 
4.2.2 Experimental methods for MNP synthesis 
 
The MNPs were prepared by a co-precipitation method.21, 29-31 The synthetic 
and functionalizing procedure of the MNP is shown schematically in Figure 4.1.  
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Figure 4.1 Illustration of the procedures for MNPs Preparation and modification.  
It should be noted that several hundred strands of the cDNAs are attached 
to each MNP, and only one is shown here for simplicity. (Reprinted by 
permission of the Royal Society Chemistry)32 
 
5 mmol FeCl2·4H2O and 10 mmol FeCl3·6H2O were dissolved in 50 mL 
deoxygenated H2O under magnetic stirring. Then 4.3 ml NH3·H2O (35%) 
solution mixed with 50 mL deoxygenated H2O was added into the above 
solution dropwise with N2 gas bubbling, forming black precipitates. The mixture 
was heated at 80 oC for 30 min in an oil bath under vigorous stirring and then 
for another 2 h at 90 oC following the addition of 50 mL of 0.2 M trisodium citrate 
(see Figure 4.1). The obtained Fe3O4 MNPs appeared as a black precipitate 
which was separated by centrifugation (4000 g for 3 min) and then washed 
once with acetone. Finally, the MNPs were dispersed in deionized water (with 
the volume being adjusted to 30 mL).21, 29-31 
 
Fe3O4/SiO2 core/shell MNPs were prepared by using a modified Stöber 
method.33 In typical preparation, 1 mL of the hydrophilic Fe3O4 seeds prepared 
above was firstly diluted with the mixture of 4 mL deionized water and 20 mL 
absolute ethanol. Under continuous stirring and N2 bubbling, 0.43 mL NH3·H2O 
(35%) solution and 0.5 mL tetraethyl orthosilicate (TEOS) were consecutively 
added to the above suspension. The hydrolysis/condensation reaction was 
allowed to proceed for 3 h under N2 gas bubbling at room temperature (see 
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Figure 4.1). Subsequently the obtained Fe3O4/SiO2 core/shell MNPs were 
separated by centrifuging at 4000 rpm for 5 min and then washed by water 
twice. Finally, the obtained MNPs were re-dispersed in deionized water (total 
volume: 1 mL). 
 
Amine functionalised Fe3O4/SiO2 core/shell MNPs were prepared as follows: 20-
21, 30, 33-35 1 mL of the silica-coated Fe3O4/SiO2 core/shell MNPs prepared above 
was dispersed in 4 mL deionized water and 20 mL absolute ethanol. Then 0.43 
mL NH3·H2O (35%) solution and 0.5 mL of (3-aminopropyl)triethoxysilane 
(APTES) were consecutively added to the solution under continuous stirring and 
N2 gas bubbling. The reaction was carried out for 3 h at room temperature, 
leaving to APTES to hydrolyse and subsequently condense on the MNP surface 
to introduce amine groups (see Figure 4.1). Afterwards, the amine 
functionalized MNPs (NH2-MNPs) were separated, washed and then re-
dispersed in deionized water. Concentration of the MNP suspension was 
estimated by comparing the suspension’s weight with pure water of the same 
volume. 
 
5 mg NH2-MNP and 2.5 mg SM(PEG)12 were mixed and incubated in PBS 
buffer (containing 1mM EDTA, pH = 7.2) at room temperature for 1 h, leading to 
the MNP surface being functionalised with maleimide groups. Thereafter, the 
MNPs were washed by PBS buffer (containing 1mM EDTA, pH = 7.2) twice, and 
then 5 nmol of thiolated cDNA in 1 mL PBS buffer (containing 1mM EDTA, pH = 
7.2) was added into the above MNPs and incubated for 1 h at room temperature. 
The cDNA is covalently conjugated to the MNP surface via Michael addition of 
the thiolate to the MNP surface maleimide groups (see Figure 4.1). The MNPs 
were subsequently washed twice by PBS buffer (containing 1mM EDTA, pH = 
7.2). It should be noted that all of the original and washing supernatants were 
collected and combined for UV measurement at 260 nm to determine the 
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amount of free-unbound cDNA, allowing the estimation of the cDNA conjugation 
efficiency on the MNP (assuming the reduced amount of cDNA has conjugated 
to the MNP). The cDNA loaded MNPs were then treated with 5 µL of 2-
mercaptoethanol in 1 mL PBS buffer containing 1 mg/mL BSA to cap any 
unreacted maleimide groups and to block the MNP surface to reduce non-
specific absorption of HRP-NAV.  
 
4.2.3 Experimental methods for MNP characterization 
 
XRD (X-ray diffraction) tests were performed on X’pert MPD instrument by 
PANalytic. The scan range (2θ) was from 10 to 90 ° at increments of 0.0332 ° 
with a scan speed of 0.5 second/step. 
The infra-red (IR) spectra were obtained from a Perkin elmer FT-IR 
spectrometer at room temperature. The dried sample was pressed into the disk 
and the transmission properties in the range between 4000 and 500 cm-1 were 
recorded. 
The hydrodynamic sizes of as synthesized citrated MNPs were characterized in 
PBS buffer on a Brookhaven Instruments Corp BI-200SM Laser Light Scattering 
Goniometer with a BI-APD detector using a He-Ne laser at 633 nm (scattering 
angle: 90°, temperature: 25 °C). 
The magnetic properties of the MNPs were tested with a MagLab vibration 
sample magnetometer (Oxford Instruments) operating at 55 Hz with amplitude 
of 1.5 mm. The sensitivity of the instrument is about 2 µemu, with a ﬁeld range 
of up to 9 T. The samples were measured at room temperature (290 K) at a 
magnetic ﬁeld scan rate of 9.17 mT/s. 
 
4.2.4 Experimental methods for DNA detection 
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At first, HRP-NAV was incubated with biotinylated sDNA for 1 h at 1:1 molar 
ratio in PBS buffer containing 1 mg/mL bovine serum albumin (BSA) to make 
the HRP and sDNA conjugate (HRP-sDNA). Then cDNA-MNPs were mixed 
with HRP-sDNA and target DNA of various concentrations. The final volume of 
each sample is 500 µL in PBS buffer containing 1 mg/mL BSA. After incubation 
for 1 h at room temperature (unless otherwise noted), the resulting MNPs were 
retrieved magnetically and were subsequently washed several times to remove 
any unbound target DNA and HRP-sDNA. The washing procedures were as 
follows: 500 µL PBS buffer once, 500 µL PBS buffer (containing 0.1% Tween-
20) twice, and 500 µL PBS buffer once again. Following that the MNPs 
sandwiches were dispersed in 380 µL PBS buffer, and the enzymatic 
amplification was initiated by the addition of 50 µL amplex red (0.2 mM) and 50 
µL H2O2 (0.2 mM). After a certain period, the enzymatic assays were stopped 
by adding 20 µL NaN3 (1 M) solution. The samples were centrifuged to remove 
MNPs and reduce its scattering effect, and the UV-vis absorption spectra of all 
the resulting supernatants were recorded. 
 
Likewise, ALP-sDNA conjugates were prepared by mixing ALP-NAV with 
biotinylated sDNA for 1 h at 1: 1 molar ratio in Tris buffer (containing 1 mg/mL 
BSA). Then cDNA-MNPs were mixed with ALP-sDNA and target DNA at 
various concentrations in 500 µL Tris buffer (containing 1 mg/mL BSA). After 
incubation for 1 h at room temperature, all the samples were washed to remove 
any unbound species from the MNP-dsDNA-ALP sandwiches. The washing 
procedures were similar to thouse described above, simply replacing the PBS 
buffer with Tris buffer (e.g. 500 µL Tris buffer once, 500 µL Tris buffer 
containing 0.1% Tween-20 twice, and 500 µL Tris buffer once again). Then the 
MNP sandwiches were dispersed in 430 µL Tris buffer, and then each was 
mixed with 50 µL fluorescent diphosphate (FDP) (0.2 mM) initiating the 
enzymatic amplification assay. After a certain amplification time, 20 µL PBS 
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buffer was added to the resulting solution to stop the enzymatic reaction, and 
the UV spectra of the resulting supernatants were recorded. 
 
For simultaneous two DNA target detection, MNPs-cDNA1 and MNP-cDNA2 
(15 µg each) were first mixed with 15 µL ALP-sDNA1 (0.25 µM) and 15 µL 
HRP-sDNA2 (0.25 µM) followed by addition of two different target DNA strands 
(DNA1 and DNA2 with the ratio 1 to 1) with different concentrations (0 -1 nM). 
Due to the inhibition effect of PBS buffer on ALP activity, Tris buffer was used in 
preparing samples and washing procedures (e.g. 500 µL Tris buffer once, 500 
µL Tris buffer containing 0.1% Tween-20 twice, and 500 µL Tris buffer once 
again).. After that the MNP sandwiches were dispersed in 330 µL Tris buffer, 
and 50 µL FDP (0.2 mM), 50 µL amplex red (0.2 mM) and 50 µL H2O2 (0.2 mM) 
were pipetted into each sample to initiate the enzymatic amplification assays for 
1 h. After which the enzymatic amplification were stopped by the addition of 20 
µL PBS buffer and 20 µL NaN3 (1 M) respectively. Finally, the UV spectra of the 
resulting supernatants of all samples were recorded. 
 
4.3 Characterization of MNPs  
 
A series of characterization experiments for MNP and MNP-NH2 have been 
carried out before they are used in the DNA sensing assays. Firstly, the 
magnetic retrieving property of the prepared MNP-NH2 has been demonstrated 
by placing their suspension on a magnetic track. 
 
Figure 4.2 shows that MNPs are well-dispersed in water, forming a uniform 
suspension before applying an external magnetic field. Upon placing onto a 
standard biomag separation device for 1 min, almost all of the MNPs have been 
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attracted to the side wall of the tube, confirming that the MNPs are easily 
retrieved upon applying a magnetic field for easy magnetic separation. 
 
 
Figure 4.2 Representative photographs of the MNP-NH2 dispersed in water. 
The dispersion when placed onto a biomag separation device (A) and after 
waiting for 1 min (B). . (Reprinted by permission of the Royal Society 
Chemistry)32 
 
The powder XRD result is consistent with magnetite (Fe3O4) showing all of the 
major characteristic peaks expected for magnetite, which have been indicated 
in Figure 4.3A. 
 
The synthesized amine functionalized MNPs were dried and characterized 
using IR spectroscopy. A strong IR absorption band at ~569 cm-1 corresponding 
to the νFe-O vibrations of the magnetite core is seen in Figure 4.3B. The bands at 
~1085 cm-1 correspond to the Si–OH vibrations of the silica shell. A broad band 
at around 3440 cm-1 is related to –NH– and/or OH– stretching modes.36-37 
 
Uniform suspensions of the MNP and MNP-NH2 were tested by the dynamic 
light scattering (DLS) instrument and their statistical size distributions were 
shown in Figure 4.3C. The average hydrodynamic sizes of the MNP and MNP-
NH2 are determined as 28.9 ± 5.3 and 178 ± 26 nm, respectively.  
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Figure 4.3 Characterizations of the prepared MNP (MNP-NH2). 
(A) Powder X-ray diffraction (XRD) spectra of core only MNP, with the 
expected diffraction peaks for the Fe3O4. (B) Typical IR spectra of the 
MNP and MNP-NH2. (C) The hydrodynamic diameters for core only MNP 
and MNP-NH2 were determined as ~29 and ~178 nm, respectively. (D) 
Magnetization of MNP-NH2 as a function of magnetic field obtained by 
VSM. 
 
A vibrating Sample Magnetometer (VSM) was used to characterize the 
magnetic properties of MNP-NH2. Figure 4.3D displays the hysteresis loops of 
the MNP-NH2. The hysteresis loops exhibit a magnetic saturation value of 40 
emu/g at 290 K. The synthesized MNPs-NH2 form a stable, homogenous 
dispersion without aggregation in the absence of applied external magnetic field, 
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and yet they can be readily retrieved from the assay media in 1 min with an 
applied magnetic field, making them well-suited for biosensing because they 
can offer rapid target capture and effective magnetic separation (see Figure 
4.2B). 
 
4.4 Enzyme activities and inhibitors 
 
ELISA has been used to detect a wide range of targets such as proteins, 
nucleic acids and pathogens as standard in biochemical analysis and clinical 
diagnostics. ELISA assays usually employ enzymes to catalyze colorless or 
non-fluorescent substrates into colored and/or fluorescent products to report 
and amplify signals. Inspired by ELISA, here two frequently used enzymes in 
ELISA - HRP and ALP - are introduced in this system for signal amplification. 
 
HRP is isolated from horseradish roots and is a single chain polypeptide 
containing four disulfide bridges. It is a 40,000 Dalton glycoprotein containing 18% 
carbohydrate whose composition depends upon the specific isozyme.38 Apart 
from its small molecular weight, its glycosylation results in low non-specific 
binding, which makes HRP the most widely used signal amplification label in 
immunochemistry applications.39  
 
In the presence of hydrogen peroxide (H2O2), HRP could convert a wide variety 
of substrates (e.g., luminol, TMB, DAB, ABTS and amplex red). Here amplex 
red is used as enzyme substrate (e.g. hydrogen donor) to be converted to 
resorufin by reducing H2O2 to H2O under the catalysis of HRP (see Figure 
4.4A).40-41 Resorufin has absorption (extinction coefficient: 54,000 cm-1M-1) and 
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fluorescence emission maxima of 563 nm and 587 nm, respectively, allowing for 
both absorption and fluorescence based readout.  
 
HRP is stable and maintains catalyzing ability in the pH range of 5.0 to 9.0. 
HRP has been shown to possess optimum activity in the pH range of 6.0 to 6.5, 
and retain ~84% of the maximum activity at pH 7.5.42 In this study, a near- 
physiological pH (7.4) was adapted for single DNA detection using HRP as the 
efficient signal amplification element. In addition, a few compounds are found 
having inhibitory effects on HRP activity such as sodium azide, cyanide, L–
cystine, dichromate, hydroxylamine, sulfide, vanadate42, which can be used to 
terminate the enzymatic reaction after a certain period to tune the signal 
amplification power and assay time. 
 
ALP is a hydrolase enzyme which catalyzes the hydrolysis of phosphate 
monoesters by removing the phosphate substituent. As its name suggests, ALP 
is most effective at an alkaline pH.43 Moreover, it requires zinc, and magnesium 
or calcium divalent ions for its activity.44 Since ALP has specificity for phosphate 
esters of alcohols, amines, and phenols, it is often used to dephosphorylate 
proteins and nucleic acids.45-46 More importantly, ALP is also a widely used 
enzyme which conjugates to antibodies and other proteins as a label for ELISA, 
Western blotting, and histochemical detection. In this system, ALP is used to 
hydrolyze FDP, which is a colorless and nonfluorescent molecule. Sequential 
hydrolysis of the two phosphate moieties yields firstly a weakly fluorescent 
fluorescein monophosphate followed by strongly fluorescent fluorescein (see 
Figure 4.4B). The produced fluorescein as the signal reporter possesses 
excitation and emission maximum at ~490 and 514 nm respectively. Quite a few 
compounds could act as inhibitors for ALP activity, such as arsenate, cystine, 
iodine, inorganic phosphate.47 
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Figure 4.4 Illustrations for the HRP and ALP catalyzed enzymatic assays 
 
In this research, NaN3 was chosen as the stopping reagent for the enzymatic 
reaction of the HRP-NAV. To test its inhibition effect on the enzymatic assay, 
the enzymatic catalyzed absorbance change at 571 nm was monitored before 
and after addition of this inhibitor by UV spectroscopy. In the beginning, the 
enzymatic reaction of 100 fmol (200 pM in PBS buffer, final concentration) HRP-
NAV was triggered by addition of substrates (amplex red and H2O2, 20 µM each, 
final concentration). After about 15 min, 20 µL NaN3 (1M) was pipetted into the 
reaction cuvette, and the enzymatic assay was continuously recorded (see 
Figure 4.5).  
 
As inorganic phosphate is known as an inhibitor for the ALP-NAV catalyzed 
reaction, herein the inhibition ability of PBS buffer was studied. The absorbance 
change at 485 nm was monitored before and after addition of PBS buffer. The 
enzymatic reactions of 100 fmol (200 pM in Tris buffer, final concentration) ALP-
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NAV was initially triggered by addition of its substrates (FDP, 20 µM, final 
concentration). After about 10 min, 20 µL PBS buffer was pipetted into the 
reaction cuvette, and the enzymatic assay was continuously recorded (Figure 
4.5, red line).  
As shown in Figure 4.5, initially, the absorbance for both assays (at 485 nm for 
ALP-NAV and 571 nm for HRP-NAV) increased steadily with the increasing 
assay time, which indicated the formation of coloured products (resorufin and 
fluorescein) catalyzed by HRP-NAV and ALP-NAV, respectively. Upon addition 
of their respective inhibitors (NaN3 and PBS buffer for HRP-NAV and ALP-NAV 
systems respectively), the absorbance decreased at first, due to the dilution 
effect and then kept constant because the colored products were no longer 
being produced due to inhibition of the respective enzymes. The results clearly 
demonstrate that these two enzymatic reactions can be stopped immediately 
upon addition of their corresponding inhibitors. Because the enzymatic 
amplification time is critical for signal readings, the discovery of appropriate 
inhibitors allows us to control the enzymatic amplification time accurately and 
reduce the signal variations before measurement. This is especially important 
for carrying out high-throughput detections, where the use of appropriate 
enzyme inhibitors is indispensible. 
 
Moreover, the assay curves also allow us to determine the substrate turnover 
rates of HRP-NAV in PBS buffer and Tris buffer and ALP-NAV in Tris buffer. 
The extinction coefficients (ε) of the enzymatic products resorufin and 
fluorescein are 54 (mM*cm)-1 and 50.4 (mM*cm)-1. Slopes for each kinetic curve 
could be obtained by linear fitting the data for the first 5 mins. According to the 
equation below, 
Rate=Slope/([enzyme]*ε)  (4.1) 
From the slope of the assay curve, the substrate turnover rates for each 
enzymatic assay could be calculated. HRP-NAV could turnover 65 and 56 
- 126 - 
 
amplex red molecules into resorufin per second in PBS buffer and Tris buffer, 
respectively. While ALP-NAV could turnover 65 FDP molecules into fluorescein 
per second in Tris buffer at pH 8.5. 
 










 ALP in Tris 
 HRP in PBS
 HRP in Tris 
20µL PBS
 
Figure 4.5 Activities and inhibitions of the enzymes used in this study. 
Typical UV-vis assay curves show the catalytic activities of the HRP and 
ALP in different buffers and their inhibition by NaN3 and phosphate. 
 
4.5 DNA sensing using HRP as sensing element 
 
Figure 4.6 shows this approach schematically. Two short ssDNA probes, each 
complementary to one half of the DNA target, are designed. The two probes are 
modified with a biotin (blue, to be conjugated with enzymes for signal 
amplification) and -thiol (green, to be conjugated onto MNP surface for target 
capture and separation), respectively. In the presence of a target DNA strand, 
the two probes are hybridised with it forming a sandwich structure with an 
exposed terminal biotin, through which HRP is bound to the MNP surface. Thus 
detection of target DNA is now converted into detection of enzymes. After a 
series of washing procedures and magnetic separation, excess sDNA-HRP is 
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washed off from the mixture to reduce background. Subsequently, the 
enzymatic assay is carried out for signal amplification and the spectra are 
recorded. Since HRP could catalyze hundreds of thousands of amplex red 
molecules (colourless) into strongly colored resorufin over a 1 h assay period. 
The method allows sensitive DNA detection via the resulting absorption signals. 
 
 
Figure 4.6 Schematic illustration of this strategy to DNA detection.  
A biotin-probe DNA (blue) is conjugated with HRP and a thiol-probe DNA 
(green) is bound with MNP, which are then hybridized to each half of a 
complementary DNA target. The formed sandwiches are then separated 
and subjected to enzymatic assay. 
 
4.5.1 Optimization of the MNP-enzyme sandwich sensing platform 
 
4.5.1.1 Effect of cDNA-MNP surface blocking 
 
As shown in the Figure 4.1 the MNP-NH2 was first reacted with SM(PEG)12 to 
introduce maleimide function groups upon which the thiolated cDNA was 
covalently conjugated. A PEG12 linker is used here because it is well-known to 
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be one of the most effective coatings in resisting non-specific adsorption of 
biomolecules, reducing background and improving sensitivity.48 In addition, the 
amount of the MNP surface maleimide functional groups was in large excess 
over the amount of cDNA to ensure high conjugation efficiency. Therefore there 
should still be considerable unreacted free maleimide groups left on the 
nanoparticle surface, which can lead to non-specific adsorption of the HRP-NAV 
and hence significantly increased background. Thus, 2-mercaptoethanol was 
used to react with any free maleimide groups remaining after cDNA conjugation. 
Next the MNPs were further treated with a cheap protein, BSA, to block any un-
occupied sites and hence reduce non-specific adsorption of the HRP-NAV. The 
effect of cDNA-MNP surface blocking (by 2-mercaptoethanol and 1 mg/mL BSA, 
see MNP preparation part) on the assay specificity for the DNA target detection 
has been investigated.  
 
Specifically, 20 µg MNP-cDNA1 (either before or after blocking) was mixed with 
HRP-sDNA1 (10 nM, final concentration) and with or without target DNA1 (100 
pM, final concentration) in 500 µL PBS buffer. After incubation for 1 h and 
washing with PBS buffer, the resulting MNP-DNA-enzyme sandwich was 
subjected to 1 hr enzyme amplification and the absorbance at 571 nm of each 
sample was recorded and is shown in Figure 4.7. 
 
As indicated in Figure 4.7, the grey and red bars show the assay prior to and 
after the blocking (by 2-mercaptoethanol and 1 mg/mL BSA, see MNP 
preparation part), respectively. The signal/background ratio for 5 fmol DNA1 
target increases from ~4.4 (before blocking) to ~62 after blocking, confirming 
surface blocking is essential to achieve high signal/background ratio. Therefore 
all cDNA-MNPs have been blocked by 2-mercaptoethanol and BSA before 
being used. 
 















Figure 4.7 Effect of cDNA-MNP surface blocking on the assay specificity for 
DNA target detection. . (Reprinted by permission of the Royal Society 
Chemistry)32 
 
4.5.1.2 Evaluation of the effect of MNP amount 
 
Evaluation of the effect of MNP amount on the assay sensitivity has been 
carried out by using various amounts (0-40 µg) of MNP-cDNA1 with a fixed 
amount of 5 pmol HRP-sDNA to detect DNA1 (200 pM, final concentration) in 
PBS 7.4 buffer. After 1 h incubation and washing, 40 mins enzyme amplification 
was carried out and the absorbance of each sample was recorded. In the mean 
time, the mixtures of various amounts of MNP-cDNA with 5 pmol HRP-sDNA 
without target DNA were also prepared and tested as controls. 
 
Figure 4.8 shows the effect of the cDNA-MNP amount on the signal response 
for detecting 5 fmol DNA target: red dots● show the assay without the DNA 
target (background due to non-specific adsorption), and black squares■ show 
the assay with 5 fmol DNA target, and blue triangles▲ (black squares■ - red 
dots●) show the net contribution from the DNA target.  
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 With DNA target
 No DNA target




cDNA-MNP amount (µg)  
Figure 4.8 Absorbance of samples using different amounts of cDNA-MNPs to 
detect 200 pM (5 fmol) DNA1 and corresponding blank controls. . 
(Reprinted by permission of the Royal Society Chemistry)32 
 
Although 2-mercaptoethanol and BSA were used to treat the MNPs to reduce 
the non-specific absorption, this cannot eliminate the non-specific adsorption of 
the enzyme completely. A small amount of the HRP-NAV can still absorb on the 
MNPs surface non-specifically, contributing to some background signal. As 
displayed in Figure 4.8, although increasing the amount of MNP-cDNA used in 
the assay produced a stronger signal, indicating more efficient target capture, 
however, the background due to enzyme nonspecific absorption also increased 
significantly. As a result, the net contribution from the DNA target only (black – 
red) actually decreased when the amount of MNPs was over 20 µg. Therefore, 
20 µg cDNA-MNP was found to be optimum here because it gave the maximum 
net signal from the DNA target. Thus 20µg MNP-cDNA was employed for the 
later experiments. 
 
4.5.1.3 Evaluation of temperature effect 
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Temperature is an important environmental factor for biosensing because it 
could affect specific recognition kinetics and moreover the enzyme activity. 
Herein, the dependence on temperature was assessed.  
 
20 µg MNP-cDNA3 were mixed with 20 µL HRP-sDNA3 (0.25 µM) and target 
DNA3 of various concentrations. The final volume of each sample is 500 µL in 
PBS buffer (containing 1 mg/mL BSA). Four sets of samples as described 
above were prepared and incubated for 1 h at 4 different temperatures (4 °C, 
15 °C, 24 °C, 37 °C). After this, all of the samples were washed to remove 
unbound target DNA and HRP-sDNA, and finally the UV spectra of all the 
supernatants of samples were recorded after 1 h enzymatic amplification at 
room temperature. 
 
As shown in Figure 4.9, temperature does affect the sensitivity of the assay. 
Specifically, in the tested temperature range, as temperature goes up, the 
sensitivity (slope of the calibration curve) increases correspondingly and 
reaches its maximum value at 24 °C. As the temperature increases further to 
37 °C, the sensitivity is maintained almost the same as that at 24 °C (roughly 
about room temperature. Therefore all assays were subsequently carried out at 
room temperature without specific temperature controls. Here, the sensitivity 
reflects the combined effects of the enzyme activity and the DNA hybridization 
efficiency (e.g. capture efficiency). 
  
HRP was reported to be reasonably thermal stable, its tertiary structure melted 
at ~45 °C to be a pre-molten globule form.49-50 Its optimum activity temperature 
was reported to be 45 °C-50 °C according to the product introduction from 
invitrogen. The depletion of the heme catalytic centre from the cavity in HRP 
structure takes place at ~74 °C.50 The DNA hybridization melting temperature 
was evaluated using the “Sci tool” on “integrated DNA technologies” website to 
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be ~52 °C. However, in this experiment, since the concentration of the target 
DNA sequences used here is much lower (down to ~pM range, with the cDNA 
and sDNA concentration of ~10 nM), the melting temperature of the resulting 
nicked dsDNA structure would be much lower than 52 °C. 
 
At lower temperature (for instance 4 °C), the DNA hybridization is facilitated, 
while the enzymatic activity is severely hampered. As the temperature goes up 
to 37 °C, which is still below the optimum activity temperature of HRP, 49-50 the 
catalytic reactivity of HRP is assumed to be increasing accordingly. However, 
the similar sensitivity of the assay observed at 24 °C and 37 °C may suggest 
that the DNA hybridization efficiency is reduced as temperature is increased 
from 24 to 37 °C.  
 





























Figure 4.9 Effects of temperatures on DNA sensing ability.  
(A) Absorbance responses of DNA titrations at different testing 
temperatures. (B) Slopes (sensing sensitivity) of each linear curve of DNA 
titrations at different temperatures. 
 
Inspection of the temperature dependence of the sensing system indicates that 
this sensing platform can work over a wide temperature range (4 - 37 °C) 
although its sensitivity varies with temperature. Therefore, all of the subsequent 
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experiments are carried out at room temperature (~24 °C) for convenience and 
optimum results. 
 
4.5.1.4 Evaluation of cDNA loading amounts on MNPs 
 
The loading amounts of cDNA3 on the MNP surface could also affect the 
sensing ability of the system. 20 µg MNPs conjugated with different amounts of 
cDNA3 were mixed with 20 µL HRP-sDNA3 (0.25 µM) and target DNA3 of 
various concentrations in 500 µL PBS buffer (all containing 1 mg/mL BSA). After 
1 h incubation and washing process, enzymatic amplification (1 h) was carried 
out. Finally the UV spectra of all the samples were recorded.  
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Figure 4.10 Effect of cDNA loading amounts on the MNP on the capture 
efficiency (assay absorbance response).  
(A) Absorbance responses of DNA titrations by MNPs with different cDNA 
loading amounts. (B) Slopes (sensing sensitivity) of each linear curve of 
DNA titrations by MNPs with different cDNA loading amounts. . (Reprinted 
by permission of the Royal Society Chemistry)32 
 
As shown in Figure 4.10A, for the MNP loaded with the lowest amount of cDNA 
(0.005 nmol cDNA per mg MNP, Black squares■, total cDNA on 20 µg MNP 
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was 100 fmol), the absorbance increases linearly with the increasing target 
DNA3 concentration initially, but becomes quickly saturated at 50 pM (25 fmol in 
500 µL). This result seems to suggest that not all MNP immobilised cDNAs can 
hybridize to (capture) the target DNA, and its maximum capture (hybridization) 
efficiency here is found to be ~25% (25/100). 
 
Moreover, as the loading amounts of the capture DNA on MNPs increase, the 
sensitivity of the sensor (slope of the sensing curve) increases at first, but 
achieves a maximum value at ~0.5 nmol/mg. Therefore this loading is 
determined as optimum, and is used for all subsequent assays.  
 
4.5.2 Wide range DNA titrations using optimized experimental 
conditions 
 
Using the optimized experimental conditions, a wider target DNA concentration 
range was implemented as follows to demonstrate the dynamic range of the 
sensing system. 
 
Specifically, 20 µg MNPs loaded with ~10 pmol cDNA were mixed with 5 pmol 
HRP-sDNA3 and various amounts of target DNA3 (0 - 0.5 pmol). The final 
volume of each sample was 500 µL in PBS buffer (containing 1 mg/mL BSA). 
After 1 h incubation at room temperature, a washing process was carried out to 
remove any unbound species. Then the MNP-dsDNA-HRP sandwiches were 
subjected to enzymatic amplification for 1 h. After which, 20 µL NaN3 (1 M) was 
added into each sample to stop the enzymatic assay and the UV spectra of all 
the supernatants of samples were recorded. 
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Figure 4.11 Wide range DNA quantification using HRP as signal reporter. 
(A) Absorption spectra with inset: sample photo; (B) calibration curve for 
quantification of DNA with Inset: linear fitted amplified region over 0-200 
pM DNA target. 
 
Figure 4.11 demonstrates the absorption spectra and calibration curve for DNA 
titration. Like other typical enzymatic reactions, the absorbance initially 
displayed a rapid and linear increase with the increasing target DNA 
concentration up to 200 pM (Figure 4.11B). As the target DNA concentration is 
increased further, the absorbance-concentration relationship deviates from 
linear and gradually becomes saturated (see Figure 4.11B data points for 0.5 - 
1 nM). This may be attributed to the depletion of amplex red concentration at 
higher target DNA (hence HRP) concentrations. The initial low target DNA 
concentration parts (data points for 0 - 200 pM) of the calibration curve showed 
a good linearity (R2 = 0.998, see Figure 4.11B inset). 
 
4.5.3 Kinetic studies for DNA titrations and HRP activities 
 
This MNP-enzyme sandwich assay for DNA detection is based upon the 
conversion of the target DNA strands into MNP-dsDNA-HRP sandwiches for 
target DNA detection. Thus the amount of enzyme HRP bound on the MNPs 
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represents the target DNA conjugation efficiency. To investigate the target 
capture efficiency of this proposed system, kinetic studies of both HRP of 
different concentration and DNA titrations have been carried out.  
 
For the HRP activity assay, solutions with different amounts (0 - 7.5 fmol) of 
HRP-NAV were prepared in 1300 µL PBS buffer (containing 1g/L BSA). The 
enzymatic activity assay was triggered by the addition of 200 µL substrates 
(containing amplex red and H2O2, 150 µM each in PBS buffer), and real-time 
absorbance changes were monitored by UV-Vis spectroscopy (see Figure 
4.12A). 
 
Similarly, for kinetics studies of DNA titrations, 20 µg cDNA3-MNPs were mixed 
with 5 pmol HRP-sDNA3 and target DNA3 of various amounts (0 - 150 fmol) in 
500 µL PBS 7.4 buffer (containing 1 mg/mL BSA). After 1 h incubation and 
washing processes, the MNP sandwiches were dispersed in 1300 µL PBS 7.4 
buffer (containing 1 mg/mL BSA), the enzymatic assay was initiated by the 
addition of 200 µL substrates (containing amplex red and H2O2, 150 µM each in 
PBS 7.4 buffer), and real-time absorbance changes were monitored (see Figure 
4.12B).  
 
Here, it is assumed that the free HRP in solution and bound HRP on MNPs 
have the same enzymatic activities. By carefully examining the correlations 
between the kinetic results of these two sets of experiments, the capture 
efficiency and theoretical detection limit are deduced. Using the fitted function 
for pure HRP activity (y*105=3.01+14.6*x, from Figure 4.12C), the conjugated 
HRP amounts on the MNPs through each individual MNP- dsDNA-HRP activity 
rate were calculated. Then, a plot demonstrating the correlation between the 
amount of target DNA and corresponding conjugated HRP on the MNP was 
obtained (see Figure 4.13). Since each conjugated HRP molecule on the MNP 
- 137 - 
 
indicates one target DNA mediated sandwich formation (assuming no 
dehybridisation of the MNP-dsDNA-HRP sandwich during the washing step), 
the successful target capture efficiency could be demonstrated by the ratio of 
conjugated HRP molecules to total target DNA amounts.  
 








































































Figure 4.12 The results for both sets (HRP only and MNP-DNA-HRP complex) 
of kinetic studies.  
Real time enzymatic kinetic curves for the HRP only (A) and MNP-DNA-
HRP complex (B) reactions are displayed. The relationship between the 
catalytic reaction rates and HRP amount (C) and total target DNA amounts 
(D) were fitted to a linear relationship. 
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Figure 4.13 Correlation between the total amount of target DNA and conjugated 
HRP on the MNPs mediated by target DNA.  
 
According to the fitted linear function, target DNA strands which lead directly to 
HRP conjugation on the MNP surface were only 7% of the total target DNA 
amounts, suggesting a successful DNA conversion rate of 7% using current 
experimental conditions. It should be possible to improve this by reducing the 
washing time (reducing the possible DNA loss from dsDNA dehybridisation), 
and also minimizing the loss of MNP during washing (it is unavoidable that a 
small fraction of the MNPs will be lost in each washing step). In the absence of 
target DNA strands (e.g. x = 0), the background signal is negative (-0.05), which 
might be caused by the scattering effect of MNPs in the suspension. On the 
other hand, this indicates the background of this sensing system is ultralow.  
 
As shown in Figure 4.12A (time traces of HRP activity), the HRP with 
concentration down to 50 fM (0.075 fmol) is clearly detectable, from which the 
theoretical detection limit of this sensing platform is estimated as ~715 fM (50 
fM/0.07) by this simple absorption assay. It may be concluded from the above 
kinetics results of HRP only and MNP-dsDNA-HRP complex, that increasing the 
target DNA conversion to MNP-linked HRP would be an important factor for 
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further sensitivity improvement. This issue may be solved by introducing a DNA 
ligase which could ligate the two probes to reduce the possible loss of 
conjugated HRP during the washing procedures. Otherwise, an enzyme with a 
higher activity is necessary to lower the detection limit. Seeking for enzymes 
that possesses higher catalytic activities is important to further improve the 
sensitivity of this assay. Nevertheless, even using current experimental 
condition without further optimization, a sub-pM level theoretical detection limit 
without DNA target amplification is already competitive in the DNA sensing field. 
 
In addition, DNA titrations subjected to different enzymatic amplification times 
were examined and the results are displayed in Figure 4.14. Over the whole 
DNA concentration range (0 - 1 nM), the titration curves show linearity in 
between 0 - 120 mins enzymatic amplification time. As the amplification time 
further extends to 180 mins (magenta plots) and 300 mins (dark yellow plots), 
the titration curves tend to deviate from linearity. These results indicate that the 
linear dynamic range is being narrowed down as the enzymatic time increasing. 
If examined more carefully over the lower DNA concentration range (see Figure 
4.14B), all of the titration curves over the 0 – 100 pM concentration range are of 
good linearity, while their slopes which represent sensitivities are enhanced 
proportionally as the enzymatic amplification time increase (see Figure 4.14C).  
 
The dynamic range is an important factor to evaluate an assay’s feasibility in 
real sample applications. By carefully tuning the enzymatic amplification time, 
the dynamic range could be adjusted correspondingly. For example, the 
dynamic range could be enlarged by reducing the enzymatic amplification time. 
On the other hand, increasing the amplification time can offer higher signal to 
background ratio thus enhancing sensitivity. Moreover, the MNPs could easily 
be retrieved by using an external magnet, thus the species of interest bound 
onto the MNPs could be easily concentrated or diluted where required, which 
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can be further combined with the adjustment of enzymatic amplification time to 
achieve the desired dynamic range to suit the specific assay needs. 
 






















































Figure 4.14 DNA titration studies subjected to different enzymatic amplification 
times. 
(A) DNA titration curves corresponding to different enzymatic amplification 
times (0 - 300 mins, the amplification times are indicated on each curve). 
(B) The enlarged region over 0 - 100 pM DNA target. (C) The relationship 
between the corresponding slopes of curves in (B) and amplification times. 
 
4.5.4 Generality and stability of MNP-cDNA 
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A major challenge of the proposed protocol is to apply the method for the 
detection of target DNAs in real biological samples, which are complex media. 
To test its feasibility, DNA samples in diluted human serum (10% in PBS buffer) 
were analyzed. 
 
Specifically, 20 µg cDNA3-MNPs were mixed with 5 pmol HRP-sDNA3 and 
target DNA3 of various amounts (0 -50 fmol). The final volume of each sample 
is 500 µL in 10% (v/v) human serum /PBS buffer. After incubation and washing 
processes, the MNP sandwiches were subjected to enzymatic amplification for 
1 h followed by stopping the amplification by addition of 20 µL NaN3 (1 M). The 
UV-Vis absorption spectra of the supernatants of all samples were recorded.  
 
 





























Figure 4.15 Absorbance spectra and calibration curve for DNA titrations in 
diluted human serum (10% in PBS 7.4 buffer). 
 
As shown in Figure 4.15, a good linear relationship between target 
concentration and absorbance has been obtained, which indicates this sensing 
platform also worked in human serum media. This is attributed to the robust 
surface modification and functionalisation of the MNPs, which minimized non-
specific adsorption and the interference from serum proteins. The higher 
sensitivity of this experiment in the serum than that in PBS buffer (slopes of the 
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calibration curves are 0.0025 and 0.0016, respectively) may be attributed to the 
batch-to-batch variations of the HRP activities. 
 
The stability of the MNP-cDNA is another important issue in developing 
practical and commercial assays, which often require the reagents to have a 
long shelf-life. To address this challenge, the MNP-cDNA probe suspension (in 
pure water) was examined after 5 months storage time in a fridge (4 °C).  
 
20 µg cDNA2-MNPs (either freshly prepared or 5 months old) were mixed with 5 
pmol HRP-sDNA2 and target DNA2 of various amounts (0 -100 fmol) in 500 µL 
PBS buffer. After incubation and washing processes, the MNP sandwiches 
were subjected to enzymatic assays in PBS buffer for 1 h. Finally, the 
amplification assay was stopped by addition of 20 µL NaN3 (1 M) and the UV-
Vis absorbance spectra of the supernatants of all the samples were recorded.  
 































Figure 4.16 Target DNA titration studies using freshly prepared and 5 months 
old cDNA-MNP. 
 
As shown in Figure 4.16, DNA quantitation has been realized by using the 5 
month old cDNA-MNPs with similar sensitivity to that using freshly prepared 
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MNP-cDNA. The 5 month old cDNA-MNPs not only remain magnetically 
responsive, but also exhibit reasonable good sensing ability. In this designed 
system, the synthesized and cDNA conjugated MNPs are stable due to a dense 
silica coating shell which can effectively protect the Fe3O4 core from further 
oxidation or etching caused by its environment. Besides, the PEG linker 
between the cDNA and MNP surface allows the necessary distance and 
repulsion between particles which avoids aggregation issues. 
 
4.6 DNA detection using ALP as signal reporter 
 
To further demonstrate the generality of the MNP-enzyme based sandwich 
assay for DNA detection, ALP was further used to substitute HRP in detecting a 
different DNA target. Because inorganic phosphate could effectively inhibit the 
enzymatic ability of ALP,47 Tris buffer (pH 8.5) was employed instead of PBS 
buffer in preparing the samples, washing and signal amplification procedures. 
 
For single DNA detection using ALP as signal amplifier, ALP-NAV was 
conjugated to biotin-sDNA first by 1 to 1 ratio for further use in the same way as 
that used for HRP. Then MNP-cDNA2 (20 µg) was mixed with 20 µL ALP-
sDNA2 (0.25 µM) and target DNA2 of various concentrations ranging from 0 - 
200 pM. The final volume of each assay was also 500 µL in Tris buffer 
(containing 1 mg/mL BSA). After 1 h incubation at room temperature, all the 
samples were washed with 500 µL Tris buffer once, Tris buffer (containing 0.1% 
Tween-20) twice, and Tris buffer once again to remove any unbound species. 
Then the MNP-dsDNA-enzyme sandwiches were dispersed in 430 µL Tris 
buffer, and then each was mixed with 50 µL FDP (0.2 mM) to initiate the 
enzymatic amplification assay. After 1 h, 20 µL PBS buffer was added to stop 
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the enzymatic reaction, and the UV spectra of all the supernatants of samples 
were recorded. 
 



























Figure 4.17 DNA detection using ALP as signal amplifier. 
(A) Absorption spectra of samples with different concentrations of target 
DNA2. (B) The linear relation between concentration of target and 
absorbance at 485 nm.  
 
ALP also has efficient catalytic properties which can turnover colorless 
molecules, FDP, into a highly coloured (and fluorescent) product, fluorescein 
which has its maximum absorption at 485 nm. The DNA sensing ability of this 
system involving ALP as signal amplifier has been tested (see Figure 4.17), 
where a good linear relationship (R2 = 0.994) between the absorbance and 
target DNA concentration over the 0 - 200 pM range was also obtained. The 
results clearly show that ALP is as just powerful as HRP in terms of substrate 
turnover (signal amplification) efficiency. As a result, after converting the target 
DNA into an ALP via the sandwich binding, it can also turnover hundreds of 
thousands non-coloured FDP molecules into strongly coloured product 
molecules, thus offering great signal amplification.  
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4.7 Simultaneous quantifications of two DNA targets 
 
 
Figure 4.18 Illustration for simultaneous two target DNA detection principle. 
Two types of MNPs each modified by a unique cDNA, were mixed with two 
different signal probes conjugated with either ALP or HRP. Upon addition 
of specific DNA targets, two different MNP-dsDNA-enzyme sandwiches 
are formed specifically, allowing specific detection of two different DNA 
targets via their respective enzymatic amplified signals, where absorbance 
from resorufin (λabs maximum at 571 nm) and fluorescein (λabs maximum at 
485 nm) represent DNA1 and DNA2 respectively.  
 
The ability of detection of multiple DNA biomarkers simultaneously opens new 
opportunities for understanding the disease, molecular diagnosis and new drug 
discovery.51 It is therefore critical to develop robust, sensitive, and simple 
detection methods that can perform multiple DNA targets analysis.  
 
Compared to PCR, which have a limited multiplex ability and often offer false-
positive results due to target variations,52 this proposed approach based on the 
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MNPs and enzyme probes is simple, highly sensitive, selective, and possesses 
DNA multiplexing capacity. The large surface to volume ratio of MNPs and 
magnetic retrieval properties allows the efficient capture and separation of 
several DNA strands simultaneously, and DNA targets may be detected in the 
same solution by combining different enzymes. The principle of simultaneous 
detection of double DNA targets via sandwich assays is shown in Figure 4.18. 
cDNA1 modified MNPs and HRP-sDNA1 are mixed with cDNA2 modified MNPs 
and ALP-sDNA2 conjugates. Then in the presence of target DNA1, HRP would 
be bound to MNP-cDNA1 surface through specific DNA hybridizations. Likewise, 
target DNA2 mediated sandwich formation would link ALP to the MNP-cDNA2, 
effectively converting target DNA1 and DNA2 into HRP and ALP, respectively. 
Thus the two HRP and ALP catalyzed enzymatic assays can be used to amplify 
the target DNA1 and DNA2 signal, respectively. Through UV-vis evaluation, the 
absorbance from the produced resorufin (λabs maximum at 571 nm) and 
fluorescein (λabs maximum at 485 nm) can be used to quantify the concentration 
of DNA1 and DNA2, respectively.  
 
Detailed experimental procedures are as described above in the experimental 
methods, and UV spectra of all the supernatants of samples were recorded and 
are shown in Figure 4.19.  
 
As shown in Figure 4.19, the absorbance signals from resorufin (at 571 nm) and 
fluorescein (at 485 nm) represent DNA1 and DNA2, respectively. And the 
correlations between absorbance intensities and target DNA concentrations are 
demonstrated in Figure 4.19B. The linear dynamic range is 0 - 500 pM for both 
plots with similar slope (assay sensitivities). The absorption spectrum with 5 pM 
target DNA is clearly distinguishable from the background only (see Figure 
4.19B inset), the detection limit here for both DNA target is therefore estimated 
as 5 pM. 







































For DNA1: y=0.03532+0.00104*x (R2=0.975)
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Figure 4.19 Multiplex DNA detection. 
(A) Absorption spectra of the samples with various DNA concentrations 
(the two DNA targets are of the same concentrations). (B) The resulting 
calibration curves of the two different DNA targets, linear fits over the 0-
500 pM range for both DNA targets are given. The inset in (B) shows the 
zoomed spectra of samples without target (0 pM, background) and with 5 
pM target.  
 
These results presented here thus established a simple, versatile, multiplexed 
DNA sensing technique by simply using a set of unique MNP-cDNA and 
enzyme-sDNA probes that can form sequence-specific dsDNA sandwiches in 
the presence of the specific DNA target. An advantage of the approach here is 
the use of MNPs as nanoscale carriers to template the cDNA/target/sDNA 
sandwich formation, allowing for rapid, efficient target capture in a 
homogeneous solution and followed by convenient magnetic separation of 
unwanted species. Moreover, a large excess of the MNP-cDNA and enzyme-
sDNA probes can be used to push the equilibrium of the target toward the 
captured state, allowing detection of target well-below its thermal dynamic 
dissociation constant Kd.18, 53-56 Alternative approaches using a solid support to 
capture and separate the ligated products can suffer from low hybridization 
efficiency and slow binding kinetics, as a result, they require a longer assay 
time and often exhibit lower sensitivity (see Table 4.2).57 
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Table 4.2 Comparison of the sensing performances of several recently reported 
DNA assays.  
*(No. = number of target detected; LOD = limit of detection; S/N = signal to 
noise ratio) 




MNP-enzyme sandwich assay 2 5 ~27 This work 
Photonic crystal hydrogel beads 2 0.66 ~18 60 
Electrochemical detection based on bar-
coded GNPs 
2 ~4 ~12 23 
MNP-dye sandwich assay 2 100 ~90 61 
Au particle-on-wire Surface-Enhanced 
Raman Scattering (SERS) sensor 
4 10 ~88 62 
Fluorescence based on Ag@Poly(m-
phenylenediamine) Nanoparticles 
3 250 ~8.8 63 
chemiluminescence resonance energy 
transfer (CRET) between QD and DNAzyme 
1 10000 ~14 64 
Graphene quenched fluorescence 3 1000 ~13 28 
Graphene-Based High-Efficiency Surface-
Enhanced Raman Scattering (SERS) 
2 10 ~22 65 
Zn(II)-protoporphyrin IX/G-quadruplex 
complex with Exo III-assisted analyte 
recycle 
1 200 ~15 66 
MNP-enzyme probe via personal glucose 
meter detection 
1 40 ~60 67 
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Both enzymes employed here allow for sensitive detection of DNA target, 
because they both offer highly efficient enzymatic turnover rates. The MNP-
enzyme sandwich binding format can effectively convert each captured DNA 
target into a specific enzyme. During the 1 h amplification time, each enzyme 
can turnover more than 200,000 colorless substrates into strongly coloured 
product (see the calculated turnover rate of the HRP and ALP from Figure 4.5), 
allowing sensitive, simple colorimetric detection of target DNA.58-59 Besides, the 
enzymatic products (fluorescein from FDP by ALP and resorufin from amplex 
red by HRP) have distinct absorption spectra which have hardly any overlap, 
and thus the signal outputs for each of the two different target DNAs could be 
easily distinguished and analyzed. 
 
Moreover, another advantage of this approach is its general applicability: it can 
effectively target any DNA of interest by simply changing the sequences of the 
cDNA-/sDNA- probe pair. Compared to other reported DNA detection methods, 
this sensing method is simple to operate, having really low background 
interference, and more importantly can offer superior sensitivity and specificity 
to many other recently reported multiplexed DNA assays (see Table 4.2 for 




In summary, a simple, sensitive and quantitative DNA detection methodology 
has been successfully developed using MNP-cDNA and enzyme-sDNA probes 
in a sandwich binding format. This assay combines the advantages of the MNP 
based efficient target capture and easy magnetic separation, delicate MNP 
surface coating and blocking for greatly reduced background, together with the 
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great efficiency of enzyme based signal amplification, allowing low pM 
sensitivity for specific DNA. Such a low detection limit is better than or 
comparable with the other recently reported sensitive DNA sensors. Moreover, 
this assay also works equally efficiently even in complex media, such as 10% 
human serum, implying it has good potential for specific target DNA detection in 
real clinical samples. More importantly, this method also has the capability of 
detecting two different DNA targets in a homogenous phase simultaneously. 
Therefore it is believed that the sensing platform developed herein should have 
great potential for a wide range of DNA based multiplexed biosensing and 
disease diagnostic applications. 
 
Nevertheless, there are several strategies that can be used to address some of 
the issues related to the current assay format and further improve its sensitivity. 
First, the possible positive signal loss during the washing process due to the 
dissociation of the dsDNA sandwich format, which results in the detachment of 
enzymes from MNPs, is a limitation of this system (e.g. a target DNA to HRP 
enzyme conversion rate of ~7% was determined in Figure 4.13). This issue can 
be addressed by introducing a DNA ligase that can ligate the two probes 
templated by target DNA, making the signal DNA (hence enzyme) covalently 
bound to the MNPs and preventing signal loss during the washing process due 
to dsDNA dehybridisation. Second, this sensor could be further optimized by 
using more efficient alternative enzymes as the signal reporter and amplifier to 
improve the sensitivity. Furthermore, the use of multiple enzymes in one target 
recognition will offer greater signal amplification power and hence further 
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Chapter 5 
Sensitive single nucleotide polymorphism (SNP) discrimination 




Single-point mutations (SPMs) or SNPs in genetics are associated with 
numerous important human diseases, such as cancer, diabetes, vascular 
disease, and some forms of mental illness, etc. Therefore, the sensitive 
detection of specific SPMs and SNPs in particular genes has considerable 
value in disease diagnosis, and prediction of patients’ responses to treatment, 
risk of relapse of disease and outcomes.1-4 However, the inherent small 
difference in thermodynamic stability from a single-base mismatch between the 
perfect-match and its SNP targets makes it challenging to be able to achieve 
both high SNP discrimination and sensitivity. Over the past decade, several 
different approaches capable of SNP discrimination have been reported, such 
as high resolution DNA melting analysis (~µM level sensitivity),5-9 single 
molecule fluorescence (via different annealing and melting kinetics between the 
perfect- and SNP- targets);10 molecular beacon,11-13 hybridization chain 
reaction,14 surface enhanced Raman scattering15 and electrochemical chemical 
detection.16 Despite such developments, most methods reported so far 
displayed relatively low SNP discrimination ratios (ca. < 20 fold) and/or limited 
sensitivity, and can also suffer from poor fidelity when analyzing samples with 
large excesses of DNA contaminants.  
 
More recently, several enzyme based approaches have been developed to 
improve SNP detection and discrimination. For example, nicking 
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endonucleases,17 and restriction enzymes2 have been used to discriminate 
SNPs from perfect-match target via the specific enzyme restriction sites. 
Nevertheless, these approaches are only suitable for detection of SNPs 
containing the enzyme recognition sequences, limiting their application scope. 
Whereas enzymes, such as S1 nuclease, endonuclease (I, III and IV) and λ 
exonuclease, are suitable for all DNA sequences with delicate designs, and 
therefore can be used as a general method for SPM/-SNP detection. However, 
the poor SNP discriminating ability of these enzymes means they have to be 
combined with other more specific enzymes to achieve the desired SNP 
discrimination, such as the combined use of endonuclease IV and λ 
exonuclease in a recent SNP detection system.18 DNA Polymerase, widely used 
in PCR for DNA target amplification, possesses high specificity and is also 
suitable for SNP detection.16, 19  
 
On the other hand, the ligation reaction based on Taq DNA ligase is general, 
and can be applied to any target of interest. Moreover, it has high selectivity in 
ligating two nicked DNA strands hybridised to a full-complementary DNA 
template over those having a single-base mismatch at the nicking site. It is 
therefore well-suited for sensitive SNP and point-mutation detections.20-21 
Indeed, a few sensitive, specific assays that may be suitable for genotyping and 
point-mutation detection have been realized with ligase-based approaches,22-27 
such as the combination of the ligation chain reaction (LCR) and conjugate 
polymer based FRET,22 and GNP based colorimetric assay23 for sensitive SNP 
detection. The ligation reaction has also been combined with other signal 
amplification strategies, e.g. RCA,24-26 and polymerase mediated target 
displacement,27 to further enhance sensitivity. Despite these, the development 
of simple, sensitive diagnostic assays suitable for rapid detection of SNPs and 
point mutations associated with specific diseases remains a challenge. Herein, 
a novel, general and highly sensitive approach for specific, label-free detection 
of SNPs is developed using the KRAS somatic mutations (codons 12/13) that 
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are widely found in several human cancers (e.g. colorectal, pancreas, ductal 
and lung) as the model cancer DNA targets. This sensor can detect as little as 
30 amol of unlabelled DNA targets, and can offer high discrimination, up to > 
380 fold after background correction, between the full-match and the SNP 
targets. It can quantitate the KRAS cancer SNP mutant in large excesses of 
coexisting wild-type DNA target down to 0.75% level (e.g. < 1% of the DNA 
targets being the SNP cancer mutant). 
 
5.2 Design principle 
 
Figure 5.1 shows this approach schematically. Two short ssDNA probes, each 
complementary to one half of the DNA target, are designed. The two probes are 
modified with a 5’-biotin (blue, for signal amplification) and 5’-phosphate (green, 
for magnetic capture of ligated product, see later), respectively. First, the two 
probes are hybridised to a ssDNA target, forming a nicked dsDNA at annealing 
temperature (45 °C). The two probes hybridised to a full-complementary DNA 
target are subsequently ligated by the Taq DNA ligase at 45 °C, producing a 
covalently ligated DNA product with a terminal biotin (the ligated product). 
Whereas a single-base mismatch in the probes/SNP target duplex at the nick 
site can prevent such ligation, so the two probes remain unlinked. Upon heating 
to denaturation temperature (95 °C), the DNA targets are dehybridised 
(released) from the ligated products (or un-ligated probes), which are 
subsequently used to template the ligation of a 2nd pair of biotin-/phosphate- 
probes as temperature is reduced to 45 °C. In this way, the DNA target is 
recycled, and hence this process is named as target-recycled ligation (TRL). 
Excess biotin-/phosphate- probes over the target DNA are used to minimize the 
re-hybridisation of the target to the ligated products. Repeating the denaturation, 
annealing and ligation process thus recycles the DNA target, producing a 
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ligated product during each cycle, leading to accumulation of the ligated 
products as the number of thermal cycles is increased. 
 
 
Figure 5.1 Schematic illustration of this strategy to specific SNP DNA detection.  
A biotin-probe (blue) and a phosphate-probe (green) are hybridized to 
each half of a complementary DNA target, which are then ligated by the 
Taq DNA ligase if the sequences between the probes and target are fully 
complementary, but not for those having a single-base mismatch (ca. SNP) 
at the nicking site. The system is then subjected to multiple cycles of 
denaturation, annealing and ligation, where each full-match template 
produces a ligated product in each cycle. A capture-DNA modified MNP 
(note hundreds of capture-DNA strands are linked to each MNP, only one 
is shown here for simplicity) is added to capture the ligated products, and 
followed by magnetic separation. Finally, a NAV conjugated HRP (NAV-
HRP) is bound to the MNP, allowing for sensitive detection of the full-
match DNA target via the HRP catalysed enzymatic assay. (Reprinted by 
permission of the Royal Society Chemistry)28 
 
After 5-30 thermal cycles, a capture-DNA (with sequence complementary to the 
phosphate-probe section and in large excess) modified MNP (Cap-MNP) is then 
added to capture the free ligated products via hybridization. For ligated products 
pre-hybridised to the DNA targets, the capture-DNAs may displace the DNA 
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targets via a toehold mediated strand displacement. A large excess of the Cap-
MNP over the target DNA is used here (>100 fold) to ensure efficient target 
capture and strand-displacement. After that, a magnetic separation followed by 
several rounds of washing is applied to separate the MNP-captured ligated 
products from unbound free species. The MNPs (with the captured products) 
are subsequently treated with a NAV conjugated HRP (NAV-HRP), converting 
each captured DNA product (with a terminal biotin) into an HRP enzyme via the 
strong, biospecific biotin-NAV interaction.29-30 This allows for sensitive detection 
of the ligated product (from the templated ligation by the full-match DNA target) 
via the efficient HRP catalysed conversion of a non-fluorescent substrate, 
amplex red, into a strongly fluorescent product, resorufin,29, 31 for the real-time 
fluorescence monitoring on a conventional 96 well fluorescence plate reader. 
An advantage here is general applicability: it can target any DNA of interest by 
simply changing the sequences of the phosphate-/biotin- probe pair. In practice, 
a common phosphate-probe and a specific biotin-probe (P2 or P3) are 
employed to detect each of the two KRAS mutants (T2 or T3, see Table 5.1) 
that are associated with the human colorectal cancer. 
 
The stringent matching requirement of the Taq DNA ligase for ligating the two 
probes at the nick site20-21 enables this approach to be highly specific for the 
perfect-match over the SNP target(s). To separate the ligated products from 
other species after ligation, gel electrophoresis is commonly used, but it has 
poor sensitivity, often at µM level.32 Alternative approaches using a solid 
support to capture and separate the ligated products can suffer from low 
hybridization efficiency and slow kinetics, limiting their sensitivity.33 MNPs are 
highly attractive here because of their tiny particle sizes and super-
paramagnetic properties, allowing the formation of a stable, uniform dispersion 
in the media for rapid, homogeneous target capture without an applied magnetic 
field, while still being readily retrievable upon applying an external magnetic 
field.25, 27, 34-36 Here, the Cap-MNP is employed to capture the ligated products 
- 160 - 
 
via strand displacement, where a ssDNA hybridises to a short complementary 
toehold first, leading to progressive displacement of the pre-hybridised 
strands.37 Its kinetics can be regulated by tuning the length of toeholds. Strand 
displacement is widely used in designing DNA nanomachines38, logic circuits39, 
hybridization chain reaction40, DNA-templated synthesis,41 as well as DNA 
detection and point-mutation discrimination,42-45 but is rarely used for DNA 
capture and separation. In this design, a large excess of the Cap-MNPs (100-
100,000 fold excess over the full-match target) are used here to hybridise to the 
overhang toeholds in phosphate-probe/ligated product(s) and to displace pre-
hybridised target strands. More-over, the capture and displacement efficiency 
also benefits from the enhanced affinity of the Cap-MNPs for the ligated 
products via polyvalent binding similar to those observed for multivalent DNA- 
GNP conjugates: where 2 orders of magnitude higher binding affinity for the 
same DNA target has been reported for multivalent DNA-GNP conjugates over 
the corresponding doubled-stranded DNA in solution.46-47 
 
5.3 Experimental section 
 
5.3.1 Materials and reagents 
 
Taq DNA ligase and 10 × ligation buffer (200 mM Tris-HCl, 250 mM potassium 
acetate, 100 mM magnesium acetate, 10 mM NAD, 100 mM dithiothreitol and 
1.0 % Triton X-100, pH 7.6) were purchased from New England Biolabs (UK). 
All DNA probes and target strands were purchased commercially from the IBA 
GmbH (Germany). They were all HPLC purified by the supplier and their 
sequences are summarised in Table 5.1.  
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Table 5.1 The DNA sequences and their abbreviations used in this study. 
(Reprinted by permission of the Royal Society Chemistry)28 
DNA code DNA Sequences 
Phosphate-probe PO4--5’-T GGC GTA GGC AAG AGT ACG ACA-3’ 
Biotin-probe 1 (P1) Biotin-5’-TTT TTT GTG GTA GTT GGA GCT GG-3’ 
Biotin-probe 2 (P2) Biotin-5’-TTT TTT GTG GTA GTT GGA GCT GA-3’ 
Biotin-probe 3 (P3) Biotin-5’-TTT TTT GTG GTA GTT GGA GCT GT-3’ 
Biotin-probe 4 (P4) Biotin-5’-TTT TTT GTG GTA GTT GGA GCT GC-3’ 
Wild-type target (T1) 
3’-CAC CAT CAA CCT CGA CCA CCG CAT CCG 
TTC TCA-5’ 
Mutant target 2 (T2) 
3’-CAC CAT CAA CCT CGA CTA CCG CAT CCG 
TTC TCA-5’ 
Mutant target 3 (T3) 
3’-CAC CAT CAA CCT CGA CAA CCG CAT CCG 
TTC TCA-5’ 
Mutant target 4 (T4) 
3’-CAC CAT CAA CCT CGA CGA CCG CAT CCG 
TTC TCA-5’ 
Capture DNA 
3’-A CCG CAT CCG TTC TCA TGC TGT TTT TTT 
TTT-5’-C6SH 
 
HRP-NAV and amplex red were purchased from Thermo Scientific (UK) and 
Invitrogen Life Technologies (UK), respectively. All other chemicals and 
reagents were purchased from Sigma-Aldrich (UK) and used without further 
purification unless otherwise stated. PBS buffer (137 mM NaCl, 10 mM 
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Na2HPO4, 2.7 mM KCl, 1.8 mM KH2PO4, pH 7.4) was made with ultra-pure 
MilliQ water (resistance > 18 MΩ.cm-1). The MNPs were in house synthesized 
and modified as described in chapter 4. 
 
5.3.2 Experimental methods 
 
Typically, TRL reaction was performed in 50 µL 1 × ligation buffer containing the 
Taq DNA ligase (25 units), biotin-probe and phosphate-probe (1 pmol each), 
and the various concentrations of mutant or/and wild-type DNA targets. Certain 
thermal cycles were carried out, with each cycle consisting of a 2 min 
denaturation at 95 °C and 5 min annealing/ligation. After the final cycle, the Taq 
ligase was inactivated by addition of EDTA (8 µL, 50 mM).  
 
Subsequently, the capture DNA modified MNPs (Cap-MNP, 20 µg, loaded with 
~10 pmol of the capture DNA) were added to initiate strand displacement and 
ligated product capture at room temperature overnight, although incubation for 1 
hour was found just as effective as for overnight. After magnetic separation, the 
MNPs with bound ligated products were dispersed in 200 µL PBS 7.4 buffer 
(containing 1 mg/mL BSA) and incubated with HRP-NAV (1 pmol) for 0.5 h. The 
MNPs were then magnetically separated (assisted with a brief ~30 s 
centrifugation) and then washed once with PBS 7.4 buffer, twice with PBS 7.4 
buffer containing 0.1% Tween-20 and once more with PBS 7.4 buffer.  
 
The MNPs (with bound enzymes) were subsequently transferred to a 96 well 
plate for high throughput screening where different sensing conditions were 
evaluated simultaneously. The enzymatic assay was triggered by the addition of 
amplex red and H2O2 (2 µM each, final concentration) in PBS 7.4 buffer (200 µL 
final assay volume), and real-time fluorescence changes were monitored on an 
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Envision plate reader using BODIPY TMR FP 531 as excitation filter and Cy3 
595 as emission filter. 
 
5.4 Detection of perfectly matched target 
 
This approach is first used to detect one of the KRAS cancer mutants T2 (25 
fmol) as the perfect-match target using the biotin-probe 2 (P2) and phosphate-
probe (1 pmol each). Taq DNA ligase was used to ligate the two probes 
templated by T2 (25 fmol). 30 thermal cycles were carried out, with each cycle 
consisting of a 2 min denaturation at 95 °C and 5 min annealing/ligation at 
45 °C. After the final cycle, the Taq ligase was inactivated followed by addition 
of the Cap-MNPs to initiate strand displacement and ligated product capture at 
room temperature overnight. After magnetic separation, the produced MNPs 
conjugates were incubated with HRP-NAV (1 pmol) for 0.5 h. Then after 
magnetic separation and washing process, the MNPs were subsequently 
transferred to a 96 well plate. The enzymatic assay was triggered by the 
addition of amplex red and H2O2 and real-time fluorescence changes were 
monitored on an Envision plate reader. Besides, a set of control experiments 
were implemented for comparison. 
 
Figure 5.2 reveals that the rate of fluorescence increase for the sample 
containing both the T2 and ligase (e) is much greater than that of the controls 
either containing no ligase (d, 79(±12) fold) or T2 (C, 87(±13) fold). This result 
clearly demonstrates that the fluorescence response observed herein is due to 
the T2 templated ligation only, with almost no contribution from non-specific 
adsorption of the NAV-HRP. The negligible false positive for controls without 
either the ligase or T2 (c or d) confirms the success and excellent specificity of 
this approach for target DNA detection. 
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 c: MNP-Cap+ligase; no T2































Figure 5.2 (A) Real time fluorescence response and (B) rate of Fluorescence 
increase for different samples.  
All samples are subjected to identical thermal cycle treatments and contain 
the same amount of amplex red (2 µM) and H2O2 (2 µM). The samples are: 
(a) PBS, (b) cDNA-MNP in PBS, (c) cDNA-MNP + ligase but no T2; (d) 
cDNA-MNP + T2 but no Taq ligase; and (e) cDNA-MNP + T2 + Taq DNA 
ligase. (Reprinted by permission of the Royal Society Chemistry)28 
 
Prior to using the approach to quantitate target DNA, the effect of the number of 
thermal cycles on the specific DNA signal has been examined. Biotin-probe4 
(P4) and phosphate-probe (1 pmol each) were used to detect 100 fmol fully-
matched mutant DNA target (T4). The TRL was subjected for specific thermal 
cycles (0 - 30 cycles), with each cycle consisting of a 2 min denaturation at 
95 °C and 5 min annealing/ligation at 45 °C. The experimental procedures 
otherwise were the same as described above. 
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Figure 5.3 Effect of thermal cycle number on the rate of fluorescence increase. 
(A) Real time-dependent fluorescence responses for samples subjected to 
different thermal cycles (cycle numbers are indicated on each curve). (B) 
The corresponding correlation between fluorescence increasing rate and 
thermal cycle numbers. The initial part of the plot is fitted to a linear 
function. (Reprinted by permission of the Royal Society Chemistry)28 
 
As shown in Figure 5.3, the signal increases linearly during the first 5 cycles 
(indicating linear amplification), but the rate of increase gradually levels off as 
more thermal cycles are used (due to depletion of the DNA probes, a 10 fold 
DNA probes to target DNA ratio is used here). Nevertheless, the assay with 30 
thermal cycles gives the highest signal, being 8.6 times that without thermal 
cycle, confirming the success of the TRL for signal amplification. 30 thermal 
cycles are therefore used in all assays to enhance signals unless otherwise 
noted. 
 
Quantification of target T2 (0 - 25 fmol) was carried out by using perfect 
matched biotin probe2 (P2) and phosphate probe (1 pmol each). 30 thermal 
cycles with each cycle consisting of a 2 min denaturation at 95 °C and 5 min 
annealing/ligation at 45 °C were carried out. The experimental procedures 
otherwise are the same as described above. 
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Figure 5.4 Full complementary DNA target quantification.  
(A) Real time-dependent fluorescence responses for samples containing 
different amounts (0-25 fmol, the amounts are indicated on each curve) of 
the full-match DNA target, T2. (B) The corresponding correlation between 
the rate of fluorescence increase and amounts of the T2 target, fitted to a 
linear function (y = 368.8 + 65.2*x, R2 = 0.9997). Inset: amplified region 
over 0 -1200 amol T2 range. (Reprinted by permission of the Royal 
Society Chemistry)28 
 
Figure 5.4A shows the time-dependent evolution of fluorescence intensity at 
different amounts of the perfect-match target, T2, which clearly show that the 
rate of resorufin production increases with the increasing amount of the target 
DNA. The relationship between target DNA amount and the rate of fluorescence 
increase is found to be highly linear over the 0 - 25 fmol range (R2 = 0.9997), 
suggesting that this approach can offer excellent target DNA quantitation 
accuracy. The LOD based on 3σ/slope is estimated as 30 amol (600 fM in 50 
µL).48 The LOD here is comparable to or better than several recently reported 
sensitive DNA assays (Table 5.3). This high sensitivity is attributed to the great 
signal amplification power of the enzyme (where each NAV-HRP can turnover 
several hundred thousand non-fluorescent amplex red substrates into strongly 
fluorescent resorufin products over a 30 min assay period), 29 efficient target 
capture and magnetic separation, and the careful optimisation of the Cap-MNP 
probe which leads to negligible nonspecific adsorption of the enzyme, and 
hence greatly reduced background. In addition, the magnetic capture and 
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separation process was also carefully arranged (see experimental section 5.3.2): 
the Cap-MNP was added after the thermal cycles to avoid the aggregation of 
the MNPs at high temperatures. I found MNP aggregation can lead to 
decreased target capture efficiency and significantly increased background. 
 
5.5 Mimicking DNA melting assay 
 
The melting temperature (Tm) of nucleic acids is the temperature at which half of 
dsDNAs are dehybridised into ssDNA structures. The melting is typically 
considered as dissociation of the two strands in a dsDNA into two single 
stranded states, where intermediate states are often ignored.9 In this approach, 
a pair of the biotin-/ phosphate- probes are first hybridised to target DNA 
(mutant or wild-type), forming a probes/target duplex with a nick site, which are 
then ligated by the ligase to form a covalently linked product. At high annealing 
temperatures, few probes can form stable sandwiches with the target DNA, 
leading to a decrease of the ligated products. Therefore the ligation efficiency 
(enzymatic activity after NAV-HRP binding) is a useful indication of the 
probes/target sandwich formation, which may be controlled by the 
annealing/ligation temperature. 
 
The effect of annealing temperature on the detection of the full-match target T2 
(100 fmol) using the phosphate-/biotin-probe 2 (1 pmol) was tested. In this 
mimicking DNA melting assay, the experimental procedures were similar to 
those described above, except only 5 thermal cycles were used. Each cycle 
included a 2 min denaturation at 95 °C and a 5 min annealing/ligation at specific 
temperatures shown in Figure 5.5. 
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Figure 5.5 Relationship between the rate of fluorescence increase and ligation 
temperatures.  
According to the fitted melting curves, Tms were calculated and are 
indicated by blue solid lines crossing blue diamonds. (Reprinted by 
permission of the Royal Society Chemistry)28 
 
The signal obtained from the SNP target only (e.g. 100 fmol T1) was found 
indistinguishable from the background (no target), due to the high specificity of 
this assay. Therefore two samples with the identical amount of total DNA (100 
fmol), one containing the T2 only and the other being a T2/T1 mixture (molar 
ratio = 1/9), were studied and the results were shown in Figure 5.5. 
 
The relationship between the annealing temperature and the fluorescence 
change rate (which is positively correlated to the amount of ligated products) 
closely resembles a typical DNA melting assay (see Figure 5.5). At low 
annealing/ligation temperatures (e.g. 45 - 55 °C), the fluorescence signal was 
constant, suggesting the probes/target sandwich was stable over this 
temperature range and hence efficiently ligated. As the temperature was 
increased further, the signal decreased sharply, implying the dissociation of the 
probes/target sandwich under such elevated temperatures. The data can be 
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fitted by a sigmoidal function to extract the mimicked Tm of each DNA sample.8-9, 
49  
yS	 = TUV∗XPYX	          (5.1) 
The fluorescence increase rate versus ligation temperature can be fitted well by 
the above equation (with R2 = 0.99 and 0.91), yielding Tm values of 62.6 and 
61.1 °C for the pure T2 and 1:9 molar mixed T2:T1 targets, respectively (Figure 
5.5). The presence of 9-fold excess of the SNP target T1 led to ~1.5 °C 
decrease of the effective Tm. This is not unexpected because a fixed amount of 
total DNA (T1 + T2) was used, so the T2 concentration in the later was only 10% 
that of the former (T1 could not contribute to positive ligation, see the previous 
paragraph). The maximum fluorescence response for the (T1 + T2) mixture was 
~15% that of the pure T2 sample, which is likely due to competition of T1 in 
forming unligatable probes/T1 duplex, reducing the chances of forming ligatable 
probes/T2 duplex.  
 
Recently, a colorimetric detection of low abundance mutants with excellent 
specificity has been reported by Zu et al. using the sharp melting behaviour of 
nanoparticle-immobilised target DNAs.50 However, this assay required stringent 
temperature adjustment according to specific target sequences and mutant 
concentration. In addition, it only gave nM levels of absolute sensitivity. The 
approach here, having fM sensitivity together with excellent SNP discrimination 
ability via both the inferred Tm and fluorescence response, appears to be well-
suited for accurate SNP and point-mutation detection. 
 
5.6 SNP discrimination 
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5.6.1 Detection of SNPs 
 
I further evaluated the potential of this approach in specific detection of the 
SNPs in the KRAS gene that are associated with many human cancers (e.g. 
colorectal, pancreas, ductal and lung). 
 
In this regard, four DNA targets (100 fmol each) are used in these experiments: 
the wild-type T1 (counting from 5’, base 17=C), two cancer mutants: T2 
(17C→T), T3 (17C→A), and T4 (17C→ G, a cancer irrelevant mutation but is 
used here to demonstrate the general applicability of this sensor), which can be 
detected by their full-match biotin-probes, P1, P2, P3, and P4, respectively. 30 
thermal cycles with each cycle consisting of a 2 min denaturation at 95 °C and 5 
min annealing/ligation at 45 °C were carried out. The experimental procedures 
otherwise are the same as described in 5.3.2. 
 
Typical time-dependent assay fluorescence responses using P2 to detect such 
DNA targets were shown in Figure 5.6A. The full-match P2/T2 clearly exhibited 
much greater fluorescence signal than those containing a single-base mismatch, 
i.e. this sensor is highly specific. In fact, this high level of full-match target 
specificity was achieved throughout the whole probe/target combinations: 
greatly increased signals were only observed for the full-match probe/target 
combinations (e.g. P1/T1; P2/T2; P3/T3 or P4/T4), but not for those containing 
a single mismatch (e.g. P1/T2-T4; P2/T1, P2/T3-T4; P3/T1-T2, P3/T4 or P4/T1-
T3, see Figure 5.6B).  
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Figure 5.6 Specificity of the sensor in discriminating the full-match against other 
single-base mismatch DNA targets.  
(A) Typical time-dependent fluorescence assay curves of using the P2 
(perfect-match to T2) to detect other different SNP targets. (B) 
Comparison of the average fluorescence increase rates (slopes of 
fluorescence response curves as shown in Figure 5.6A) for different 
target/probe combinations (n = 3). (Reprinted by permission of the Royal 
Society Chemistry)28 
 
Figure 5.6 revealed that the fluorescence signals of the latter were typically 
comparable to blank controls, ranging from 0.81 ± 0.09% (for P2/T4) to 4.6±1.0% 
(P4/T2) that of their respective full-match samples before background correction 
(BC, except for P3/T1 or P4/T3, which was 8.3 ± 0.9% or 19 ± 4.0% that of the 
P3/T3 or P4/T4 signal, respectively). The detailed discrimination ratios (DRs) 
between the full-match Pn/Tn (n = 1 - 4) samples over their corresponding 
single-base mismatch Pn/Tm (n ≠ m; n/m = 1 - 4) samples are summarised in 
Table 5.2. Impressive SNP DRs of up to 121(± 14) fold before background 
correction (P2/T2 over P2/T4) were obtained, which further increased to up to 
383(± 45) fold after BC. This level of SNP discrimination ratio is among the 
highest reported in the literature (see Table 5.3).  
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Table 5.2 The discrimination ratios (DRs) of specific biotin-probes for their 
respective full-match over other SNP DNA targets.  
The data shown in the brackets are after background correction, error bars are 
the standard deviations of 3 parallel samples. DR is defined as signal ratio of 
the full-match target, Pn/Tn, over their respective SNP targets, Pn/Tm (where n 
≠ m). (Reprinted by permission of the Royal Society Chemistry)28 
Target (base 
17)\Probe 
P1 (G) P2 (A) P3 (T) P4 (C) 
T1 (C) 1 (1) 
35 ± 4.1 
(43 ± 5.1) 
12 ± 0.4 
 (13 ± 0.4) 
91 ± 6.2 
(298 ± 20) 
T2 (T) 
53 ± 15 
(70 ± 20) 
1 (1) 
30 ± 1.1 
 (36 ± 1.2) 
21 ± 1.4  
(25 ± 1.7) 
T3 (A) 
57 ± 16  
(78 ± 22) 
76 ± 8.9  
(133 ± 16) 
1(1) 
5.2 ± 0.4  
(5.4 ± 0.4) 
T4 (G) 
96 ± 27 
 (176 ± 50) 
121 ± 14 
(383 ± 45) 
27 ± 1.0  
(32 ± 1.1) 
1(1) 
Blank 212 ± 60 (  ̶  ) 175 ± 21 (  ̶  ) 
162 ± 5.8 
(  ̶  ) 
130 ± 9 (   ̶ ) 
 
Moreover, two DNA targets T1 and T2 at low concentration (5 fmol each) were 
discriminated by using biotin probe P2 and phosphate probe (1 pmol each) 
subjected to 5 thermal cycles (each cycle contains a 2 min denaturation at 
95 °C and 5 min annealing/ligation at 45 °C). The experimental procedures 
otherwise are the same as described in 5.3.2.). This experiment shows that 
even at relatively low target abundance (e.g. 5 fmol), this approach could offer a 
- 173 - 
 
SNP discrimination ratio of > 3 fold before background correction, increasing to 
13.5 fold after BC (see Figure 5.7).  
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Figure 5.7 Discrimination between the full-match (T2) and single mismatch 
target (wild-type T1) at low target abundance (5 fmol).  
Five thermal cycles with an annealing temperature of 45 °C were used. (A) 
Time-dependent fluorescence intensity change for the blank control 
(black), SNP target T1 (red) and perfect-match target T2 (green). (B) The 
corresponding fluorescence rate changes of the three samples. The 
discrimination ratio between the full-match T2 and the SNP target T1 was 
determined as ~3.03 fold before background correction, which was 
increased to ~13.5 fold after background correction (e.g. Blank control 
background signal was subtracted from the T2 and T1 signals). (Reprinted 
by permission of the Royal Society Chemistry)28 
 
All these results confirm the excellent specificity of this approach in SNP 
detection. It is also noteworthy that all of the perfect-match Pn/Tn samples here 
gave > 130 fold greater absolute signals over their respective blank controls, 
which is considerably higher than most other ultra-sensitive DNA sensors 
reported recently (see Table 5.3 for details). For biosensing, a high absolute 
signal-to-background ratio (S/B) is highly advantageous because not only can 
this increase the accuracy of target quantification, but it can also simplify the 
data analysis by eliminating any requirement of background correction.  
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Table 5.3 Comparison of the sensing performances of several recently reported, 
sensitive SNP assays. (Reprinted by permission of the Royal Society 
Chemistry)28 
*LOD = limit of detection, where for the full-match DNA/RNA target, this value is 
given in total DNA amount and/or concentration; BC = background correction; 
SNP DR: discrimination ratio between full-match and SNP target; S/B: absolute 
signal-to-blank background ratio. 
¶ The 0.5% LOD for rare allele here referred to the SNP over 1,3-double 
mismatch target, not the full-match target. 
Sensing Method 









Target-recycled ligation + 







212 0.75% This work 
Taq DNA Polymerase + 
conjugated polymer FRET ? ~8 ~8 2% 4 
Multi-colour molecular 
beacons + GNP ~500 pM ~2.5-10 
~5.2-
30 ? 11 
Molecular beacon probe + 
enzymatic amplification 
1000 pM 
(RNA) ~7 ~10 10% 13 
Pyrene excimer probes + 
hybridization chain 
reaction 
0.26 pM ~10 ~32 ? 14 
Endonuclease IV + 
lambda exonuclease  1 fmol ~2.2-3 ~6 0.5%
¶ 18 
LCR + exonuclease + 
conjugated polymer FRET 1 fM ~3 ~6 1% 22 
LCR + gold nanoparticle 20 aM ? ? ~0.1% 23 
Nanoparticles+ ligation + 
silver amplification ~1 pM ~20-30 ~29 ? 33 
Ligation mediated strand 
displacement + DNAzyme 
signal amplification 
0.1 fM 106 108 ? 42 
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5.6.2 Quantification of rare DNA allele frequency 
 
The high sensitivity and excellent SNP detection specificity make this assay 
well-suited for quantification of low abundance alleles. To evaluate this potential, 
a series of samples containing different amounts of the cancer mutant T2 (e.g. 
0-50 fmol) mixed with large excess of the wild-type T1 (fixed at 500 fmol) were 
detected using the biotin probe P2. 30 thermal cycles with each cycle consisting 
of a 2 min denaturation at 95 °C and 5 min annealing/ligation at 45 °C were 
implemented. The experimental procedures otherwise are the same as 
described in 5.3.2. The results are shown in Figure 5.8. 
 



































Figure 5.8 Quantification of the DNA target T2 (KRAS cancer mutant) in the 
presence of a large excess the wild type SNP target T1.  
(A) Time-dependent fluorescence responses of samples with different 
ratios of T2 to T1, with fixed amount of T1 (500 fmol). (B) Relationship 
between the logarithmic rate of increase of fluorescence increase rate and 
the allele frequency, the data were fitted to a linear function (R2 = 0.98). 
(Reprinted by permission of the Royal Society Chemistry)28 
 
Figure 5.8A revealed that the rate of fluorescence increase initially showed a 
gradual increase with the increasing T2/T1 (full-match /SNP) ratio over 0-5%. 
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As the T2/T1 ratio was further increased, the rate of fluorescence response was 
greatly enhanced: the signal for the 10% T2/T1 sample was a massive 345 fold 
higher than that for the 0% T2/T1 sample. Moreover, the log (fluorescence 
increase rate) was found to increase roughly linearly (R2 = 0.98) with the 
increasing T2/T1 ratio (Figure 5.8B), where an allele frequency down to as low 
as 1% was clearly detectable. The estimated theoretical LOD of the allele 
frequency was 0.75% based on 3σ/slope.48 Therefore, quantification of the low 
abundant KRAS 12 cancer specific SNP mutant (T2) can be realized in even > 
100-fold excesses of the wild-type target T1. This result is comparable to or 
better than most other recently reported, sensitive SNP detection techniques 
(see Table 5.3 for details). Furthermore, the LOD for a low level SNP cancer 
mutant in a large excess of coexisting wild-type target here is also comparable 
to the high resolution melting or gene sequencing technique (LOD: 0.1 - 1%) 
developed in the Makrigiorgos group, one of the most sensitive SNP detection 
techniques.51-52 Therefore, this approach appears to be well-placed for sensitive 
detection of rare point mutations associated with important human diseases (e.g. 





In summary, this chapter has demonstrated a highly sensitive, specific DNA 
detection approach which combines TRL, strand displacement, MNP mediated 
target capture/separation, efficient enzymatic signal amplification, and the high 
efficiency and SNP discrimination ability of the Taq DNA ligase. This approach 
can quantitate amol levels of unlabelled target DNA with excellent discrimination 
ratio, up to 121 fold before background correction (increasing to >380 fold after 
background correction), between the full-match and SNP target. It can 
quantitate trace amounts of single point cancer mutants in large excesses of 
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wild-type targets with an LOD down to 0.75%. This assay can also mimic DNA 
melting behaviours, making SNP detection highly reliable. Moreover, it is also 
general, and can be readily extended to other DNA targets of interest by simply 
changing the biotin-probes used (e.g. P1 for T1, P2 for T2; P3 for T3; P4 for T4 
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Chapter 6 
Overall conclusions and future directions 
 
6.1 overall conclusions and future directions 
 
This thesis includes two parts: Part I is based on the FRET studies between 
small-molecule ligands capped QD and his-tag appended FPs; Part II is the 
development of a sensitive and selective DNA sensing platform by combining 
magnetic capture/separation and enzymatic signal amplifcation. 
 
The FRET between a CdSe/ZnS core/shell QD capped with three different 
small-molecule ligands (MPA, GSH, DHLA) and a His6-tagged FP (mCherry) 
has been studied. The Förster radius (R0) and corresponding donor-acceptor 
distances (r) for each of the QD-FP FRET systems were evaluated by using the 
Förster dipole-dipole interaction formula. Interestingly, both the FRET efficiency 
(E) and r were found to be strongly dependent on the capping small-molecule 
ligands on the QD surface. Two kinds of molecular models were proposed to 
explain the possible reasons behind these observations. The dissociation 
constants (Kds) and kinetics of the self-assembled QD-FP systems were also 
evaluated. Results demonstrate that the QD-FP self-assembly interaction is fast 
and strong, which can complete in minutes at low nM concentration, suggesting 
that the QD-His6-tagged biomolecule self-assembly is an effective strategy for 
prepare compact QD-bioconjugates which may have a wide range of sensing 
and biomedical applications. 
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The QD-His-tag self-assembly process can be extended to other systems for 
biosensing, imaging etc. Future efforts could focus on the investigation of the 
affinities between proteins and their specific recognizing molecules such as 
sugars, aptamers, and antigens based on FRET studies at SM levels. Moreover, 
the development of biosensors (DNA sensors, aptasensors, and antigen 
sensors) for ultrasensitive and specific disease diagnostics based on single 
molecule fluorescence is also a promising topic, because SM fluorescence 
possesses unique capabilities of detecting static conformational heterogeneity 
and dynamic conformational changes of single biological molecules that are not 
detectable at the bulk level both in solution and immobilized to surfaces.1-3  
 
Moreover, a facile, rapid, and sensitive DNA sensor has been developed by 
combining the efficient MNP-based target capture and magnetic separation 
together with the highly efficient signal amplification power of enzymes to 
achieve ultra-sensitivity. This sensor shows similar sensing ability in both pure 
buffer and complex media (such as 10% human serum in buffer) and 
demonstrates excellent linear correlations between signals and target 
concentrations. Moreover, this developed strategy is able to quantitate two 
distinct DNA strands in a homogenous phase simultaneously with a detection 
limit of ~5 pM. Therefore, the MNP-enzyme sandwich sensor is anticipated to 
have excellent potential for a wide range of DNA based multiplexed biosensing 
and diagnostic applications. 
 
In future work, the sensing platform developed here will be extended to detect 
low-abundant disease biomarkers (such as specific cells, small molecules, 
enzymes, antigens or hormones) using specific nucleic acid aptamers. 4-5 
Moreover, the use of sensitive DNA amplification strategies (e.g. nanoparticle 
barcode assay6, RCA7) could be introduced for greater sensitivities. The 
advantages of using nucleic acid aptamers such as high chemical/thermal 
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stability, cheap production via completely in vitro processes without using 
animals, no batch-to-batch variation, and ease of site-specific incorporation of 
bespoke labels and functional groups, make the MP-aptamer biosensors 
extremely attractive and powerful in broad biosensing and biodiagnostic 
applications.  
 
In addition, a novel, highly sensitive and selective approach for label-free DNA 
detection and SNP discrimination has been developed by combining TRL, MNP 
assisted target capture/ separation, and efficient enzymatic amplification.  
 
This approach shows a detection limit of 600 fM for unlabelled single-stranded 
DNA targets detection. The SNP discrimination ratio between a perfect-match 
cancer specific mutant and its single-base mismatch (wild-type) DNA target 
achieved by this approach (up to 380 fold with background correction) is among 
the highest reported in the literature. In addition, this assay consistently yields a 
high signal to background (S/B) ratio of >100, which can effectively eliminate 
the need for background correction and is advantageous for accurate target 
quantitation. More importantly, it can quantitate a rare cancer mutant (KRAS 
codon 12) in large excess of coexisting wild-type DNAs down to 0.75%. This 
sensor offers one of the best SNP discrimination and S/B ratios among recently 
reported sensitive DNA sensors. As a result, this sensor appears to be well-
suited for sensitive SNP detection and a wide range of DNA mutation based 
diagnostic applications. 
 
Although this assay has demonstrated excellent sensitivities in detecting cancer 
specific SNPs (KRAS codon12/13) against the wild type non-cancerous target 
that makes it highly useful for early cancer diagnosis, it still remains at the 
proof-of-principle stage where all the experiments were carried out using 
synthetic DNAs rather than the clinical targets. Moreover, its absolute sensitivity 
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still remains at sub-pM level, and therefore a PCR amplification may still be 
needed for clinical application. Therefore, further efforts should focus on 
developing more specific, effective signal amplification strategies (for instance, 
by introducing LCR8-9 or RCA10-11) to further improve the assay sensitivity and 
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